# EDGAR Filing Document

**Accession Number:** 0001299709
**File Stem:** 0001299709-25-000184
**Filing Date:** 2025-10
**Character Count:** 272847
**Document Hash:** f71ec2751e4ac5b4764001fae18c1c92
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001299709-25-000184.hdr.sgml**: 20251030

**ACCESSION NUMBER**: 0001299709-25-000184

**CONFORMED SUBMISSION TYPE**: 10-Q

**PUBLIC DOCUMENT COUNT**: 99

**CONFORMED PERIOD OF REPORT**: 20250930

**FILED AS OF DATE**: 20251030

**DATE AS OF CHANGE**: 20251030

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Axos Financial, Inc.
- **CENTRAL INDEX KEY:** 0001299709
- **STANDARD INDUSTRIAL CLASSIFICATION:** SAVINGS INSTITUTION, FEDERALLY CHARTERED [6035]
- **ORGANIZATION NAME:** 02 Finance
- **EIN:** 330867444
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 0630

**FILING VALUES:**
- **FORM TYPE:** 10-Q
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-37709
- **FILM NUMBER:** 251435844

**BUSINESS ADDRESS:**
- **STREET 1:** 9205 WEST RUSSELL ROAD
- **STREET 2:** SUITE #400
- **CITY:** LAS VEGAS
- **STATE:** NV
- **ZIP:** 89148
- **BUSINESS PHONE:** (858) 649-2218

**MAIL ADDRESS:**
- **STREET 1:** 9205 WEST RUSSELL ROAD
- **STREET 2:** SUITE #400
- **CITY:** LAS VEGAS
- **STATE:** NV
- **ZIP:** 89148

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** BofI Holding, Inc.
- **DATE OF NAME CHANGE:** 20040805

?xml version='1.0' encoding='ASCII'? ax-20250930

**UNITED STATES**

**SECURITIES AND EXCHANGE COMMISSION**

**WASHINGTON, D.C. 20549**

**FORM 10-Q**

☒ **QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934**

**For the quarterly period ended September 30, 2025**

☐ **TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934**

**Commission file number: 001-37709**![axosfina13.jpg](ax-20250930_g1.jpg)

**AXOS FINANCIAL, INC.**

***(Exact name of registrant as specified in its charter)***

---

| | |
|:---|:---|
| **Delaware** | **33-0867444** |
| ***(State or other jurisdiction of<br>incorporation or organization)*** | ***(I.R.S. Employer<br>Identification No.)*** |

---

**9205 West Russell Road, Suite 400**, **Las Vegas**, **NV 89148** 

***(Address of principal executive offices) (zip code)***

**Registrant's telephone number, including area code: (858) 649-2218** 

---

| | | |
|:---|:---|:---|
| **Securities registered pursuant to Section 12(b) of the Act:** | **Securities registered pursuant to Section 12(b) of the Act:** | **Securities registered pursuant to Section 12(b) of the Act:** |
| **<u>Title of each class</u>** | **<u>Trading Symbol(s)</u>** | **<u>Name of each exchange on which registered</u>** |
| **Common stock, $0.01 par value** | **AX** | **New York Stock Exchange** |

---

__________________________________________________________________________________________

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. ☒ Yes&nbsp;&nbsp;&nbsp;&nbsp;☐ No

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). ☒ Yes&nbsp;&nbsp;&nbsp;&nbsp;☐ No

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of "large accelerated filer," "accelerated filer," "smaller reporting company," and "emerging growth company" in Rule 12b-2 of the Exchange Act.

---

| | | | |
|:---|:---|:---|:---|
| Large accelerated filer | ☒ | Accelerated filer | ☐ |
| Non-accelerated filer | ☐ | Smaller reporting company | ☐ |
| | | Emerging growth company | ☐ |

---

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).&nbsp;&nbsp;&nbsp;&nbsp;☐ Yes&nbsp;&nbsp;&nbsp;&nbsp;☒ No

The number of shares outstanding of the registrant's common stock on the last practicable date: 56,644,002 shares of common stock, $0.01 par value per share, as of October 17, 2025.

------

<u>[**Table of Contents**](#i7c17675c26f44bbd9ee68808b9f08846_7)</u>

**AXOS FINANCIAL, INC.**

**INDEX**

---

| | |
|:---|:---|
| | **Page** |
| **<u>[PART I – FINANCIAL INFORMATION](#i7c17675c26f44bbd9ee68808b9f08846_10)</u>** | <u>[1](#i7c17675c26f44bbd9ee68808b9f08846_10)</u> |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>[ITEM 1. &nbsp;&nbsp;&nbsp;&nbsp; FINANCIAL STATEMENTS](#i7c17675c26f44bbd9ee68808b9f08846_13)</u> | <u>[1](#i7c17675c26f44bbd9ee68808b9f08846_13)</u> |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>[Condensed Consolidated Balance Sheets (unaudited)](#i7c17675c26f44bbd9ee68808b9f08846_16)</u> | <u>[1](#i7c17675c26f44bbd9ee68808b9f08846_16)</u> |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>[Condensed Consolidated Statements of Income (unaudited)](#i7c17675c26f44bbd9ee68808b9f08846_19)</u> | <u>[2](#i7c17675c26f44bbd9ee68808b9f08846_19)</u> |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>[Condensed Consolidated Statements of Comprehensive Income (unaudited)](#i7c17675c26f44bbd9ee68808b9f08846_22)</u> | <u>[3](#i7c17675c26f44bbd9ee68808b9f08846_22)</u> |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>[Condensed Consolidated Statements of Stockholders' Equity (unaudited)](#i7c17675c26f44bbd9ee68808b9f08846_25)</u> | <u>[4](#i7c17675c26f44bbd9ee68808b9f08846_25)</u> |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>[Condensed Consolidated Statements of Cash Flows (unaudited)](#i7c17675c26f44bbd9ee68808b9f08846_28)</u> | <u>[5](#i7c17675c26f44bbd9ee68808b9f08846_28)</u> |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>[Notes to Condensed Consolidated Financial Statements (unaudited)](#i7c17675c26f44bbd9ee68808b9f08846_31)</u> | <u>[6](#i7c17675c26f44bbd9ee68808b9f08846_31)</u> |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>[1. Summary of Significant Accounting Policies](#i7c17675c26f44bbd9ee68808b9f08846_34)</u> | <u>[6](#i7c17675c26f44bbd9ee68808b9f08846_34)</u> |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>[2.](#i7c17675c26f44bbd9ee68808b9f08846_37)[Acquisitions](#i7c17675c26f44bbd9ee68808b9f08846_37)</u> | <u>[8](#i7c17675c26f44bbd9ee68808b9f08846_37)</u> |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>[3. Fair Value](#i7c17675c26f44bbd9ee68808b9f08846_40)</u> | <u>[10](#i7c17675c26f44bbd9ee68808b9f08846_40)</u> |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>[4. Available-for-Sale Securities](#i7c17675c26f44bbd9ee68808b9f08846_43)</u> | <u>[14](#i7c17675c26f44bbd9ee68808b9f08846_43)</u> |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>[5. Loans & Allowance for Credit Losses](#i7c17675c26f44bbd9ee68808b9f08846_46)</u> | <u>[16](#i7c17675c26f44bbd9ee68808b9f08846_46)</u> |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>[6. Derivatives](#i7c17675c26f44bbd9ee68808b9f08846_49)</u> | <u>[21](#i7c17675c26f44bbd9ee68808b9f08846_49)</u> |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>[7. Offsetting of Derivatives and Securities Financing Agreements](#i7c17675c26f44bbd9ee68808b9f08846_52)</u> | <u>[22](#i7c17675c26f44bbd9ee68808b9f08846_52)</u> |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>[8. Stockholders' Equity and Stock-Based Compensation](#i7c17675c26f44bbd9ee68808b9f08846_55)</u> | <u>[23](#i7c17675c26f44bbd9ee68808b9f08846_55)</u> |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>[9. Earnings per Common Share](#i7c17675c26f44bbd9ee68808b9f08846_61)</u> | <u>[24](#i7c17675c26f44bbd9ee68808b9f08846_61)</u> |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>[10. Commitments and Contingencies](#i7c17675c26f44bbd9ee68808b9f08846_64)</u> | <u>[25](#i7c17675c26f44bbd9ee68808b9f08846_64)</u> |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>[11. Segment Reporting and Revenue Information](#i7c17675c26f44bbd9ee68808b9f08846_67)</u> | <u>[26](#i7c17675c26f44bbd9ee68808b9f08846_67)</u> |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>[12. Borrowings, Subordinated Notes and Debentures](#i7c17675c26f44bbd9ee68808b9f08846_70)</u> | <u>[27](#i7c17675c26f44bbd9ee68808b9f08846_70)</u> |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>[13. Other Assets](#i7c17675c26f44bbd9ee68808b9f08846_73)</u> | <u>[28](#i7c17675c26f44bbd9ee68808b9f08846_73)</u> |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>[14. Variable I](#i7c17675c26f44bbd9ee68808b9f08846_1004)[nterest Entities](#i7c17675c26f44bbd9ee68808b9f08846_1004)</u> | <u>[28](#i7c17675c26f44bbd9ee68808b9f08846_1004)</u> |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>[ITEM 2. &nbsp;&nbsp;&nbsp;&nbsp; MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS](#i7c17675c26f44bbd9ee68808b9f08846_76)</u> | <u>[30](#i7c17675c26f44bbd9ee68808b9f08846_76)</u> |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>[USE OF NON-GAAP MEASURES](#i7c17675c26f44bbd9ee68808b9f08846_79)</u> | <u>[32](#i7c17675c26f44bbd9ee68808b9f08846_79)</u> |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>[SELECTED FINANCIAL INFORMATION](#i7c17675c26f44bbd9ee68808b9f08846_82)</u> | <u>[33](#i7c17675c26f44bbd9ee68808b9f08846_82)</u> |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>[RESULTS OF OPERATIONS](#i7c17675c26f44bbd9ee68808b9f08846_85)</u> | <u>[35](#i7c17675c26f44bbd9ee68808b9f08846_85)</u> |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>[SEGMENT RESULTS](#i7c17675c26f44bbd9ee68808b9f08846_88)</u> | <u>[38](#i7c17675c26f44bbd9ee68808b9f08846_88)</u> |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>[FINANCIAL CONDITION](#i7c17675c26f44bbd9ee68808b9f08846_91)</u> | <u>[39](#i7c17675c26f44bbd9ee68808b9f08846_91)</u> |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>[LIQUIDITY](#i7c17675c26f44bbd9ee68808b9f08846_94)</u> | <u>[42](#i7c17675c26f44bbd9ee68808b9f08846_94)</u> |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>[CAPITAL RESOURCES AND REQUIREMENTS](#i7c17675c26f44bbd9ee68808b9f08846_97)</u> | <u>[43](#i7c17675c26f44bbd9ee68808b9f08846_97)</u> |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>[ITEM 3. &nbsp;&nbsp;&nbsp;&nbsp; QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK](#i7c17675c26f44bbd9ee68808b9f08846_100)</u> | <u>[45](#i7c17675c26f44bbd9ee68808b9f08846_100)</u> |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>[ITEM 4. &nbsp;&nbsp;&nbsp;&nbsp; CONTROLS AND PROCEDURES](#i7c17675c26f44bbd9ee68808b9f08846_103)</u> | <u>[47](#i7c17675c26f44bbd9ee68808b9f08846_103)</u> |
| **<u>[PART II – OTHER INFORMATION](#i7c17675c26f44bbd9ee68808b9f08846_106)</u>** | <u>[48](#i7c17675c26f44bbd9ee68808b9f08846_106)</u> |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>[ITEM 1. &nbsp;&nbsp;&nbsp;&nbsp; LEGAL PROCEEDINGS](#i7c17675c26f44bbd9ee68808b9f08846_109)</u> | <u>[48](#i7c17675c26f44bbd9ee68808b9f08846_109)</u> |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>[ITEM 1A. RISK FACTORS](#i7c17675c26f44bbd9ee68808b9f08846_112)</u> | <u>[48](#i7c17675c26f44bbd9ee68808b9f08846_112)</u> |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>[ITEM 2. &nbsp;&nbsp;&nbsp;&nbsp; UNREGISTERED SALES OF EQUITY SECURITIES, USE OF PROCEEDS, AND ISSUER PURCHASES OF EQUITY SECURITIES](#i7c17675c26f44bbd9ee68808b9f08846_115)</u> | <u>[48](#i7c17675c26f44bbd9ee68808b9f08846_115)</u> |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>[ITEM 3. &nbsp;&nbsp;&nbsp;&nbsp; DEFAULTS UPON SENIOR SECURITIES](#i7c17675c26f44bbd9ee68808b9f08846_118)</u> | <u>[48](#i7c17675c26f44bbd9ee68808b9f08846_121)</u> |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>[ITEM 4. &nbsp;&nbsp;&nbsp;&nbsp; MINE SAFETY DISCLOSURES](#i7c17675c26f44bbd9ee68808b9f08846_121)</u> | <u>[48](#i7c17675c26f44bbd9ee68808b9f08846_121)</u> |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>[ITEM 5. &nbsp;&nbsp;&nbsp;&nbsp; OTHER INFORMATION](#i7c17675c26f44bbd9ee68808b9f08846_124)</u> | <u>[48](#i7c17675c26f44bbd9ee68808b9f08846_124)</u> |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>[ITEM 6. &nbsp;&nbsp;&nbsp;&nbsp; EXHIBITS](#i7c17675c26f44bbd9ee68808b9f08846_127)</u> | <u>[49](#i7c17675c26f44bbd9ee68808b9f08846_127)</u> |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>[SIGNATURES](#i7c17675c26f44bbd9ee68808b9f08846_130)</u> | <u>[50](#i7c17675c26f44bbd9ee68808b9f08846_130)</u> |

---

------

<u>[**Table of Contents**](#i7c17675c26f44bbd9ee68808b9f08846_7)</u>

**PART I – FINANCIAL INFORMATION**

**ITEM 1. FINANCIAL STATEMENTS**

**AXOS FINANCIAL, INC.**

**CONDENSED CONSOLIDATED BALANCE SHEETS**

***(Unaudited)***

---

| | | |
|:---|:---|:---|
| ***(Dollars in thousands, except par value)*** | **September 30, <br>2025** | **June 30, <br>2025** |
| **ASSETS** | | |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Cash and cash equivalents | $2560692 | $1933845 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Restricted cash | 324903 | 242509 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total cash, cash equivalents and restricted cash | 2885595 | 2176354 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Trading securities | 533 | 649 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Available-for-sale securities | 57798 | 66008 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Stock of regulatory agencies | 35299 | 35163 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Loans held for sale, carried at fair value | 12202 | 10012 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Loans—net of allowance for credit losses of $307,431 as of September 30, 2025 and $290,049 as of June 30, 2025 | 22635137 | 21049610 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Servicing rights, carried at fair value | 26243 | 27218 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Securities borrowed | 182518 | 139396 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Customer, broker-dealer and clearing receivables | 263095 | 252720 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Goodwill and other intangible assets—net | 205747 | 134502 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Other assets | 1127650 | 891446 |
| TOTAL ASSETS | $27431817 | $24783078 |
| **LIABILITIES AND STOCKHOLDERS' EQUITY** |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Deposits: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Non-interest-bearing | $3387318 | $3040696 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Interest bearing | 18877435 | 17788847 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total deposits | 22264753 | 20829543 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Advances from the Federal Home Loan Bank | 60000 | 60000 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Secured financings | 782423 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Borrowings, subordinated notes and debentures | 510064 | 312671 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Securities loaned | 204620 | 139426 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Customer, broker-dealer and clearing payables | 385821 | 350606 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Accounts payable and other liabilities | 431015 | 410155 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total liabilities | 24638696 | 22102401 |
| COMMITMENTS AND CONTINGENCIES (Note 10) |  |  |
| STOCKHOLDERS' EQUITY: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Common stock—$0.01 par value; 150,000,000 shares authorized; 71,356,152 shares issued and 56,643,547 shares outstanding as of September 30, 2025; 71,101,642 shares issued and 56,483,617 shares outstanding as of June 30, 2025 | 714 | 711 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Additional paid-in capital | 557740 | 548895 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Accumulated other comprehensive income (loss)—net of income tax | 64 | 348 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Retained earnings | 2730877 | 2618525 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Treasury stock, at cost; 14,712,605 shares as of September 30, 2025 and 14,618,025 shares as of June 30, 2025 | (496274) | (487802) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total stockholders' equity | 2793121 | 2680677 |
| TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY | $27431817 | $24783078 |

---

*See accompanying notes to the condensed consolidated financial statements.*

------

<u>[**Table of Contents**](#i7c17675c26f44bbd9ee68808b9f08846_7)</u>

**AXOS FINANCIAL, INC.**

**CONDENSED CONSOLIDATED STATEMENTS OF INCOME**

***(Unaudited)*** 

---

| | | |
|:---|:---|:---|
| | **Three Months Ended** | **Three Months Ended** |
| | **September 30,** | **September 30,** |
|<br>***(Dollars in thousands, except earnings per common share)*** | **2025** | **2024** |
| INTEREST AND DIVIDEND INCOME: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Loans, including fees | $429575 | $438229 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Securities borrowed and customer receivables | 6777 | 6271 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Investments and other | 29384 | 39762 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total interest and dividend income | 465736 | 484262 |
| INTEREST EXPENSE: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Deposits | 169364 | 187269 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Advances from the Federal Home Loan Bank | 313 | 529 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Securities loaned | 285 | 540 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Other borrowings | 4724 | 3876 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total interest expense | 174686 | 192214 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Net interest income | 291050 | 292048 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Provision for credit losses | 17255 | 14000 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Net interest income, after provision for credit losses | 273795 | 278048 |
| NON-INTEREST INCOME: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Broker-dealer fee income | 10948 | 11060 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Advisory fee income | 8525 | 7945 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Banking and service fees | 10820 | 8613 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Mortgage banking and servicing rights income | 1395 | 450 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Prepayment penalty fee income | 652 | 541 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total non-interest income | 32340 | 28609 |
| NON-INTEREST EXPENSE: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Salaries and related costs | 76605 | 74293 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Data and operational processing | 22057 | 18985 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Depreciation and amortization | 8341 | 7450 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Advertising and promotional | 12207 | 14253 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Professional services | 13333 | 9895 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Occupancy and equipment | 4620 | 4318 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;FDIC and regulatory fees | 5619 | 5956 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Broker-dealer clearing charges | 4203 | 4307 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;General and administrative expense | 9261 | 8008 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total non-interest expense | 156246 | 147465 |
| INCOME BEFORE INCOME TAXES | 149889 | 159192 |
| INCOME TAXES | 37537 | 46852 |
| NET INCOME | $112352 | $112340 |
| Basic earnings per common share | $1.99 | $1.97 |
| Diluted earnings per common share | $1.94 | $1.93 |

---

*See accompanying notes to the condensed consolidated financial statements.*

------

<u>[**Table of Contents**](#i7c17675c26f44bbd9ee68808b9f08846_7)</u>

**AXOS FINANCIAL, INC.**

**CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME**

***(Unaudited)***

---

| | | |
|:---|:---|:---|
| | **Three Months Ended** | **Three Months Ended** |
| | **September 30,** | **September 30,** |
|<br>***(Dollars in thousands)*** | **2025** | **2024** |
| NET INCOME | $112352 | $112340 |
| Net unrealized gain (loss) from available-for-sale securities, net of income tax | 254 | 1319 |
| Net unrealized gain (loss) on cash flow hedges, net of income tax | (538) | 382 |
| &nbsp;&nbsp;&nbsp;&nbsp;Other comprehensive income (loss) | (284) | 1701 |
| COMPREHENSIVE INCOME | $112068 | $114041 |

---

*See accompanying notes to the condensed consolidated financial statements.*

------

<u>[**Table of Contents**](#i7c17675c26f44bbd9ee68808b9f08846_7)</u>

**AXOS FINANCIAL, INC.**

**CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY**

***(Unaudited)***

---

| | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| | **For the Three Months Ended September 30, 2025** | **For the Three Months Ended September 30, 2025** | **For the Three Months Ended September 30, 2025** | **For the Three Months Ended September 30, 2025** | **For the Three Months Ended September 30, 2025** | **For the Three Months Ended September 30, 2025** | **For the Three Months Ended September 30, 2025** | **For the Three Months Ended September 30, 2025** | **For the Three Months Ended September 30, 2025** |
| | **Common Stock** | **Common Stock** | **Common Stock** | **Common Stock** | **Additional Paid-in Capital** | **Accumulated Other Comprehensive Income (Loss), Net of Income Tax** | **Retained Earnings** | **Treasury<br>Stock** | **Total** |
| | **Number of Shares** | **Number of Shares** | **Number of Shares** | | **Additional Paid-in Capital** | **Accumulated Other Comprehensive Income (Loss), Net of Income Tax** | **Retained Earnings** | **Treasury<br>Stock** | **Total** |
|<br><br>***(Dollars in thousands)*** | **Issued** | **Treasury** | **Outstanding** |<br>**Amount** | **Additional Paid-in Capital** | **Accumulated Other Comprehensive Income (Loss), Net of Income Tax** | **Retained Earnings** | **Treasury<br>Stock** | **Total** |
| BALANCE—June 30, 2025 | 71101642 | (14618025) | 56483617 | $711 | $548895 | $348 | $2618525 | $(487802) | $2680677 |
| Net income |  |  |  |  |  |  | 112352 |  | 112352 |
| Other comprehensive income (loss) |  |  |  |  |  | (284) |  |  | (284) |
| Stock-based compensation activity | 254510 | (94580) | 159930 | 3 | 8845 |  |  | (8472) | 376 |
| BALANCE—September 30, 2025 | 71356152 | (14712605) | 56643547 | $714 | $557740 | $64 | $2730877 | $(496274) | $2793121 |

---

**AXOS FINANCIAL, INC.**

**CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY**

***(Unaudited)***

---

| | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| | **For the Three Months Ended September 30, 2024** | **For the Three Months Ended September 30, 2024** | **For the Three Months Ended September 30, 2024** | **For the Three Months Ended September 30, 2024** | **For the Three Months Ended September 30, 2024** | **For the Three Months Ended September 30, 2024** | **For the Three Months Ended September 30, 2024** | **For the Three Months Ended September 30, 2024** | **For the Three Months Ended September 30, 2024** |
| | **Common Stock** | **Common Stock** | **Common Stock** | **Common Stock** | **Additional Paid-in Capital** | **Accumulated Other Comprehensive Income (Loss), Net of Income Tax** | **Retained Earnings** | **Treasury<br>Stock** | **Total** |
| | **Number of Shares** | **Number of Shares** | **Number of Shares** | | **Additional Paid-in Capital** | **Accumulated Other Comprehensive Income (Loss), Net of Income Tax** | **Retained Earnings** | **Treasury<br>Stock** | **Total** |
|<br><br>***(Dollars in thousands)*** | **Issued** | **Treasury** | **Outstanding** |<br>**Amount** | **Additional Paid-in Capital** | **Accumulated Other Comprehensive Income (Loss), Net of Income Tax** | **Retained Earnings** | **Treasury<br>Stock** | **Total** |
| BALANCE—June 30, 2024 | 70221632 | (13327067) | 56894565 | $702 | $510232 | $(2466) | $2185617 | $(403489) | $2290596 |
| Net income |  |  |  |  |  |  | 112340 |  | 112340 |
| Other comprehensive income (loss) |  |  |  |  |  | 1701 |  |  | 1701 |
| Stock-based compensation activity | 340701 | (143050) | 197651 | 4 | 10563 |  |  | (9476) | 1091 |
| BALANCE—September 30, 2024 | 70562333 | (13470117) | 57092216 | $706 | $520795 | $(765) | $2297957 | $(412965) | $2405728 |

---

*See accompanying notes to the condensed consolidated financial statements*.

------

<u>[**Table of Contents**](#i7c17675c26f44bbd9ee68808b9f08846_7)</u>

---

| | | |
|:---|:---|:---|
| **AXOS FINANCIAL, INC.** | **AXOS FINANCIAL, INC.** | **AXOS FINANCIAL, INC.** |
| **CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS** | **CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS** | **CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS** |
| ***(Unaudited)*** | ***(Unaudited)*** | ***(Unaudited)*** |
| | **Three Months Ended** | **Three Months Ended** |
| | **September 30,** | **September 30,** |
| ***(Dollars in thousands)*** | **2025** | **2024** |
| CASH FLOWS FROM OPERATING ACTIVITIES: |  |  |
| &nbsp;&nbsp;Net income | $112352 | $112340 |
| &nbsp;&nbsp;Adjustments to reconcile net income to net cash provided by (used in) operating activities: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Depreciation and amortization | 8341 | 7450 |
| &nbsp;&nbsp;&nbsp;&nbsp;Other accretion and amortization | (21699) | (37358) |
| &nbsp;&nbsp;&nbsp;&nbsp;Stock-based compensation expense | 10826 | 10239 |
| &nbsp;&nbsp;&nbsp;&nbsp;Trading activity | 116 | (241) |
| &nbsp;&nbsp;&nbsp;&nbsp;Provision for credit losses | 17255 | 14000 |
| &nbsp;&nbsp;&nbsp;&nbsp;Deferred income taxes | 38919 | 464 |
| &nbsp;&nbsp;&nbsp;&nbsp;Origination of loans held for sale | (47122) | (69570) |
| &nbsp;&nbsp;&nbsp;&nbsp;Unrealized and realized gains on loans held for sale | (783) | (2881) |
| &nbsp;&nbsp;&nbsp;&nbsp;Proceeds from sale of loans held for sale | 44922 | 74532 |
| &nbsp;&nbsp;&nbsp;&nbsp;Change in the fair value of servicing rights | 1207 | 1765 |
| &nbsp;&nbsp;&nbsp;&nbsp;Gain on repurchase of subordinated notes |  | (604) |
| &nbsp;&nbsp;Net change in assets and liabilities which provide (use) cash: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Securities borrowed | (43122) | (17114) |
| &nbsp;&nbsp;&nbsp;&nbsp;Customer, broker-dealer and clearing receivables | (10375) | (22746) |
| &nbsp;&nbsp;&nbsp;&nbsp;Other assets | (52699) | 4243 |
| &nbsp;&nbsp;&nbsp;&nbsp;Securities loaned | 65194 | 21706 |
| &nbsp;&nbsp;&nbsp;&nbsp;Customer, broker-dealer and clearing payables | 35215 | 14858 |
| &nbsp;&nbsp;&nbsp;&nbsp;Accounts payable and other liabilities | (40114) | (40295) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Net cash provided by operating activities | 118433 | 70788 |
| CASH FLOWS FROM INVESTING ACTIVITIES: |  |  |
| &nbsp;&nbsp;Purchases of available-for-sale securities |  | (16000) |
| &nbsp;&nbsp;Proceeds from sale and repayment of available-for-sale securities | 8569 | 21564 |
| &nbsp;&nbsp;Purchase of stock of regulatory agencies |  | (12446) |
| &nbsp;&nbsp;Net change in loans held for investment | (637164) | (48333) |
| &nbsp;&nbsp;Proceeds from sale of loans originally classified as held for investment | 82304 | 27800 |
| &nbsp;&nbsp;Proceeds from sale of other real estate owned and repossessed assets | 260 | 2202 |
| &nbsp;&nbsp;Acquisition of business, net of cash acquired | (474448) |  |
| &nbsp;&nbsp;Purchases of furniture, equipment, software and intangibles | (9149) | (17770) |
| &nbsp;&nbsp;Purchases of other investments | (3826) | (2558) |
| &nbsp;&nbsp;Distributions received from other investments | 75 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Net cash used in investing activities | (1033379) | (45541) |
| CASH FLOWS FROM FINANCING ACTIVITIES: |  |  |
| &nbsp;&nbsp;Net increase in deposits | 1435210 | 614112 |
| &nbsp;&nbsp;Payments related to settlement of restricted stock units | (8473) | (9476) |
| &nbsp;&nbsp;Repurchase of subordinated notes |  | (11803) |
| &nbsp;&nbsp;Payment of debt issuance costs | (2550) |  |
| &nbsp;&nbsp;Proceeds from issuance of subordinated notes | 200000 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Net cash provided by financing activities | 1624187 | 592833 |
| NET CHANGE IN CASH, CASH EQUIVALENTS AND RESTRICTED CASH | 709241 | 618080 |
| CASH, CASH EQUIVALENTS AND RESTRICTED CASH—Beginning of year | $2176354 | $2185776 |
| CASH, CASH EQUIVALENTS AND RESTRICTED CASH—End of period | $2885595 | $2803856 |
| SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION: |  |  |
| &nbsp;&nbsp;Interest paid on interest-bearing liabilities | 173499 | 192306 |
| &nbsp;&nbsp;Income taxes paid | 79736 | 40158 |
| &nbsp;&nbsp;Transfers to other real estate and repossessed vehicles from loans held for investment | 493 | 585 |
| &nbsp;&nbsp;Transfers from loans held for investment to loans held for sale | 82279 | 28140 |
| &nbsp;&nbsp;Transfers from loans held for sale to loans held for investment | 537 |  |
| &nbsp;&nbsp;Operating lease liabilities from obtaining right of use assets |  | 212 |
| &nbsp;&nbsp;Non-cash Contingent Consideration | 30810 |  |

---

*See accompanying notes to the condensed consolidated financial statements.*

------

<u>[**Table of Contents**](#i7c17675c26f44bbd9ee68808b9f08846_7)</u>

**AXOS FINANCIAL, INC.**

**NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS**

**FOR THE THREE MONTH PERIODS ENDED SEPTEMBER 30, 2025 AND 2024**

***(Unaudited)***

 **1.&nbsp;&nbsp;&nbsp;&nbsp;SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES**

***Basis of Presentation***

The condensed consolidated financial statements include the accounts of Axos Financial, Inc. and its wholly owned subsidiaries ("Axos" or the "Company"). Axos Bank (the "Bank"), its wholly owned subsidiaries, the activities of three lending-related trust entities and certain other lending activity constitute the Banking Business Segment, and Axos Securities, LLC and its wholly owned subsidiaries constitute the Securities Business Segment. All significant intercompany balances and transactions have been eliminated in consolidation. The Notes to the Condensed Consolidated Financial Statements are an integral part of the Company's financial statements. On December 7, 2023, the Company acquired from the Federal Deposit Insurance Corporation ("FDIC") two loan portfolios with an aggregate unpaid principal balance of $1.3 billion at a 37% discount to par. For additional information on the "FDIC Loan Purchase," see Note 2—*"Acquisitions"* in the Company's Annual Report on Form 10-K for the fiscal year ended June 30, 2025 ("2025 Form 10-K") filed with the Securities and Exchange Commission ("SEC").

The accompanying interim condensed consolidated financial statements, presented in accordance with accounting principles generally accepted in the United States of America ("GAAP"), are unaudited and reflect all adjustments which, in the opinion of management, are necessary for a fair statement of financial condition and results of operations for the interim periods. All adjustments are of a normal and recurring nature. Results for the three months ended September 30, 2025 are not necessarily indicative of results that may be expected for any other interim period or for the year as a whole. Certain information and note disclosures normally included in the audited annual financial statements prepared in accordance with GAAP have been condensed or not repeated herein pursuant to the rules and regulations of the SEC with respect to interim financial reporting. The accompanying unaudited condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements and accompanying notes for the year ended June 30, 2025 included in the 2025 Form 10-K.

***Significant Accounting Policies***

For further information regarding the Company's significant accounting policies, see Note 1*—"Organizations and Summary of Significant Accounting Policies"* in the 2025 Form 10-K. During the three months ended September 30, 2025, there were no significant updates to the Company's significant accounting policies, other than as noted below and the adoption of the accounting standards noted herein.

***New Accounting Standards***

*Recently Adopted Accounting Standards*

In December 2023, the Financial Accounting Standards Board ("FASB") issued Accounting Standards Update ("ASU") 2023-09, which requires further granularity on the disclosure of income taxes, including:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Certain prescribed line items in the income tax rate reconciliation presented both in dollar and percentage terms;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Income taxes paid, income before income taxes and income taxes disaggregated by federal, state and foreign taxes; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Further disaggregation of income taxes paid by any individual jurisdiction equal to or exceeding five percent of total income taxes paid.

The Company adopted this standard as of July 1, 2025 and the required annual-only disclosures will be provided in the Company's Annual Report on Form 10-K for the fiscal year ended June 30, 2026. There was no impact on the Company's financial condition or results of operations upon adoption.

------

<u>[**Table of Contents**](#i7c17675c26f44bbd9ee68808b9f08846_7)</u>

*Accounting Standards Issued But Not Yet Adopted*

In November 2024, the FASB issued ASU 2024-03, which requires disaggregation of operating expenses by relevant expense caption on the statement of income into prescribed categories, including employee compensation, depreciation and intangible asset amortization. The standard is effective for fiscal years beginning after December 15, 2026, and interim periods within fiscal years beginning after December 15, 2027. The Company does not expect any significant impact on its financial condition or results of operations upon adoption.

In September 2025, the FASB issued ASU 2025-06, which amends certain aspects of the accounting for and disclosure of internal-use software costs. Among other things, the standard requires capitalization only after management authorizes and commits to funding a project and it is probable the project will be completed and used as intended. The standard is effective for all entities for annual reporting periods beginning after December 15, 2027, and for interim periods within those annual reporting periods. Early adoption is permitted as of the beginning of an annual reporting period. The Company is currently evaluating how it plans to adopt this accounting standard from the three available adoption alternatives provided in the ASU.

------

<u>[**Table of Contents**](#i7c17675c26f44bbd9ee68808b9f08846_7)</u>

**2. &nbsp;&nbsp;&nbsp;&nbsp;ACQUISITIONS**

***Verdant Commercial Capital, LLC.*** On September 30, 2025, the Company completed the acquisition of 100% of the membership interests in Verdant Commercial Capital, LLC ("Verdant") in an all-cash transaction, which increases the Company's scale and enhances the Company's existing equipment leasing business.

The following table presents the purchase price for the acquisition of Verdant as of September 30, 2025:

---

| | |
|:---|:---|
| *(Dollars in thousands)* |  |
| Adjusted Verdant book value<sup>1</sup> | $39301 |
| Purchase price premium paid by Axos | 3930 |
| **PURCHASE PRICE** | $43231 |

---

<sup>1</sup> *Represents August 31, 2025 Verdant book value adjusted for certain items, including provision for credit losses and debt prepayment fees, according to the terms of the acquisition agreement.*

In the transaction the Company acquired approximately $1.2 billion of loans and leases, including direct financing leases and equipment under operating lease arrangements. Total consideration for the transaction was approximately $571.8 million, comprising $500.0 million to settle certain debt of Verdant, cash of $41.0 million, and potential performance-based cash consideration ("Contingent Consideration"), which was determined to have a fair value of $30.8 million as of September 30, 2025. This Contingent Consideration can be earned over a four-year period commencing with the date of acquisition, and the potential payment of which ranges from zero to $50.0 million based on the return on equity of Verdant. This Contingent Consideration is included in "Accounts payable and other liabilities" in the Consolidated Balance Sheet. For additional information related to the Contingent Consideration, see Note 3—*"Fair Value."*

Upon acquisition, the assets and liabilities of Verdant were adjusted to their respective fair values (with the exception of purchased credit deteriorated ("PCD") assets, as further discussed below) as of the closing date of the transaction, including the identifiable intangible assets acquired. Goodwill has been recorded representing the excess of the purchase price over the fair value of the net assets acquired and is expected to be fully tax-deductible. The goodwill recognized is the result of expected synergies and operational efficiencies, among other factors, and has been assigned to the Banking Business Segment. The Company's accounting for the acquisition has not been finalized as the Company continues to evaluate the post-closing adjustment amount, which is expected to have an insignificant effect on the value of the goodwill recognized as of September 30, 2025. The allocation will be updated, if necessary, through the measurement period, which ends no later than one year from the acquisition date.

The following table provides the Verdant preliminary purchase consideration allocation as of the date of acquisition:

---

| | |
|:---|:---|
| *(Dollars in thousands)* | **September 30, 2025** |
| **ASSETS:** |  |
| &nbsp;&nbsp;&nbsp;Cash and cash equivalents | $31635 |
| &nbsp;&nbsp;Restricted cash | 34924 |
| &nbsp;&nbsp;Loans—net of allowance for credit losses of $7,795 | 1020322 |
| &nbsp;&nbsp;Other assets<sup>1</sup> | 223842 |
| &nbsp;&nbsp;Goodwill and other intangible assets—net | 72767 |
| TOTAL ASSETS | $1383490 |
| **LIABILITIES:** |  |
| &nbsp;&nbsp;Secured financings | $782423 |
| &nbsp;&nbsp;Accounts payable and other liabilities | 29250 |
| TOTAL LIABILITIES | $811673 |
| **TOTAL CONSIDERATION** (Including $500.0 million to settle certain debt of Verdant and $30.8 million of Contingent Consideration) | $571817 |
| Amount paid to settle certain debt of Verdant, excluding $2.2 million of transaction costs included in the purchase price | (497776) |
| Contingent Consideration | (30810) |
| PURCHASE PRICE | $43231 |

---

<sup>1</sup> *Includes $212.6 million of equipment under operating lease arrangements.*

------

<u>[**Table of Contents**](#i7c17675c26f44bbd9ee68808b9f08846_7)</u>

The fair value estimates used in valuing certain acquired assets and liabilities are based, in part, on inputs that are unobservable. For loans, these include, but are not limited to, forecasted future cash flows and discount rates and for equipment under operating lease arrangements, cost and market valuation approaches were utilized.

The following table details the intangible assets acquired in the acquisition:

---

| | | |
|:---|:---|:---|
| *(Dollars in thousands)* | **September 30, 2025** | **Weighted-Average Life (Years)** |
| Vendor relationships | $11200 | 13.6 |
| Trade name | 2600 | 5.0 |
| Developed technologies | 5100 | 3.0 |
| Total intangible assets acquired | $18900 | 9.6 |

---

The following valuation approaches were utilized to estimate the acquisition-date fair value for the intangible assets acquired:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• *Vendor relationships:* Fair value was estimated with an income approach using a multi-period excess earnings method which discounts expected future cash flows, taking into account historic customer attrition rates and contributory asset charges, among other factors.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• *Trade name:* Fair value was estimated with an income approach using a relief-from-royalty method which considers the hypothetical royalty rate the Company would have paid if it did not own the trade name, taking into account discounted expected future cash flows, market royalty rates and expected useful life, among other factors.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• *Developed technologies:* Fair value was estimated with a cost approach using a replacement cost methodology, taking into account replacement costs, among other factors.

The following table summarizes the PCD loans and leases acquired in the acquisition:

---

| | |
|:---|:---|
| *(Dollars in thousands)* | **September 30, 2025** |
| Unpaid principal balance | $211002 |
| Non-credit discount | (342) |
| Allowance for credit losses at acquisition | (7795) |
| Purchase price allocated to PCD assets | $202865 |

---

Verdant's results are included in the Company's consolidated results from September 30, 2025. Verdant net revenue included in Company's Condensed Consolidated Statement of Income for the three months ended September 30, 2025 was not significant and Verdant incurred a net loss of $5.8 million for the three months ended September 30, 2025, reflecting the post-acquisition provision for credit losses on the loans and leases acquired.

The following table shows the Company and Verdant proforma combined net interest income, non-interest income and net income. The proforma financial information presented in the table below was computed by combining the historical financial information of the Company and Verdant along with the effects of the acquisition method of accounting for business combinations as though the Company acquired Verdant on July 1, 2024. Also included in the proforma financial information are certain adjustments, including $1.3 million of acquisition-related costs, as well as adjustments related to amortization expense of the intangible assets acquired in the Verdant acquisition and the elimination of the amortization expense of Verdant's intangible assets prior to its acquisition by the Company. The proforma information does not reflect the potential benefits of cost and funding synergies, opportunities to earn additional revenues or other factors and therefore does not represent what the actual net revenues and net income would have been had the Company actually acquired Verdant as of this date.

---

| | | |
|:---|:---|:---|
| | **Three Months Ended** | **Three Months Ended** |
|<br>*(Dollars in thousands)* | **September 30, 2025** | **September 30, 2024** |
| Net interest income | 297473 | 295460 |
| Non-interest income | 35340 | 31365 |
| Net income | 104433 | 106718 |

---

------

<u>[**Table of Contents**](#i7c17675c26f44bbd9ee68808b9f08846_7)</u>

**3. &nbsp;&nbsp;&nbsp;&nbsp;FAIR VALUE**

The following tables set forth the Company's financial assets and liabilities measured at fair value on a recurring basis at September 30, 2025 and June 30, 2025. Assets and liabilities are classified in their entirety based on the lowest level of input significant to the fair value measurement:

---

| | | | |
|:---|:---|:---|:---|
| | **September 30, 2025** | **September 30, 2025** | **September 30, 2025** |
|<br>***(Dollars in thousands)*** | **Significant Other<br>Observable<br>Inputs<br>(Level 2)** | **Significant<br>Unobservable<br>Inputs<br>(Level 3)** | **Total** |
| ASSETS: |  |  |  |
| &nbsp;&nbsp;&nbsp;Trading securities | $533 | $— | $533 |
| &nbsp;&nbsp;&nbsp;Available-for-sale securities: |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Agency MBS | 46606 |  | 46606 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Non-Agency MBS |  | 11192 | 11192 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Municipal |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total—Available-for-sale securities: | $46606 | $11192 | $57798 |
| &nbsp;&nbsp;&nbsp;Loans held for sale | $12202 | $— | $12202 |
| &nbsp;&nbsp;&nbsp;Servicing rights | $— | $26243 | $26243 |
| &nbsp;&nbsp;Other assets—Derivative instruments<sup>1</sup> | $17892 | $— | $17892 |
| LIABILITIES: |  |  |  |
| &nbsp;&nbsp;Accounts payable and other liabilities—Derivative instruments | $64619 | $— | $64619 |
| &nbsp;&nbsp;Accounts payable and other liabilities—Contingent Consideration | $— | $30810 | $30810 |
|  | **June 30, 2025** | **June 30, 2025** | **June 30, 2025** |
| ***(Dollars in thousands)*** | **Significant Other<br>Observable<br>Inputs<br>(Level 2)** | **Significant<br>Unobservable<br>Inputs<br>(Level 3)** | **Total** |
| ASSETS: |  |  |  |
| &nbsp;&nbsp;&nbsp;Trading securities | $649 | $— | $649 |
| &nbsp;&nbsp;&nbsp;Available-for-sale securities: |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Agency MBS | 46757 |  | 46757 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Non-Agency MBS |  | 15569 | 15569 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Municipal | 3682 |  | 3682 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total—Available-for-sale securities: | $50439 | $15569 | $66008 |
| &nbsp;&nbsp;&nbsp;Loans held for sale | $10012 | $— | $10012 |
| &nbsp;&nbsp;&nbsp;Servicing rights | $— | $27218 | $27218 |
| &nbsp;&nbsp;Other assets—Derivative instruments<sup>1</sup> | $17734 | $— | $17734 |
| LIABILITIES: |  |  |  |
| &nbsp;&nbsp;&nbsp;Accounts payable and other liabilities—Derivative instruments | $68498 | $— | $68498 |
| <sup>1</sup> *Other assets - Derivative instruments are presented net of $50.8 million and $55.4 million of variation margin on centrally-cleared derivatives as of September 30, 2025 and June 30, 2025, respectively.* | <sup>1</sup> *Other assets - Derivative instruments are presented net of $50.8 million and $55.4 million of variation margin on centrally-cleared derivatives as of September 30, 2025 and June 30, 2025, respectively.* | <sup>1</sup> *Other assets - Derivative instruments are presented net of $50.8 million and $55.4 million of variation margin on centrally-cleared derivatives as of September 30, 2025 and June 30, 2025, respectively.* | <sup>1</sup> *Other assets - Derivative instruments are presented net of $50.8 million and $55.4 million of variation margin on centrally-cleared derivatives as of September 30, 2025 and June 30, 2025, respectively.* |

---

The following section describes the valuation methodologies used by the Company to measure various financial instruments at fair value, including an indication of the level in the fair value hierarchy in which each instrument is generally classified. For additional information on the other valuation methodologies used by the Company, see Note 3*—"Fair Value"* in the 2025 Form 10-K.

***Contingent Consideration.*** The fair value of the Contingent Consideration liability is determined using a Nelson-Siegel stochastic simulation, which models various scenarios based on business forecasts, including monthly asset growth of the Verdant business and other inputs in accordance with the terms of the agreement. The resulting simulated cash flows are then discounted to present value and averaged to determine fair value.

------

<u>[**Table of Contents**](#i7c17675c26f44bbd9ee68808b9f08846_7)</u>

The following tables present additional information about assets measured at fair value on a recurring basis and for which the Company has utilized Level 3 inputs to determine fair value:

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **For the Three Months Ended** | **For the Three Months Ended** | **For the Three Months Ended** | **For the Three Months Ended** |
| | **September 30, 2025** | **September 30, 2025** | **September 30, 2025** | **September 30, 2025** |
|<br>***(Dollars in thousands)*** | **Available-for-sale Securities:<br>Non-Agency MBS** | **Servicing Rights**<sup>1</sup> | **Accounts payable and other liabilities—Contingent Consideration** | **Total** |
| Opening balance | $15569 | $27218 | $— | $42787 |
| Total gains or losses for the period: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Included in earnings—Mortgage banking and servicing rights income |  | (1189) |  | (1189) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Included in other comprehensive income | 116 |  |  | 116 |
| Purchases, retentions, issues, sales and settlements: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Purchases/Retentions |  | 214 | 30810 | 31024 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Settlements | (4493) |  |  | (4493) |
| Closing balance | $11192 | $26243 | $30810 | $68245 |
| Change in unrealized gains or losses for the period included in earnings for assets held at the end of the reporting period | $— | $(1189) | $— | $(1189) |

---

<sup>1</sup> *Earnings from servicing rights were attributable to: time and payoffs, representing a decrease in servicing rights value due to passage of time, including the impact from both regularly scheduled loan principal payments and loans that were paid down or paid off during the period of $0.4 million for the three months ended September 30, 2025, and a decrease in servicing rights value resulting from market-driven changes in interest rates of $0.8 million for the three months ended September 30, 2025. Additions to servicing rights were related to purchases and servicing rights retained upon sale of loans held for sale.* 

---

| | | | |
|:---|:---|:---|:---|
| | **For the Three Months Ended** | **For the Three Months Ended** | **For the Three Months Ended** |
| | **September 30, 2024** | **September 30, 2024** | **September 30, 2024** |
|<br>***(Dollars in thousands)*** | **Available-for-sale Securities:<br>Non-Agency MBS** | **Servicing Rights**<sup>1</sup> | **Total** |
| Opening balance | $110928 | $28924 | $139852 |
| Total gains or losses for the period: |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Included in earnings—Mortgage banking and servicing rights income |  | (1852) | (1852) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Included in other comprehensive income | 782 |  | 782 |
| Purchases, retentions, issues, sales and settlements: |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Purchases/Retentions |  | 263 | 263 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Settlements | (20401) |  | (20401) |
| Closing balance | $91309 | $27335 | $118644 |
| Change in unrealized gains or losses for the period included in earnings for assets held at the end of the reporting period | $— | $(1852) | $(1852) |

---

<sup>1</sup> *Earnings from servicing rights were attributable to: time and payoffs, representing a decrease in servicing rights value due to passage of time, including the impact from both regularly scheduled loan principal payments and loans that were paid down or paid off during the period of $0.2 million for the three months ended September 30, 2024 and a decrease in servicing rights value resulting from market-driven changes in interest rates of $1.6 million for the three months ended September 30, 2024. Additions to servicing rights were related to purchases and servicing rights retained upon sale of loans held for sale.*

------

<u>[**Table of Contents**](#i7c17675c26f44bbd9ee68808b9f08846_7)</u>

The table below summarizes the quantitative information about Level 3 fair value measurements:

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **September 30, 2025** | **September 30, 2025** | **September 30, 2025** | **September 30, 2025** |
|<br>***(Dollars in thousands)*** | **Fair Value** | **Valuation Technique** | **Unobservable Input** | **Range (Weighted Average)**<sup>1</sup> |
| Available-for-sale securities: Non-Agency MBS | $11192 | Discounted Cash Flow | Projected Constant Prepayment Rate,<br>Projected Constant Default Rate,<br>Projected Loss Severity,<br>Discount Rate over SOFR Swaps,<br>Credit Enhancement | 2.5 to 30.0% (20.1%)<br>1.5 to 9.9% (6.1%)<br>35.0 to 68.9% (46.6%)<br>2.5 to 4.3% (2.8%)<br>0.0 to 65.6% (41.8%) |
| Servicing Rights | $26243 | Discounted Cash Flow | Projected Constant Prepayment Rate,<br>Life (in years),<br>Discount Rate | 5.2 to 28.7% (10.3%)<br>2.2 to 12.7 (8.9) <br>9.5 to 11.2% (9.8%) |
| Accounts payable and other liabilities—Contingent Consideration | $30810 | Nelson-Siegal Stochastic Model | Monthly Asset Growth,<br>Credit Spread | (7.4)% to 14.5% (3.6%) <br>2.9% to 2.9% (2.9%)  |

---

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **June 30, 2025** | **June 30, 2025** | **June 30, 2025** | **June 30, 2025** |
|<br>***(Dollars in thousands)*** | **Fair Value** | **Valuation Technique** | **Unobservable Input** | **Range (Weighted Average)**<sup>1</sup> |
| Available-for-sale securities: Non-Agency MBS | $15569 | Discounted Cash Flow | Projected Constant Prepayment Rate,<br>Projected Constant Default Rate,<br>Projected Loss Severity,<br>Discount Rate over SOFR Swaps,<br>Credit Enhancement | 2.5 to 30.0% (22.4%)<br>1.5 to 11.9% (8.7%)<br>35.0 to 68.9% (43.4%)<br>2.5 to 4.1% (2.7%)<br>0.0 to 99.0% (22.8%) |
| Servicing Rights | $27218 | Discounted Cash Flow | Projected Constant Prepayment Rate,<br>Life (in years),<br>Discount Rate | 5.2 to 26.6% (9.7%)<br>2.5 to 12.8 (9.3) <br>9.5 to 11.2% (9.8%) |

---

<sup>1</sup> *The weighted average for Available-for-sale securities: Non-agency MBS is based on the relative fair value of the securities, for Servicing Rights is based on the relative unpaid principal of the loans being serviced and for Accounts payable and other liabilities—Contingent Consideration.is based on annual projected consideration.*

For non-agency mortgage-backed securities, a significant increase (decrease) in default rate, loss severity (potentially offset by the level of credit enhancement) or discount rate in isolation would result in a significantly lower (higher) fair value measurement, while a significant increase in the voluntary prepayment rate would result in a significant increase in fair value if the security is valued below par value, or a significant decrease in fair value if the security is valued above par value. Generally, a change in the assumptions used for the default rate is accompanied by a directionally opposite change in the assumption used for the voluntary prepayment rate.

For servicing rights, significant increases in the voluntary prepayment rate or discount rate in isolation would result in a significantly lower fair value measurement, while a significant increase in expected life in isolation would result in a significantly higher fair value measurement. Generally, a change in the voluntary prepayment rate is accompanied by a directionally opposite change in expected life.

For the Contingent Consideration, a significant increase (decrease) in the asset growth in isolation would result in a significantly higher (lower) fair value measurement, and a significant increase (decrease) in the discount rate in isolation would result in a significantly lower (higher) fair value measurement.

The aggregate fair value of loans held for sale, carried at fair value, the contractual balance (including accrued interest), and the unrealized gain were:

---

| | | |
|:---|:---|:---|
| ***(Dollars in thousands)*** | **September 30, 2025** | **June 30, 2025** |
| Aggregate fair value | $12202 | $10012 |
| Contractual balance | 11931 | 9870 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Unrealized gain | $271 | $142 |

---

------

<u>[**Table of Contents**](#i7c17675c26f44bbd9ee68808b9f08846_7)</u>

The total interest income and amount of gains and losses from changes in fair value included in earnings for loans held for sale, carried at fair value, were:

---

| | | |
|:---|:---|:---|
| | **For the Three Months Ended September 30,** | **For the Three Months Ended September 30,** |
|<br>***(Dollars in thousands)*** | **2025** | **2024** |
| Interest income | $181 | $288 |
| Change in fair value | 540 | 17 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total | $721 | $305 |

---

**Fair Value of Financial Instruments**

Carrying amounts and estimated fair values of financial instruments at September 30, 2025 and June 30, 2025 were:

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| | **September 30, 2025** | **September 30, 2025** | **September 30, 2025** | **September 30, 2025** | **September 30, 2025** |
| | | **Fair Value** | **Fair Value** | **Fair Value** | |
|<br>***(Dollars in thousands)*** |<br>**Carrying<br>Amount** | **Level 1** | **Level 2** | **Level 3** |<br>**Total Fair Value** |
| Financial assets: |  |  |  |  |  |
| &nbsp;&nbsp;Cash, cash equivalents and restricted cash | $2885595 | $2885595 | $— | $— | $2885595 |
| &nbsp;&nbsp;Trading securities | 533 |  | 533 |  | 533 |
| &nbsp;&nbsp;Available-for-sale securities | 57798 |  | 46606 | 11192 | 57798 |
| &nbsp;&nbsp;Stock of regulatory agencies | 35299 |  | 35299 |  | 35299 |
| &nbsp;&nbsp;Loans held for sale, at fair value | 12202 |  | 12202 |  | 12202 |
| &nbsp;&nbsp;Loans held for investment—net | 22635137 |  |  | 22879586 | 22879586 |
| &nbsp;&nbsp;Securities borrowed | 182518 |  |  | 180783 | 180783 |
| &nbsp;&nbsp;Customer, broker-dealer and clearing receivables | 263095 |  |  | 261446 | 261446 |
| &nbsp;&nbsp;Servicing rights | 26243 |  |  | 26243 | 26243 |
| &nbsp;&nbsp;Other assets - derivative instruments<sup>1</sup> | 17892 |  | 17892 |  | 17892 |
| Financial liabilities: |  |  |  |  |  |
| &nbsp;&nbsp;Total deposits | 22264753 |  | 21943152 |  | 21943152 |
| &nbsp;&nbsp;Advances from the Federal Home Loan Bank | 60000 |  | 57203 |  | 57203 |
| &nbsp;&nbsp;Secured financings | 782423 |  | 782423 |  | 782423 |
| &nbsp;&nbsp;Borrowings, subordinated notes and debentures | 510064 |  | 490626 |  | 490626 |
| &nbsp;&nbsp;Securities loaned | 204620 |  |  | 203553 | 203553 |
| &nbsp;&nbsp;Customer, broker-dealer and clearing payables | 385821 |  |  | 385821 | 385821 |
| &nbsp;&nbsp;Accounts payable and other liabilities - derivative instruments | 64619 |  | 64619 |  | 64619 |
| &nbsp;&nbsp;Accounts payable and other liabilities—Contingent Consideration | 30810 |  |  | 30810 | 30810 |

---

------

<u>[**Table of Contents**](#i7c17675c26f44bbd9ee68808b9f08846_7)</u>

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| | **June 30, 2025** | **June 30, 2025** | **June 30, 2025** | **June 30, 2025** | **June 30, 2025** |
| | | **Fair Value** | **Fair Value** | **Fair Value** | |
|<br>***(Dollars in thousands)*** |<br>**Carrying<br>Amount** | **Level 1** | **Level 2** | **Level 3** |<br>**Total Fair Value** |
| Financial assets: |  |  |  |  |  |
| &nbsp;&nbsp;Cash, cash equivalents and restricted cash | $2176354 | $2176354 | $— | $— | $2176354 |
| &nbsp;&nbsp;Trading securities | 649 |  | 649 |  | 649 |
| &nbsp;&nbsp;Available-for-sale securities | 66008 |  | 50439 | 15569 | 66008 |
| &nbsp;&nbsp;Stock of regulatory agencies | 35163 |  | 35163 |  | 35163 |
| &nbsp;&nbsp;Loans held for sale, at fair value | 10012 |  | 10012 |  | 10012 |
| &nbsp;&nbsp;Loans held for investment—net | 21049610 |  |  | 21288921 | 21288921 |
| &nbsp;&nbsp;Securities borrowed | 139396 |  |  | 138103 | 138103 |
| &nbsp;&nbsp;Customer, broker-dealer and clearing receivables | 252720 |  |  | 251126 | 251126 |
| &nbsp;&nbsp;Servicing rights | 27218 |  |  | 27218 | 27218 |
| &nbsp;&nbsp;Other assets - derivative instruments<sup>1</sup> | 17734 |  | 17734 |  | 17734 |
| Financial liabilities: |  |  |  |  |  |
| &nbsp;&nbsp;Total deposits | 20829543 |  | 20642953 |  | 20642953 |
| &nbsp;&nbsp;Advances from the Federal Home Loan Bank | 60000 |  | 56934 |  | 56934 |
| &nbsp;&nbsp;Borrowings, subordinated notes and debentures | 312671 |  | 285282 |  | 285282 |
| &nbsp;&nbsp;Securities loaned | 139426 |  |  | 138698 | 138698 |
| &nbsp;&nbsp;Customer, broker-dealer and clearing payables | 350606 |  |  | 350606 | 350606 |
| &nbsp;&nbsp;Accounts payable and other liabilities - derivative instruments | 68498 |  | 68498 |  | 68498 |

---

<sup>1</sup> *Other assets - derivative assets are presented net of $50.8 million and $55.4 million of variation margin on centrally-cleared derivatives as of September 30, 2025 and June 30, 2025, respectively.*

The carrying amount represents the estimated fair value for cash, cash equivalents and restricted cash, stock of regulatory agencies, interest-bearing deposits, accrued interest receivable and payable, demand deposits, short-term debt, and variable rate loans or deposits that reprice frequently and fully. For fixed rate loans, deposits, borrowings or subordinated debt and for variable rate loans, deposits, borrowings or subordinated debt with infrequent repricing or repricing limits, fair value is based on discounted cash flows using current market rates applied to the estimated life and credit risk. A discussion of the methods of valuing trading securities, available-for-sale securities, loans held for sale and derivatives can be found in Note 3*—"Fair Value"* in the 2025 Form 10-K. The fair value of off-balance sheet items is not considered material.

**4. &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;AVAILABLE-FOR-SALE SECURITIES**

The amortized cost and fair value of available-for-sale securities were:

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **September 30, 2025** | **September 30, 2025** | **September 30, 2025** | **September 30, 2025** |
|<br>***(Dollars in thousands)*** | **Amortized<br>Cost** | **Unrealized<br>Gains** | **Unrealized<br>Losses** | **Fair<br>Value** |
| Mortgage-backed securities (MBS): |  |  |  |  |
| &nbsp;&nbsp;Agency<sup>1</sup> | $47845 | $389 | $(1628) | $46606 |
| &nbsp;&nbsp;Non-agency<sup>2</sup> | 9901 | 1330 | (39) | 11192 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total mortgage-backed securities | 57746 | 1719 | (1667) | 57798 |
| Total available-for-sale securities | $57746 | $1719 | $(1667) | $57798 |
|  | **June 30, 2025** | **June 30, 2025** | **June 30, 2025** | **June 30, 2025** |
| ***(Dollars in thousands)*** | **Amortized<br>Cost** | **Unrealized<br>Gains** | **Unrealized<br>Losses** | **Fair<br>Value** |
| Mortgage-backed securities (MBS): |  |  |  |  |
| &nbsp;&nbsp;Agency<sup>1</sup> | $48229 | $327 | $(1799) | $46757 |
| &nbsp;&nbsp;Non-agency<sup>2</sup> | 14395 | 1232 | (58) | 15569 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total mortgage-backed securities | 62624 | 1559 | (1857) | 62326 |
| Municipal | 3682 |  |  | 3682 |
| Total available-for-sale securities | $66306 | $1559 | $(1857) | $66008 |

---

<sup>1</sup> *Includes securities guaranteed by Ginnie Mae, a U.S. government agency, and the government sponsored enterprises Fannie Mae and Freddie Mac.*

<sup>2</sup> *Private sponsors of securities collateralized primarily by first-lien mortgage loans on commercial properties or by pools of 1-4 family residential first mortgages. Primarily super senior securities secured by prime, Alt-A or pay-option adjustable rate mortgages.*

------

<u>[**Table of Contents**](#i7c17675c26f44bbd9ee68808b9f08846_7)</u>

The Company evaluates available-for-sale securities in an unrealized loss position based on an analysis of a number of factors, including, but not limited to: (1) the credit characteristics of the securities, such as the forecasted cash flows, credit ratings, credit enhancement, and government agency or government-sponsored enterprise backing, as applicable; and (2) whether the Company intends to sell or will be required to sell any of the securities before recovering the amortized cost basis. Based on its analysis, the Company determined the unrealized losses on available-for-sale securities are primarily driven by the increase in interest rates since the securities were purchased, and accordingly no credit losses were recognized on available-for-sale securities in the three months ended September 30, 2025 and September 30, 2024. There was no amount in the allowance for credit losses for available-for-sale securities at September 30, 2025 and June 30, 2025.

The face amounts of available-for-sale securities pledged to secure borrowings were $0.6 million and $0.6 million as of September 30, 2025 and June 30, 2025.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;There were no sales of available-for-sale securities during the three months ended September 30, 2025.<br>

Securities with unrealized losses, aggregated by investment category and length of time that individual securities have been in a continuous unrealized loss position, were:

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| | **September 30, 2025** | **September 30, 2025** | **September 30, 2025** | **September 30, 2025** | **September 30, 2025** | **September 30, 2025** |
| | **Available-for-sale securities in loss position for** | **Available-for-sale securities in loss position for** | **Available-for-sale securities in loss position for** | **Available-for-sale securities in loss position for** | **Available-for-sale securities in loss position for** | **Available-for-sale securities in loss position for** |
| | **Less Than<br>12 Months** | **Less Than<br>12 Months** | **More Than<br>12 Months** | **More Than<br>12 Months** | **Total** | **Total** |
|<br><br>***(Dollars in thousands)*** | **Fair<br>Value** | **Gross<br>Unrealized<br>Losses** | **Fair<br>Value** | **Gross<br>Unrealized<br>Losses** | **Fair<br>Value** | **Gross<br>Unrealized<br>Losses** |
| MBS: |  |  |  |  |  |  |
| &nbsp;&nbsp;Agency | $106 | $(1) | $16034 | $(1627) | $16140 | $(1628) |
| &nbsp;&nbsp;&nbsp;Non-agency | 2099 | (21) | 199 | (18) | 2298 | (39) |
| &nbsp;&nbsp;&nbsp;&nbsp;Total MBS | 2205 | (22) | 16233 | (1645) | 18438 | (1667) |
| &nbsp;&nbsp;&nbsp;&nbsp;Total available-for-sale securities | $2205 | $(22) | $16233 | $(1645) | $18438 | $(1667) |
|  | **June 30, 2025** | **June 30, 2025** | **June 30, 2025** | **June 30, 2025** | **June 30, 2025** | **June 30, 2025** |
|  | **Available-for-sale securities in loss position for** | **Available-for-sale securities in loss position for** | **Available-for-sale securities in loss position for** | **Available-for-sale securities in loss position for** | **Available-for-sale securities in loss position for** | **Available-for-sale securities in loss position for** |
|  | **Less Than<br>12 Months** | **Less Than<br>12 Months** | **More Than<br>12 Months** | **More Than<br>12 Months** | **Total** | **Total** |
| ***(Dollars in thousands)*** | **Fair<br>Value** | **Gross<br>Unrealized<br>Losses** | **Fair<br>Value** | **Gross<br>Unrealized<br>Losses** | **Fair<br>Value** | **Gross<br>Unrealized<br>Losses** |
| MBS: |  |  |  |  |  |  |
| &nbsp;&nbsp;Agency | $108 | $— | $16212 | $(1799) | $16320 | $(1799) |
| &nbsp;&nbsp;&nbsp;Non-agency | 2138 | (43) | 10695 | (15) | 12833 | (58) |
| &nbsp;&nbsp;&nbsp;&nbsp;Total MBS | 2246 | (43) | 26907 | (1814) | 29153 | (1857) |
| &nbsp;&nbsp;&nbsp;&nbsp;Total available-for-sale securities | $2246 | $(43) | $26907 | $(1814) | $29153 | $(1857) |

---

The following table sets forth the expected maturity distribution of our mortgage-backed securities, which is based on assumed prepayment rates, and the maturity distribution of our non-MBS, which is based on the contractual maturity:

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| | **As of September 30, 2025** | **As of September 30, 2025** | **As of September 30, 2025** | **As of September 30, 2025** | **As of September 30, 2025** |
|<br>***(Dollars in thousands)*** | **Total Amount** | **Due Within One Year** | **Due after One but within Five Years** | **Due after Five but within Ten Years** | **Due After Ten Years** |
| MBS: |  |  |  |  |  |
| &nbsp;&nbsp;Agency | $47845 | $11999 | $29382 | $4746 | $1718 |
| &nbsp;&nbsp;Non-Agency | $9901 | $6698 | $1470 | $1115 | $618 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total MBS | $57746 | $18697 | $30852 | $5861 | $2336 |
| Available-for-sale—Amortized cost | $57746 | $18697 | $30852 | $5861 | $2336 |
| Available-for-sale—Fair value | $57798 | $18655 | $30681 | $6017 | $2445 |

---

------

<u>[**Table of Contents**](#i7c17675c26f44bbd9ee68808b9f08846_7)</u>

**5.&nbsp;&nbsp;&nbsp;&nbsp;LOANS & ALLOWANCE FOR CREDIT LOSSES**

The Company categorizes the loan portfolio into five segments: Single Family - Mortgage & Warehouse, Multifamily and Commercial Mortgage, Commercial Real Estate, Commercial & Industrial - Non Real Estate ("Non-RE") and Auto & Consumer. For further detail of the segments of the Company's loan portfolio, see Note 1*—"Organizations and Summary of Significant Accounting Policies"* in the 2025 Form 10-K. The Company acquired approximately $1.0 billion of loans and leases, including $211.0 million of PCD assets, as part of the Verdant acquisition, which was completed on September 30, 2025. The loans and leases acquired in the Verdant acquisition are included in the commercial & industrial - Non-RE portfolio. For additional information on the Verdant acquisition, see Note 2, "*Acquisitions*."

The following table sets forth the composition of the loan portfolio:

---

| | | |
|:---|:---|:---|
| ***(Dollars in thousands)*** | **September 30, 2025** | **June 30, 2025** |
| Single Family - Mortgage & Warehouse | $4540889 | $4395278 |
| Multifamily and Commercial Mortgage | 2793762 | 2940739 |
| Commercial Real Estate | 7295572 | 6937187 |
| Commercial & Industrial - Non-RE | 7980981 | 6795497 |
| Auto & Consumer | 531044 | 482996 |
| &nbsp;&nbsp;&nbsp;Total gross loans | 23142248 | 21551697 |
| Allowance for credit losses - loans | (307431) | (290049) |
| Unaccreted premiums (discounts) and loan fees | (199680) | (212038) |
| &nbsp;&nbsp;&nbsp;Total net loans | $22635137 | $21049610 |

---

Accrued interest receivable on loans held for investments totaled $120.8 million and $109.6 million as of September 30, 2025 and June 30, 2025, respectively.

At September 30, 2025 and June 30, 2025, the Company pledged certain loans totaling $4,112.0 million and $4,284.7 million, respectively, to the FHLB and $8,320.3 million and $8,227.7 million, respectively, to the Federal Reserve Bank of San Francisco ("FRBSF").

The following table presents loan-to-value ("LTV") for the Company's real estate loans outstanding as of September 30, 2025:

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Total Real Estate Loans** | **Single Family - Mortgage & Warehouse** | **Multifamily and Commercial Mortgage** | **Commercial Real Estate** |
| Weighted-Average LTV | 48% | 57% | 49% | 43% |
| Median LTV | 51% | 53% | 47% | 43% |

---

The following table presents the components of the provision for credit losses:

---

| | | |
|:---|:---|:---|
| | **For September 30,**  | **For September 30,**  |
|<br>***(Dollars in thousands)*** | **2025** | **2024** |
| Provision for credit losses - loans | $15255 | $11500 |
| Provision for credit losses - unfunded lending commitments | 2000 | 2500 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total provision for credit losses | $17255 | $14000 |

---

------

<u>[**Table of Contents**](#i7c17675c26f44bbd9ee68808b9f08846_7)</u>

The following tables summarize activity in the allowance for credit losses - loans by portfolio segment:

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| | **For the Three Months Ended September 30, 2025** | **For the Three Months Ended September 30, 2025** | **For the Three Months Ended September 30, 2025** | **For the Three Months Ended September 30, 2025** | **For the Three Months Ended September 30, 2025** | **For the Three Months Ended September 30, 2025** |
|<br>***(Dollars in thousands)*** | **Single Family-Mortgage & Warehouse** | **Multifamily and Commercial Mortgage** | **Commercial Real Estate** | **Commercial & Industrial - Non-RE** | **Auto & Consumer** | **Total** |
| Balance at July 1, 2025 | $12109 | $26238 | $113804 | $121641 | $16257 | $290049 |
| Allowance for credit losses at acquisition of PCD loans |  |  |  | 7795 |  | 7795 |
| Provision (benefit) for credit losses - loans | (1571) | (1037) | 6549 | 8856 | 2458 | 15255 |
| Charge-offs | (395) | (3918) | (4) | (255) | (1786) | (6358) |
| Recoveries | 28 |  |  |  | 662 | 690 |
| Balance at September 30, 2025 | $10171 | $21283 | $120349 | $138037 | $17591 | $307431 |

---

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| | **For the Three Months Ended September 30, 2024** | **For the Three Months Ended September 30, 2024** | **For the Three Months Ended September 30, 2024** | **For the Three Months Ended September 30, 2024** | **For the Three Months Ended September 30, 2024** | **For the Three Months Ended September 30, 2024** |
|<br>***(Dollars in thousands)*** | **Single Family-Mortgage & Warehouse** | **Multifamily and Commercial Mortgage** | **Commercial Real Estate** | **Commercial & Industrial - Non-RE** | **Auto & Consumer** | **Total** |
| Balance at July 1, 2024 | $16943 | $70771 | $87780 | $76032 | $9016 | $260542 |
| Provision (benefit) for credit losses - loans | 464 | (1806) | 7252 | 3555 | 2035 | 11500 |
| Charge-offs |  | (3357) |  | (3032) | (2849) | (9238) |
| Recoveries | 46 |  |  |  | 1004 | 1050 |
| Balance at September 30, 2024 | $17453 | $65608 | $95032 | $76555 | $9206 | $263854 |

---

For the three months ended September 30, 2025, the allowance for credit losses for loans increased as a result of PCD assets acquired in the Verdant acquisition and the provision for credit losses, partially offset by net charge-offs. The provision for credit losses was primarily driven by the post-acquisition provision for credit losses on the loans and leases acquired in the Verdant acquisition, as well as loan growth and the impact of macroeconomic variables used in the allowance for credit losses model, primarily the U.S. unemployment rate, consumer price and housing price indices, as well as the five-year U.S. Treasury rate.

Loan products within each portfolio contain varying collateral types which impact the estimate of the loss given default utilized in the calculation of the allowance for credit losses for loans. For further discussion of the model method of estimating expected lifetime credit losses, see Note 1*—"Organizations and Summary of Significant Accounting Policies"* in the 2025 Form 10-K.

The following tables present a summary of the activity in the allowance for credit losses for off-balance sheet lending commitments:

---

| | | |
|:---|:---|:---|
| | **Three Months Ended September 30,**  | **Three Months Ended September 30,**  |
|<br>***(Dollars in thousands)*** | **2025** | **2024** |
| Balance at July 1,  | $10891 | $10223 |
| Provision (benefit) for credit losses - unfunded lending commitments | 2000 | 2500 |
| Balance at September 30,  | $12891 | $12723 |

---

The increase in the allowance for off-balance sheet lending commitments for the three months ended September 30, 2025, was primarily driven by unfunded lending commitment growth, primarily in the commercial real estate and commercial & industrial - non-RE portfolios.

------

<u>[**Table of Contents**](#i7c17675c26f44bbd9ee68808b9f08846_7)</u>

***Credit Quality Disclosures.*** The following tables provide the composition of loans that are performing and nonaccrual by portfolio segment:

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| | **September 30, 2025** | **September 30, 2025** | **September 30, 2025** | **September 30, 2025** | **September 30, 2025** | **September 30, 2025** |
|<br>***(Dollars in thousands)*** | **Single Family-Mortgage & Warehouse** | **Multifamily and Commercial Mortgage** | **Commercial Real Estate** | **Commercial & Industrial - Non-RE** | **Auto & Consumer** | **Total** |
| Performing | $4473002 | $2777715 | $7273789 | $7918445 | $528887 | $22971838 |
| Nonaccrual | 67887 | 16047 | 21783 | 62536 | 2157 | 170410 |
| Total | $4540889 | $2793762 | $7295572 | $7980981 | $531044 | $23142248 |
| Nonaccrual loans to total loans | Nonaccrual loans to total loans | Nonaccrual loans to total loans |  |  |  | 0.74% |

---

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| | **June 30, 2025** | **June 30, 2025** | **June 30, 2025** | **June 30, 2025** | **June 30, 2025** | **June 30, 2025** |
|<br>***(Dollars in thousands)*** | **Single Family-Mortgage & Warehouse** | **Multifamily and Commercial Mortgage** | **Commercial Real Estate** | **Commercial & Industrial - Non-RE** | **Auto & Consumer** | **Total** |
| Performing | $4351082 | $2907702 | $6907964 | $6733693 | $480870 | $21381311 |
| Nonaccrual | 44196 | 33037 | 29223 | 61804 | 2126 | 170386 |
| Total | $4395278 | $2940739 | $6937187 | $6795497 | $482996 | $21551697 |
| Nonaccrual loans to total loans | Nonaccrual loans to total loans | Nonaccrual loans to total loans |  |  |  | 0.79% |

---

There were no nonaccrual loans without an allowance for credit losses as of September 30, 2025 and June 30, 2025. There was no interest income recognized on nonaccrual loans in the three months ended September 30, 2025 and 2024. Loans reaching 90 days past due are generally placed on nonaccrual status and risk rated as substandard or doubtful. Loans not yet reaching 90 days past due may be placed on nonaccrual status based on management's assessment of the aging of contractual principal amounts due, among other factors.

***Credit Quality Indicators.*** The Company categorizes loans into risk categories based on relevant information about the ability of borrowers to service their debt such as: current financial information, historical payment experience, credit documentation, public information and current economic trends. In addition to the borrower's primary source of repayment, in its risk rating process the Company considers all available sources of repayment, including obligor guaranties and liquidations of pledged collateral, where individually or together such sources would fully repay the loan on a timely basis. The Company analyzes loans individually by classifying the loans based on credit risk. The Company uses the following internally-defined risk ratings:

***Pass.*** Loans where repayment in full is expected through any of the borrower's sources of repayment.

***Special Mention*.** Loans where any credit risk is not considered significant yet require management's attention given certain currently identified characteristics of the borrower, collateral securing the loan and the obligor's net worth and paying capacity. If the identified credit risks are not adequately monitored or mitigated, the loan may weaken and the Company's credit position with respect to the loan may deteriorate in the future.

***Substandard*.** Loans where currently identified characteristics of the borrower, collateral securing the loan and the obligor's net worth and paying capacity, taken together, could jeopardize the repayment of the debt. A loan not fully supported by at least one available source of repayment and involves a distinct possibility that the Company will sustain some loss in that loan if the weakness is not cured. A loan supported by a guaranty, collateral sufficient to incentivize a sale or refinance, or cash flow that is sufficient for timely repayment in full will not be classified as substandard even if the loan has a well-defined weakness in other sources of repayment.

***Doubtful*.** Loans reflecting the same characteristics as those classified as substandard, but for which repayment in full in accordance with the contractual terms is currently considered highly unlikely.

The Company reviews and grades loans following a continuous review process, featuring coverage of all loan types and business lines at least quarterly. Continuous reviewing provides more effective risk monitoring because it immediately tests for potential impacts caused by changes in personnel, policy, products or underwriting standards.

------

<u>[**Table of Contents**](#i7c17675c26f44bbd9ee68808b9f08846_7)</u>

The following tables present the composition of loans by portfolio segment, fiscal year of origination and credit quality indicator, and the amount of year-to-date gross charge-offs.

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| | **September 30, 2025** | **September 30, 2025** | **September 30, 2025** | **September 30, 2025** | **September 30, 2025** | **September 30, 2025** | **September 30, 2025** | **September 30, 2025** |
| | **Loans Held for Investment by Fiscal Year of Origination** | **Loans Held for Investment by Fiscal Year of Origination** | **Loans Held for Investment by Fiscal Year of Origination** | **Loans Held for Investment by Fiscal Year of Origination** | **Loans Held for Investment by Fiscal Year of Origination** | **Loans Held for Investment by Fiscal Year of Origination** | **Revolving Loans** | **Total** |
|<br>***(Dollars in thousands)*** | **2026** | **2025** | **2024** | **2023** | **2022** | **Prior** | **Revolving Loans** | **Total** |
| Single Family-Mortgage & Warehouse |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Pass | $197266 | $652424 | $233972 | $426758 | $1033680 | $1108076 | $787877 | $4440053 |
| &nbsp;&nbsp;&nbsp;Special Mention |  |  | 1080 |  | 10689 | 19087 |  | 30856 |
| &nbsp;&nbsp;&nbsp;Substandard |  |  |  | 4503 | 11379 | 54098 |  | 69980 |
| &nbsp;&nbsp;&nbsp;Doubtful |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Total | 197266 | 652424 | 235052 | 431261 | 1055748 | 1181261 | 787877 | **4540889** |
| &nbsp;&nbsp;&nbsp;Year-to-date gross charge-offs |  |  |  |  | 48 | 347 |  | 395 |
| Multifamily and Commercial Mortgage |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Pass | 28237 | 75585 | 21577 | 631556 | 801448 | 1191542 |  | 2749945 |
| &nbsp;&nbsp;&nbsp;Special Mention |  |  |  | 3400 |  | 1547 |  | 4947 |
| &nbsp;&nbsp;&nbsp;Substandard |  |  |  | 8530 | 17007 | 13333 |  | 38870 |
| &nbsp;&nbsp;&nbsp;Doubtful |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Total | 28237 | 75585 | 21577 | 643486 | 818455 | 1206422 |  | **2793762** |
| &nbsp;&nbsp;&nbsp;Year-to-date gross charge-offs |  |  |  |  |  | 3918 |  | 3918 |
| Commercial Real Estate |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Pass | 512926 | 3112458 | 1372529 | 689214 | 409209 | 181498 | 981352 | 7259186 |
| &nbsp;&nbsp;&nbsp;Special Mention |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Substandard |  |  |  | 7060 |  | 14721 | 14605 | 36386 |
| &nbsp;&nbsp;&nbsp;Doubtful |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Total | 512926 | 3112458 | 1372529 | 696274 | 409209 | 196219 | 995957 | **7295572** |
| &nbsp;&nbsp;&nbsp;Year-to-date gross charge-offs |  |  |  |  | 4 |  |  | 4 |
| Commercial & Industrial - Non-RE |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Pass | 710648 | 1505243 | 1000419 | 363791 | 142039 | 76615 | 3804326 | 7603081 |
| &nbsp;&nbsp;&nbsp;Special Mention | 256 | 13606 | 59132 | 4026 | 1537 | 71 |  | 78628 |
| &nbsp;&nbsp;&nbsp;Substandard | 81 | 15849 | 79036 | 11936 | 154289 | 6185 | 21284 | 288660 |
| &nbsp;&nbsp;&nbsp;Doubtful |  | 599 | 4 | 3 | 10000 | 6 |  | 10612 |
| &nbsp;&nbsp;&nbsp;Total | 710985 | 1535297 | 1138591 | 379756 | 307865 | 82877 | 3825610 | **7980981** |
| &nbsp;&nbsp;&nbsp;Year-to-date gross charge-offs |  |  |  |  |  | 255 |  | 255 |
| Auto & Consumer |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Pass | 97082 | 201753 | 44395 | 60552 | 94988 | 29414 |  | 528184 |
| &nbsp;&nbsp;&nbsp;Special Mention |  | 290 |  | 332 | 163 | 53 |  | 838 |
| &nbsp;&nbsp;&nbsp;Substandard |  | 316 | 16 | 291 | 684 | 715 |  | 2022 |
| &nbsp;&nbsp;&nbsp;Doubtful |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Total | 97082 | 202359 | 44411 | 61175 | 95835 | 30182 |  | **531044** |
| &nbsp;&nbsp;&nbsp;Year-to-date gross charge-offs |  | 474 | 153 | 450 | 649 | 60 |  | 1786 |
| Total |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Pass | 1546159 | 5547463 | 2672892 | 2171871 | 2481364 | 2587145 | 5573555 | 22580449 |
| &nbsp;&nbsp;&nbsp;Special Mention | 256 | 13896 | 60212 | 7758 | 12389 | 20758 |  | 115269 |
| &nbsp;&nbsp;&nbsp;Substandard | 81 | 16165 | 79052 | 32320 | 183359 | 89052 | 35889 | 435918 |
| &nbsp;&nbsp;&nbsp;Doubtful |  | 599 | 4 | 3 | 10000 | 6 |  | 10612 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total | $1546496 | $5578123 | $2812160 | $2211952 | $2687112 | $2696961 | $5609444 | $**23142248** |
| As a % of total gross loans | 6.7% | 24.1% | 12.2% | 9.6% | 11.6% | 11.7% | 24.2% | 100% |
| Year-to-date gross charge-offs | $— | $474 | $153 | $450 | $701 | $4580 | $— | $6358 |

---

------

<u>[**Table of Contents**](#i7c17675c26f44bbd9ee68808b9f08846_7)</u>

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| | **June 30, 2025** | **June 30, 2025** | **June 30, 2025** | **June 30, 2025** | **June 30, 2025** | **June 30, 2025** | **June 30, 2025** | **June 30, 2025** |
| | **Loans Held for Investment by Fiscal Year of Origination** | **Loans Held for Investment by Fiscal Year of Origination** | **Loans Held for Investment by Fiscal Year of Origination** | **Loans Held for Investment by Fiscal Year of Origination** | **Loans Held for Investment by Fiscal Year of Origination** | **Loans Held for Investment by Fiscal Year of Origination** | **Revolving Loans** | **Total** |
|<br>***(Dollars in thousands)*** | **2025** | **2024** | **2023** | **2022** | **2021** | **Prior** | **Revolving Loans** | **Total** |
| Single Family-Mortgage & Warehouse |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Pass | $750357 | $269165 | $451330 | $1067144 | $434352 | $715620 | $599406 | $4287374 |
| &nbsp;&nbsp;&nbsp;Special Mention | 2129 | 1080 | 5362 | 3140 | 5254 | 26604 | 9967 | 53536 |
| &nbsp;&nbsp;&nbsp;Substandard |  |  |  | 7255 | 6720 | 40393 |  | 54368 |
| &nbsp;&nbsp;&nbsp;Doubtful |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Total | 752486 | 270245 | 456692 | 1077539 | 446326 | 782617 | 609373 | **4395278** |
| &nbsp;&nbsp;&nbsp;Year-to-date gross charge-offs |  | 340 |  | 400 |  | 2296 |  | 3036 |
| Multifamily and Commercial Mortgage |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Pass | 75755 | 22435 | 632120 | 859189 | 422683 | 842787 | 1450 | 2856419 |
| &nbsp;&nbsp;&nbsp;Special Mention |  |  | 3400 |  | 7255 | 18272 |  | 28927 |
| &nbsp;&nbsp;&nbsp;Substandard |  |  | 8530 | 13199 |  | 33664 |  | 55393 |
| &nbsp;&nbsp;&nbsp;Doubtful |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Total | 75755 | 22435 | 644050 | 872388 | 429938 | 894723 | 1450 | **2940739** |
| &nbsp;&nbsp;&nbsp;Year-to-date gross charge-offs |  | 375 | 86 | 5 |  | 8099 |  | 8565 |
| Commercial Real Estate |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Pass | 3135530 | 1342372 | 679875 | 575642 | 152581 | 47214 | 960145 | 6893359 |
| &nbsp;&nbsp;&nbsp;Special Mention |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Substandard |  |  |  | 9500 | 5000 | 14723 | 14605 | 43828 |
| &nbsp;&nbsp;&nbsp;Doubtful |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Total | 3135530 | 1342372 | 679875 | 585142 | 157581 | 61937 | 974750 | **6937187** |
| &nbsp;&nbsp;&nbsp;Year-to-date gross charge-offs |  |  |  | 165 |  |  |  | 165 |
| Commercial & Industrial - Non-RE |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Pass | 1231118 | 809347 | 310043 | 120385 | 38397 | 28311 | 3928415 | 6466016 |
| &nbsp;&nbsp;&nbsp;Special Mention |  | 45120 |  |  | 93 |  | 10023 | 55236 |
| &nbsp;&nbsp;&nbsp;Substandard | 3747 | 10719 | 9244 | 135778 | 2486 | 2989 | 99282 | 264245 |
| &nbsp;&nbsp;&nbsp;Doubtful |  |  |  | 10000 |  |  |  | 10000 |
| &nbsp;&nbsp;&nbsp;Total | 1234865 | 865186 | 319287 | 266163 | 40976 | 31300 | 4037720 | **6795497** |
| &nbsp;&nbsp;&nbsp;Year-to-date gross charge-offs |  |  | 883 |  | 5942 |  | 2000 | 8825 |
| Auto & Consumer |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Pass | 213318 | 47587 | 75120 | 109228 | 23084 | 11448 |  | 479785 |
| &nbsp;&nbsp;&nbsp;Special Mention | 295 | 52 | 186 | 270 | 60 | 10 |  | 873 |
| &nbsp;&nbsp;&nbsp;Substandard | 154 | 48 | 365 | 807 | 549 | 415 |  | 2338 |
| &nbsp;&nbsp;&nbsp;Doubtful |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Total | 213767 | 47687 | 75671 | 110305 | 23693 | 11873 |  | **482996** |
| &nbsp;&nbsp;&nbsp;Year-to-date gross charge-offs | 589 | 813 | 2363 | 3340 | 797 | 1813 |  | 9715 |
| Total |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Pass | 5406078 | 2490906 | 2148488 | 2731588 | 1071097 | 1645380 | 5489416 | 20982953 |
| &nbsp;&nbsp;&nbsp;Special Mention | 2424 | 46252 | 8948 | 3410 | 12662 | 44886 | 19990 | 138572 |
| &nbsp;&nbsp;&nbsp;Substandard | 3901 | 10767 | 18139 | 166539 | 14755 | 92184 | 113887 | 420172 |
| &nbsp;&nbsp;&nbsp;Doubtful |  |  |  | 10000 |  |  |  | 10000 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total | $5412403 | $2547925 | $2175575 | $2911537 | $1098514 | $1782450 | $5623293 | $**21551697** |
| As a % of total gross loans | 25.1% | 11.8% | 10.1% | 13.5% | 5.1% | 8.3% | 26.1% | 100% |
| Total year-to-date gross charge-offs | $589 | $1528 | $3332 | $3910 | $6739 | $12208 | $2000 | $30306 |

---

------

<u>[**Table of Contents**](#i7c17675c26f44bbd9ee68808b9f08846_7)</u>

The following tables provide the aging of loans by portfolio segment:

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| | **September 30, 2025** | **September 30, 2025** | **September 30, 2025** | **September 30, 2025** | **September 30, 2025** |
|<br>***(Dollars in thousands)*** | **Current** | **30-59 Days** | **60-89 Days** | **90+ Days** | **Total** |
| Single Family-Mortgage & Warehouse | $4450628 | $18357 | $10377 | $61527 | $4540889 |
| Multifamily and Commercial Mortgage | 2774831 | 3379 | 2713 | 12839 | 2793762 |
| Commercial Real Estate | 7273849 |  |  | 21723 | 7295572 |
| Commercial & Industrial - Non-RE | 7876062 | 73511 | 13906 | 17502 | 7980981 |
| Auto & Consumer | 524425 | 4094 | 1029 | 1496 | 531044 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total | $22899795 | $99341 | $28025 | $115087 | $23142248 |
| As a % of total gross loans | 98.95% | 0.43% | 0.12% | 0.50% | 100% |

---

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| | **June 30, 2025** | **June 30, 2025** | **June 30, 2025** | **June 30, 2025** | **June 30, 2025** |
|<br>***(Dollars in thousands)*** | **Current** | **30-59 Days** | **60-89 Days** | **90+ Days** | **Total** |
| Single Family-Mortgage & Warehouse | $4322681 | $13302 | $16395 | $42900 | $4395278 |
| Multifamily and Commercial Mortgage | 2870972 | 36649 | 549 | 32569 | 2940739 |
| Commercial Real Estate | 6900904 |  | 7060 | 29223 | 6937187 |
| Commercial & Industrial - Non-RE | 6783440 |  |  | 12057 | 6795497 |
| Auto & Consumer | 477694 | 3025 | 920 | 1357 | 482996 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total | $21355691 | $52976 | $24924 | $118106 | $21551697 |
| As a % of total gross loans | 99.09% | 0.25% | 0.12% | 0.55% | 100% |

---

Loans reaching 90 or more days past due are generally placed on nonaccrual. As of both September 30, 2025 and June 30, 2025 there were no loans over 90 days past due and still accruing interest.

Single family mortgage loans in process of foreclosure were $36.0 million and $30.4 million as of September 30, 2025 and June 30, 2025, respectively.

**6.&nbsp;&nbsp;&nbsp;&nbsp;DERIVATIVES**

For additional information on the Company's derivative instruments, see Note 1*—"Organizations and Summary of Significant Accounting Policies,"* Note 3*—"Fair Value"* and Note 6*—"Derivatives"* in the 2025 Form 10-K and Note 3*—"Fair Value" and Note 7 "Offsetting of Derivatives and Securities Financing Agreements"* herein.

The following table presents the notional amounts and fair values of the Company's derivative instruments. While the notional amounts give an indication of the volume of the Company's derivatives activity, the notional amounts significantly exceed, in the Company's view, the possible losses that could arise from such transactions. For most derivative contracts, the notional amount is not exchanged, rather it is a reference amount used to calculate payments.

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| | **September 30, 2025** | **September 30, 2025** | **September 30, 2025** | **June 30, 2025** | **June 30, 2025** | **June 30, 2025** |
| | | **Fair Value** | **Fair Value** | | **Fair Value** | **Fair Value** |
|<br>***(Dollars in thousands)*** |<br>**Notional Amount** | **Derivative Assets** | **Derivative Liabilities** |<br>**Notional Amount** | **Derivative Assets** | **Derivative Liabilities** |
| Derivatives designated as hedging instruments |  |  |  |  |  |  |
| &nbsp;&nbsp;Interest rate contracts<sup>1</sup> | $400000 | $1184 | $— | $400000 | $1950 | $— |
| Derivatives not designated as hedging instruments |  |  |  |  |  |  |
| &nbsp;&nbsp;Interest rate contracts<sup>1</sup> | 2627948 | 16679 | 64599 | 2761021 | 15782 | 68427 |
| &nbsp;&nbsp;Foreign exchange contracts | 9777 | 29 | 20 | 9570 | 2 | 71 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total derivatives | $3037725 | $17892 | $64619 | $3170591 | $17734 | $68498 |

---

<sup>1</sup> *Derivative Assets are presented net of $50.8 million and $55.4 million of variation margin on centrally-cleared derivatives as of September 30, 2025 and June 30, 2025, respectively.*

------

<u>[**Table of Contents**](#i7c17675c26f44bbd9ee68808b9f08846_7)</u>

***Derivatives designated as hedging instruments***

The following table presents pre-tax gains/(losses) on derivative instruments used in cash flow hedge accounting relationships.

---

| | | |
|:---|:---|:---|
| | **For the Three Months Ended September 30,**  | **For the Three Months Ended September 30,**  |
|<br>***(Dollars in thousands)*** | **2025** | **2024** |
| Amounts recorded in other comprehensive income ("OCI") | $374 | $553 |
| Amounts reclassified from AOCI to income | (1118) |  |
| Total change in OCI for period | $(744) | $553 |

---

&nbsp;&nbsp;&nbsp;&nbsp;The Company did not experience any forecasted transactions that failed to occur during the three months ended September 30, 2025 or 2024. There are no amounts excluded from the assessment of hedge effectiveness.

As of September 30, 2025, the Company expects that approximately $1.2 million of pre-tax net gain related to cash flow hedges recorded in accumulated other comprehensive income will be recognized in income over the next 12 months. The maximum length of time over which forecasted transactions are hedged is approximately 2.0 years.

***Derivatives not designated as hedging instruments***

The following table presents the pre-tax gains/(losses) related to the Company's derivative instrument activity recognized in the Condensed Consolidated Statements of Income:

---

| | | |
|:---|:---|:---|
| | **For the Three Months Ended September 30,**  | **For the Three Months Ended September 30,**  |
|<br>***(Dollars in thousands)*** | **2025** | **2024** |
| Interest rate contracts |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Banking and service fees | $(558) | $(1372) |
| &nbsp;&nbsp;&nbsp;&nbsp;Mortgage banking and servicing rights income | 417 | (251) |
| Foreign exchange contracts |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Banking and service fees | 539 |  |

---

The aggregate foreign exchange transaction gain totaled approximately $0.5 million for the three months ended September 30, 2025, and was not significant for the three months ended September 30, 2024.

**7.&nbsp;&nbsp;&nbsp;&nbsp;OFFSETTING OF DERIVATIVES AND SECURITIES FINANCING AGREEMENTS**

The Company enters into derivatives transactions as part of its mortgage banking activities, market making activity in interest rate swap and cap derivatives to facilitate customer demand and hedging activities related to interest rate and foreign exchange risk management, and enters into securities borrowed and securities loaned transactions to facilitate customer match-book activity, cover short positions and support customer securities lending. For additional information on offsetting see Note 7*—"Offsetting of Derivatives and Securities Financing Agreements"* in the 2025 Form 10-K.

The following tables present information about the offsetting of these instruments and related collateral amounts:

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| | **September 30, 2025** | **September 30, 2025** | **September 30, 2025** | **September 30, 2025** | **September 30, 2025** |
|<br>***(Dollars in thousands)*** | **Gross Assets / Liabilities** | **Amounts Offset** | **Net Balance Sheet Amount** | **Amounts Not Offset**<sup>2</sup> | **Net Assets / Liabilities** |
| Assets: |  |  |  |  |  |
| &nbsp;&nbsp;Securities borrowed | $182518 | $— | $182518 | $182518 | $— |
| &nbsp;&nbsp;Other Assets — Derivative Assets<sup>1</sup> | 17891 |  | 17891 | 10468 | 7423 |
| Liabilities: |  |  |  |  |  |
| &nbsp;&nbsp;Securities loaned | $204620 | $— | $204620 | $204620 | $— |
| &nbsp;&nbsp;Accounts Payable and Other Liabilities — Derivative Liabilities | 64618 |  | 64618 | 6682 | 57936 |

---

------

<u>[**Table of Contents**](#i7c17675c26f44bbd9ee68808b9f08846_7)</u>

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| | **June 30, 2025** | **June 30, 2025** | **June 30, 2025** | **June 30, 2025** | **June 30, 2025** |
|<br>***(Dollars in thousands)*** | **Gross Assets / Liabilities** | **Amounts Offset** | **Net Balance Sheet Amount** | **Amounts Not Offset**<sup>2</sup> | **Net Assets / Liabilities** |
| Assets: |  |  |  |  |  |
| &nbsp;&nbsp;Securities borrowed | $139396 | $— | $139396 | $139396 | $— |
| &nbsp;&nbsp;Other Assets — Derivative Assets<sup>1</sup> | 17734 |  | 17734 | 11174 | 6560 |
| Liabilities: |  |  |  |  |  |
| &nbsp;&nbsp;Securities loaned | $139426 | $— | $139426 | $139426 | $— |
| &nbsp;&nbsp;Accounts Payable and Other Liabilities — Derivative Liabilities | 68497 |  | 68497 | 6122 | 62375 |

---

<sup>1</sup> *Gross amounts of Other Assets - Derivative Assets are presented net of $50.8 million and $55.4 million of variation margin on centrally-cleared derivatives as of September 30, 2025 and June 30, 2025, respectively.*

<sup>2</sup> *Amounts not offset reflect cash collateral received on Derivative Assets of $5.3 million and $6.3 million as of September 30, 2025 and June 30, 2025, respectively, and cash collateral placed on Derivative Liabilities of $1.5 million and $1.3 million as of September 30, 2025 and June 30, 2025, respectively.* 

The securities loaned transactions represent equities with an overnight and open maturity classification as of both periods presented.

**8.&nbsp;&nbsp;&nbsp;&nbsp;STOCKHOLDERS' EQUITY AND STOCK-BASED COMPENSATION**

The Company has an equity incentive plan, the Amended and Restated 2014 Stock Incentive Plan (the "2014 Plan"), which provides for the granting of non-qualified and incentive stock options, restricted stock and restricted stock units ("RSUs"), stock appreciation rights and other awards to employees, directors and consultants. The Company also has an employment agreement with its Chief Executive Officer that provides for an award of RSUs. For additional information regarding the Company's stock-based compensation plans, see Note 16*—"Stock-Based Compensation"* in the 2025 Form 10-K.

At September 30, 2025, 868,891 shares of common stock were authorized for future awards under the 2014 Plan. As of September 30, 2025, the total compensation cost not yet recognized related to non-vested awards was $87.0 million, which is expected to be recognized over a weighted-average period of 1.5 years.

The following table presents the status and changes in RSUs:

---

| | | |
|:---|:---|:---|
| | **RSUs** | **Weighted-Average<br>Grant-Date Fair Value** |
| Non-vested balance at June 30, 2025 | 1564016 | $55.50 |
| Granted | 385696 | 90.47 |
| Vested | (254510) | 47.24 |
| Forfeited | (26093) | 57.93 |
| Non-vested balance at September 30, 2025 | 1669109 | $64.81 |

---

The total fair value of shares vested for the three months ended September 30, 2025 and September 30, 2024 was $22.8 million and $22.5 million, respectively.

***Common Stock Repurchase Program***

As of September 30, 2025, there was $148.1 million of share repurchase authorization remaining under the Compnay's common stock repurchase program. The share repurchase program will continue in effect until terminated by the Board of Directors of the Company. There were no common stock repurchases pursuant to such program for the three months ended September 30, 2025 and 2024. For additional information regarding the Company's share repurchase program, see Note 15*—"Stockholders' Equity"* in the 2025 Form 10-K.

***At-the-Market Equity Offering***

On January 28, 2025, the Company entered into an equity distribution agreement pursuant to which the Company may issue and sell through distribution agents from time to time shares of the Company's common stock in at-the-market offerings with an aggregate offering price of up to $150,000,000. The Company will issue the stock pursuant to a previously effective registration statement and a prospectus supplement filed with the SEC on January 28, 2025. No shares of the Company's common stock have been issued pursuant to this offering.

------

<u>[**Table of Contents**](#i7c17675c26f44bbd9ee68808b9f08846_7)</u>

***Accumulated Other Comprehensive Income***

AOCI includes the after-tax change in unrealized gains and losses on investment securities and cash flow hedging activities.

---

| | | | |
|:---|:---|:---|:---|
| | **For the Three Months Ended September 30, 2025** | **For the Three Months Ended September 30, 2025** | **For the Three Months Ended September 30, 2025** |
|<br>***(Dollars in thousands)*** | **Unrealized gain (loss) on available-for-sale securities** | **Cash flow hedges** | **Accumulated other comprehensive income** |
| Balance at June 30, 2025 | $(780) | $1128 | $348 |
| Other comprehensive income/(loss) | 254 | (538) | (284) |
| Balance at September 30, 2025 | $(526) | $590 | $64 |

---

---

| | | | |
|:---|:---|:---|:---|
| | **For the Three Months Ended September 30, 2024** | **For the Three Months Ended September 30, 2024** | **For the Three Months Ended September 30, 2024** |
|<br>***(Dollars in thousands)*** | **Unrealized gain (loss) on available-for-sale securities** | **Cash flow hedges** | **Accumulated other comprehensive income** |
| Balance at June 30, 2024 | $(2466) | $— | $(2466) |
| Other comprehensive income/(loss) | 1319 | 382 | 1701 |
| Balance at September 30, 2024 | $(1147) | $382 | $(765) |

---

The following table presents the pre-tax and after-tax changes in the components of other comprehensive income.

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| | **For the Three Months Ended<br>September 30, 2025** | **For the Three Months Ended<br>September 30, 2025** | **For the Three Months Ended<br>September 30, 2025** | **For the Three Months Ended<br>September 30, 2024** | **For the Three Months Ended<br>September 30, 2024** | **For the Three Months Ended<br>September 30, 2024** |
|<br>***(Dollars in thousands)*** | **Pre-tax** | **Tax effect** | **After-tax** | **Pre-tax** | **Tax effect** | **After-tax** |
| Unrealized gain/(loss) on investment securities: |  |  |  |  |  |  |
| &nbsp;&nbsp;Net unrealized gains/(losses) arising during the period | $350 | $(96) | $254 | $1884 | $(565) | $1319 |
| &nbsp;&nbsp;Reclassification adjustment for realized (gains)/losses included in net income |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Net change | $350 | $(96) | $254 | $1884 | $(565) | $1319 |
| Cash flow hedges: |  |  |  |  |  |  |
| &nbsp;&nbsp;Net unrealized gains/(losses) arising during the period | $374 | $(104) | $270 | $553 | $(171) | $382 |
| &nbsp;&nbsp;Reclassification adjustment for realized (gains)/losses included in net income | (1118) | 310 | (808) |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Net change | (744) | 206 | (538) | 553 | (171) | 382 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total other comprehensive income/(loss) | $(394) | $110 | $(284) | $2437 | $(736) | $1701 |

---

**9.&nbsp;&nbsp;&nbsp;&nbsp;EARNINGS PER COMMON SHARE**

The following table presents the calculation of basic and diluted earnings per common share ("EPS"):

---

| | | |
|:---|:---|:---|
| | **Three Months Ended** | **Three Months Ended** |
| | **September 30,** | **September 30,** |
|<br>***(Dollars in thousands, except per share data)*** | **2025** | **2024** |
| **Earnings Per Common Share** |  |  |
| Net income | $112352 | $112340 |
| Average common shares issued and outstanding | 56512587 | 56934671 |
| Earnings per common share | $1.99 | $1.97 |
| **Diluted Earnings Per Common Share** |  |  |
| Average common shares issued and outstanding | 56512587 | 56934671 |
| Dilutive effect of average unvested RSUs | 1270241 | 1233797 |
| Average dilutive common shares outstanding | 57782828 | 58168468 |
| Diluted earnings per common share | $1.94 | $1.93 |
| Weighted average antidilutive common stock equivalents (excluded from the computation of EPS) | 33122 |  |

---

For further information regarding the Company's EPS calculation, see Note 17*—"Earnings per Common Share"* in the 2025 Form 10-K.

------

<u>[**Table of Contents**](#i7c17675c26f44bbd9ee68808b9f08846_7)</u>

**10.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;COMMITMENTS AND CONTINGENCIES**

***Credit-Related Financial Instruments***. The Company is a party to credit-related financial instruments with off-balance-sheet risk in the normal course of business to meet the financing needs of its customers. These financial instruments are commitments to extend credit. Such commitments involve, to varying degrees, elements of credit and interest rate risk in excess of the amount recognized in the Consolidated Balance Sheets.

The Company's exposure to credit loss is represented by the contractual amount of these commitments. The Company follows the same credit policies in making commitments as it does for on-balance-sheet instruments.

Commitments to extend credit are agreements to lend to a customer so long as there is no violation of any condition established in the contract. Commitments generally have fixed expiration dates or other termination clauses and may require payment of a fee. Since many of the commitments may expire without being drawn upon, the total commitment amounts do not necessarily represent future cash requirements. The amount of collateral obtained, if it is deemed necessary by the Company, is based on management's credit evaluation of the customer. For single family loans classified as held for sale, the Company matches unfunded commitments to originate loans with commitments to sell loans. The Company also has standby letters of credit commitments. The following table presents a summary of off-balance sheet commitments.

---

| | |
|:---|:---|
| ***(dollars in thousands)*** | **September 30, 2025** |
| Commitments to fund loans | $5830963 |
| Commitments to sell loans | $4785 |
| Standby letters of credit | $9566 |
| Commitments to contribute capital - Non-LIHTC | $3494 |

---

In addition, the Company has $43.6 million of commitments to contribute capital to low-income housing tax credit ("LIHTC") investments included in "Accounts payable and other liabilities" on the Consolidated Balance Sheets. See Note 13—*"Other Assets"* for additional information on LIHTC investments.

In the normal course of business, Axos Clearing LLC's ("Axos Clearing") customer activities involve the execution, settlement, and financing of various customer securities transactions. These activities may expose Axos Clearing to off-balance-sheet risk in the event the customer or other broker is unable to fulfill its contracted obligations and Axos Clearing has to purchase or sell the financial instrument underlying the contract at a loss. Axos Clearing's clearing agreements with broker-dealers for which it provides clearing services requires them to indemnify Axos Clearing if customers fail to satisfy their contractual obligation.

***Litigation.*** A consolidated derivative action, In re BofI Holding, Inc., Case No. 15cv2722GPC (KSC), was filed in the United States District Court for the Southern District of California (the "Derivative Action"). The complaint in the Derivative Action set forth allegations made in a related employment action, Erhart v. BofI Holding Inc., No. 15cv2287 BAS (NLS) (S.D. Cal.) (the "Employment Action") brought by a former employee of the Company and was stayed pending resolution of the Employment Action. On October 4, 2023, the court hearing the Employment Action entered a final amended judgment awarding damages and attorneys' fees to the plaintiff. The defendant filed a Notice of Appeal from the Employment Action judgment and all orders merged therein, and the parties have filed opening and responsive briefs and an oral argument was held on January 15, 2025. On January 2, 2024, the Derivative Action plaintiff filed a Third Amended Complaint. On March 5, 2024, the court stayed the case until resolution of the appeal in the Employment Action. On February 6, 2025, the appellate court affirmed the jury's verdict in the Employment Action in a short, unpublished decision. On July 24, 2025, the Employment Action defendant filed a petition for writ of certiorari asking the United States Supreme Court to review the appellate court's decision. On October 6, 2025 the United States Supreme Court denied said petition. The Derivative Action defendants filed a Motion to Dismiss the Third Amended Complaint on April 4, 2025. A hearing on the motion was held on June 26, 2025. On September 18, 2025, the court granted defendants' motion to dismiss with prejudice citing Plaintiffs' failure to plead demand futility. On October 17, 2025, Plaintiffs filed a Notice of Appeal to the United States Court of Appeals for the Ninth Circuit. Such defendants dispute, and intend to continue vigorously defending against, the allegations raised in the Third Amended Complaint. The Derivative Action plaintiff seeks damages on behalf of the Company with respect to the Employment Action and also seeks damages on behalf of the Company in connection with a now settled securities class action that was also based upon allegations made in the Employment Action and settled within available insurance coverage without attribution of wrongdoing to the Company, its management, or its directors.

The following three putative class action lawsuits are pending in the United States District Court, Southern District of California, under the following case names and numbers: (1) In re Axos Bank d/b/a UFB Direct Litigation, 3:23-cv-02266-BJC-DTF; (2) Pliszka et al. v. Axos Bank d/b/a UFB Direct, Case No. 3:24-cv-00445-BJC-DTF; and (3) Ash et al. v. Axos Bank d/b/a UFB Direct, Case No. 3:24-cv-01157-BJC-DTF (collectively, the "UFB Actions"). The plaintiffs in the UFB Actions allege that certain rate representations made by Axos Bank with respect to its UFB products were false or misleading. Axos Bank filed

------

<u>[**Table of Contents**](#i7c17675c26f44bbd9ee68808b9f08846_7)</u>

a motion to compel arbitration or dismiss the complaint in each of the UFB Actions. On September 13, 2024, the court entered an order compelling arbitration in each lawsuit. Accordingly, a separate AAA arbitration was initiated with respect to each of the UFB Actions. On March 26, 2025, the arbitrator in the Pliszka arbitration proceedings issued an order finding that none of the claims raised are subject to arbitration, dismissing the arbitration and remanding the case back to the United States District Court. A similar conclusion was reached by the arbitrator in the Ash arbitration via an order issued on June 3, 2025. The arbitrator in the Stempel arbitration reached a contrary conclusion and entered an order finding the claims to be arbitrable on June 5, 2025. On October 11, 2024, Defendant filed an appeal seeking to enforce Defendant's updated/modified Account Agreement and Online Access Agreement in *Stempel*, Pliszka and Ash. Defendant's opening brief in such appeal was filed July 11, 2025. On September 9, 2025, the court in the *Consolidated Action* granted Defendant's renewed motion to compel arbitration. Defendant disputes, and intends to vigorously defend against, the allegations raised in the UFB Actions. The Company does not expect the ultimate outcome of the UFB Actions to have a material adverse effect on its consolidated results of operations, financial position or cash flows. It is not presently possible to state whether the likelihood of an unfavorable outcome is probable or remote, or to estimate the amount or range of any possible loss to the Company should an unfavorable outcome occur.

**11.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;SEGMENT REPORTING AND REVENUE INFORMATION**

***Segment Reporting.*** The operating segments reported below are the segments of the Company for which separate financial information is available and for which segment results are evaluated regularly by the Chief Executive Officer, who is the Chief Operating Decision Maker ("CODM"), in deciding how to allocate resources and in assessing performance. The operating segments and segment results of the Company are determined based upon the management reporting system, which assigns balance sheet and income statement items to each of the business segments and by which segment results are evaluated by the CODM in deciding how to allocate resources and in assessing performance.

The Company evaluates performance and allocates resources based on pre-tax profit or loss from operations in conjunction with its corporate strategy. Salaries and related costs represent the significant segment expense that is regularly provided to the CODM. For more information on the Company's operating segments, see Note 22*—"Segment Reporting"* in the 2025 Form 10-K.

In order to reconcile the two segments to the consolidated totals, the Company includes corporate activities and intercompany eliminations. The following tables present the operating results, goodwill, and assets of the segments:

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **For the Three Months Ended September 30, 2025** | **For the Three Months Ended September 30, 2025** | **For the Three Months Ended September 30, 2025** | **For the Three Months Ended September 30, 2025** |
|<br>***(Dollars in thousands)*** | **Banking <br>Business Segment** | **Securities Business Segment** | **Corporate/Eliminations** | **Axos Consolidated** |
| Net interest income | $287200 | $8194 | $(4344) | $291050 |
| Provision for credit losses | 17255 |  |  | 17255 |
| Non-interest income<sup>1</sup> | 12375 | 29457 | (9492) | 32340 |
| &nbsp;&nbsp;&nbsp;&nbsp;Salaries and related costs | 55340 | 14750 | 6515 | 76605 |
| &nbsp;&nbsp;&nbsp;&nbsp;Other segment items<sup>2</sup> | 73153 | 14617 | (8129) | 79641 |
| Non-interest expense<sup>1</sup> | 128493 | 29367 | (1614) | 156246 |
| Income before taxes | $153827 | $8284 | $(12222) | $149889 |
|  | **For the Three Months Ended September 30, 2024** | **For the Three Months Ended September 30, 2024** | **For the Three Months Ended September 30, 2024** | **For the Three Months Ended September 30, 2024** |
| ***(Dollars in thousands)*** | **Banking <br>Business Segment** | **Securities Business Segment** | **Corporate/Eliminations** | **Axos Consolidated** |
| Net interest income | $288492 | $7267 | $(3711) | $292048 |
| Provision for credit losses | 14000 |  |  | 14000 |
| Non-interest income<sup>1</sup> | 8590 | 29902 | (9883) | 28609 |
| &nbsp;&nbsp;&nbsp;&nbsp;Salaries and related costs | 51957 | 14725 | 7611 | 74293 |
| &nbsp;&nbsp;&nbsp;&nbsp;Other segment items<sup>2</sup> | 66358 | 13366 | (6552) | 73172 |
| Non-interest expense<sup>1</sup> | 118315 | 28091 | 1059 | 147465 |
| Income before taxes | $164767 | $9078 | $(14653) | $159192 |
| <sup>1</sup> *Includes $9.7 million and $10.6 million for the three months ended September 30, 2025 and 2024, respectively, of non-interest income earned by the Securities Business Segment and non-interest expense incurred by the Banking Business Segment for cash sorting fees related to deposits sourced from Securities Business Segment customers.*<br><sup>2</sup> *Other segment items includes the non-interest expenses other than salaries and related costs as presented in the Consolidated Statements of Income.* | <sup>1</sup> *Includes $9.7 million and $10.6 million for the three months ended September 30, 2025 and 2024, respectively, of non-interest income earned by the Securities Business Segment and non-interest expense incurred by the Banking Business Segment for cash sorting fees related to deposits sourced from Securities Business Segment customers.*<br><sup>2</sup> *Other segment items includes the non-interest expenses other than salaries and related costs as presented in the Consolidated Statements of Income.* | <sup>1</sup> *Includes $9.7 million and $10.6 million for the three months ended September 30, 2025 and 2024, respectively, of non-interest income earned by the Securities Business Segment and non-interest expense incurred by the Banking Business Segment for cash sorting fees related to deposits sourced from Securities Business Segment customers.*<br><sup>2</sup> *Other segment items includes the non-interest expenses other than salaries and related costs as presented in the Consolidated Statements of Income.* | <sup>1</sup> *Includes $9.7 million and $10.6 million for the three months ended September 30, 2025 and 2024, respectively, of non-interest income earned by the Securities Business Segment and non-interest expense incurred by the Banking Business Segment for cash sorting fees related to deposits sourced from Securities Business Segment customers.*<br><sup>2</sup> *Other segment items includes the non-interest expenses other than salaries and related costs as presented in the Consolidated Statements of Income.* | <sup>1</sup> *Includes $9.7 million and $10.6 million for the three months ended September 30, 2025 and 2024, respectively, of non-interest income earned by the Securities Business Segment and non-interest expense incurred by the Banking Business Segment for cash sorting fees related to deposits sourced from Securities Business Segment customers.*<br><sup>2</sup> *Other segment items includes the non-interest expenses other than salaries and related costs as presented in the Consolidated Statements of Income.* |

---

------

<u>[**Table of Contents**](#i7c17675c26f44bbd9ee68808b9f08846_7)</u>

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **As of September 30, 2025** | **As of September 30, 2025** | **As of September 30, 2025** | **As of September 30, 2025** |
|<br>***(Dollars in thousands)*** | **Banking <br>Business Segment** | **Securities Business Segment** | **Corporate/Eliminations** | **Axos Consolidated** |
| Goodwill | $89588 | $59953 | $1999 | $151540 |
| Total Assets | $26536563 | $841882 | $53372 | $27431817 |
|  | **As of June 30, 2025** | **As of June 30, 2025** | **As of June 30, 2025** | **As of June 30, 2025** |
| ***(Dollars in thousands)*** | **Banking <br>Business Segment** | **Securities Business Segment** | **Corporate/Eliminations** | **Axos Consolidated** |
| Goodwill | $35721 | $59953 | $1999 | $97673 |
| Total Assets | $23988748 | $751820 | $42510 | $24783078 |

---

***Revenue Information.*** The following presents non-interest income, segregated by revenue streams in-scope and out-of-scope of Accounting Standards Codification ("ASC") 606 for the periods indicated. For additional information on the Company's recognition of revenue and ASC 606, see Note 1*—"Organizations and Summary of Significant Accounting Policies"* in the 2025 Form 10-K.

---

| | | |
|:---|:---|:---|
| | **For the Three Months Ended** | **For the Three Months Ended** |
| | **September 30,** | **September 30,** |
|<br>***(Dollars in thousands)*** | **2025** | **2024** |
| Advisory fee income | $8525 | $7945 |
| Broker-dealer clearing fees | 5814 | 5072 |
| Deposit service fees | 1168 | 773 |
| Card fees | 516 | 923 |
| Bankruptcy trustee and fiduciary service fees | 569 | 1289 |
| &nbsp;&nbsp;&nbsp;&nbsp;Non-interest income (in-scope of ASC 606) | 16592 | 16002 |
| &nbsp;&nbsp;&nbsp;&nbsp;Non-interest income (out-of-scope of ASC 606) | 15748 | 12607 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total non-interest income | $32340 | $28609 |

---

**12.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;BORROWINGS, SUBORDINATED NOTES AND DEBENTURES**

***Subordinated Notes.*** On September 19, 2025, the Company completed the issuance of $200 million aggregate principal amount of the Company's 7.00% Fixed-to-Floating Rate Subordinated Notes (the "2035 Notes"). The 2035 Notes are obligations only of Axos Financial, Inc. The 2035 Notes mature on October 1, 2035 and accrue interest at a fixed rate per annum equal to 7.00%, payable semi-annually in arrears on April 1 and October 1 of each year during the fixed period, commencing on October 1, 2025. From and including October 1, 2030, to, but excluding October 1, 2035 or the date of early redemption, the 2035 Notes will bear interest at a floating rate per annum equal to three-month term SOFR plus a spread of 379 basis points, payable quarterly in arrears on January 1, April 1, July 1 and October 1 of each year, commencing on January 1, 2031. The 2035 Notes may be redeemed on or after October 1, 2030, which date may be extended at the Company's discretion, at a redemption price equal to principal plus accrued and unpaid interest, subject to certain conditions. Fees and costs incurred in connection with the debt offering amortize to "Interest expense - Other borrowings" in the Condensed Consolidated Statements of Income over the term of the 2035 Notes.

On October 1, 2025, the Company completed the redemption of the $160.5 million aggregate principal amount outstanding of its 4.875% Fixed-to-Floating Rate Subordinated Notes due 2030 (the "2030 Notes"), which were set to begin their floating period on such date. The 2030 Notes were redeemed for cash by the Company at 100% of their principal amount, plus accrued and unpaid interest, in accordance with the terms of the indenture governing the 2030 Notes. Remaining unamortized deferred financing costs associated with such notes were expensed and included under "Interest expense - Other borrowings" in the Condensed Consolidated Statements of Income.

For information on secured financings issued by variable interest entities ("VIEs") consolidated by the Company, see Note 14— "*Variable Interest Entities,"* and for additional information on other borrowings, see Note 13—*"Borrowings, Subordinated Notes and Debentures"* in the 2025 Form 10-K.

------

<u>[**Table of Contents**](#i7c17675c26f44bbd9ee68808b9f08846_7)</u>

**13.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;OTHER ASSETS**

"Other Assets" in the Consolidated Balance Sheets primarily comprises bank-owned life insurance ("BOLI"), accrued interest receivable, derivatives, net deferred income tax assets, furniture, equipment and software, right-of-use lease assets, LIHTC investments and other receivables. For additional information on other assets, see Note 9—*"Other Assets"* in the 2025 Form 10-K. For additional information on accrued interest receivable, see Note 5—*"Loans & Allowance for Credit Losses,"* and for additional information on derivatives, see Note 6—*"Derivatives."*

***LIHTC Investments.*** The Company recognized the following income and tax benefits for its LIHTC investments.

---

| | | |
|:---|:---|:---|
| | **For the Three Months Ended September 30,**  | **For the Three Months Ended September 30,**  |
|<br>***(Dollars in thousands)*** | **2025** | **2024** |
| Tax credits recognized | $2282 | $1420 |
| Other tax benefits recognized | 1090 | 312 |
| Amortization | (2564) | (1406) |
| Net benefit (expense) included in income tax expense | 808 | 326 |
| Other income (loss) included in banking and service fees | 9 |  |
| Net benefit (expense) included in the Consolidated Statements of Income | $817 | $326 |

---

The Company recognized the following investments on its balance sheets.

---

| | | |
|:---|:---|:---|
| ***(Dollars in thousands)*** | **As of September 30, 2025** | **As of June 30, 2025** |
| LIHTC investments | $82311 | $84875 |
| LIHTC unfunded commitments<sup>1</sup> | $43555 | $47381 |

---

<sup>1</sup>*LIHTC unfunded commitments are included in "Accounts Payable and Other Liabilities" on the Consolidated Balance Sheets.*

For the three months ended September 30, 2025 and 2024, there have been no significant modifications or events that resulted in the change in the nature of the LIHTC investments or any changes in the relationship with the underlying project.

For the three months ended September 30, 2025 and 2024, there has been no impairment loss recognized from the forfeiture or ineligibility of income tax credits.

**14.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;VARIABLE INTEREST ENTITIES**

The Company consolidated the results of operations and financial position of three lending-related entities, which it considers VIEs. The Company consolidated these VIEs because it or its subsidiaries is deemed to be the primary beneficiary since the Company or its subsidiaries has the power to direct the loan servicing or portfolio management activities, which are the activities that most significantly affect the VIEs' economic performance, and the Company or its subsidiaries has the obligation to absorb the majority of the losses or benefits through ownership of all of the secured financings issued by the trusts. For these VIEs, the loans transferred to the VIEs are pledged as collateral to the related secured financings.

In addition, through its acquisition of Verdant, the Company acquired additional variable interests in certain securitization trusts. Following the acquisition, the Company performed an assessment and determined it continues to direct the activities that most significantly affect the acquired VIEs' economic performance, and the Company has the obligation to absorb the majority of the losses or benefits of such acquired variable interests. As a result, the Company determined it is the primary beneficiary and continues to consolidate the VIEs as of September 30, 2025.

For these VIEs, including those acquired in the Verdant acquisition, the loans transferred to the VIEs are pledged as collateral to the related secured financings.

The following table provides a summary of the assets and liabilities of consolidated VIEs in the Company's Condensed Consolidated Balance Sheets.

------

<u>[**Table of Contents**](#i7c17675c26f44bbd9ee68808b9f08846_7)</u>

---

| | | |
|:---|:---|:---|
| ***(Dollars in thousands)*** | **As of September 30, 2025** | **As of June 30, 2025** |
| Restricted cash | $34836 | $— |
| Loans—net of allowance for credit losses | 1876611 | 1276101 |
| Other assets | 158353 |  |
| Secured financings | 753501 |  |
| Accounts payable and other liabilities | 2207 |  |

---

As part of its securitization activities, Verdant issued a series of notes to provide additional financing to its business. The notes outstanding as of September 30, 2025 are included in "Secured financings" in the Company's Condensed Consolidated Balance Sheet and are summarized in the below table:

---

| | | | | |
|:---|:---|:---|:---|:---|
| **Series** | **Classes** | **Interest Rate Range** | **Maturity Date / Range** | **Outstanding Principal at September 30, 2025**<br>***(Dollars in thousands)*** |
| 2022-01 | Class A, B, C, D | 6.59% to 8.67% | February 2030 | $14963 |
| 2023-01 | Class A-1, A-2, B, C, D | 6.05% to 7.75% | January 2031 | 129906 |
| 2024-01 | Class A-1, A-2, B, C, D | 5.68% to 7.23% | December 2031 | 215938 |
| 2025-01 | Class A-1, A-2, A-3, B, C, D | 4.66% to 6.49% | March 2028 to <br>May 2033 | 376161 |
| &nbsp;&nbsp;&nbsp;&nbsp;**Total** |  |  |  | $**736968** |

---

For additional information on the Verdant acquisition, see Note 2, "*Acquisitions*."

------

<u>[**Table of Contents**](#i7c17675c26f44bbd9ee68808b9f08846_7)</u>

**ITEM 2. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS**

***The following discussion provides information about the results of operations, financial condition, liquidity, and capital resources of Axos Financial, Inc. and subsidiaries (collectively, "we", "us" or the "Company"). This information is intended to facilitate the understanding and assessment of significant changes and trends related to our financial condition and the results of our operations. This discussion and analysis should be read in conjunction with our financial information in our 2025 Form 10-K, and the interim unaudited condensed consolidated financial statements and notes thereto contained in this report.***

Some matters discussed in this report may constitute forward-looking statements within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), and as such, may involve risks and uncertainties. These forward-looking statements can be identified by the use of terminology such as "estimate," "project," "anticipate," "expect," "intend," "believe," "will," or the negative thereof or other variations thereon or comparable terminology, or by discussions of strategy that involve risks and uncertainties. These forward-looking statements relate to, among other things, the Company's financial prospects and other projections of our performance and asset quality, our deposit balances and capital ratios, our ability to continue to grow profitably and increase our business, our ability to continue to diversify lending and deposit franchises, the anticipated timing and financial performance of other offerings, initiatives, and acquisitions, expectations of the environment in which we operate and projections of future performance. Actual results and the timing of events could differ materially from those expressed or implied in such forward-looking statements as a result of risks and uncertainties, including without limitation our ability to successfully integrate acquisitions and realize the anticipated benefits of the transactions, changes in the interest rate environment, monetary policy, inflation, tariffs, government regulation, general economic conditions, changes in the competitive marketplace, conditions in the real estate markets in which we operate, risks associated with credit quality, our ability to attract and retain deposits and access other sources of liquidity, and the outcome and effects of litigation and other factors beyond our reasonable control. These and other risks and uncertainties are discussed under the heading "Item 1A. Risk Factors" herein and in our 2025 Form 10-K, which has been filed with the SEC, could cause actual results to differ materially from those expressed or implied in any forward-looking statements. Readers are cautioned not to place undue reliance on forward-looking statements, which speak only as of the date of this report. All forward-looking statements are qualified in their entirety by this cautionary statement, and we undertake no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. All written and oral forward-looking statements made in connection with this report, which are attributable to us or persons acting on our behalf are expressly qualified in their entirety by the foregoing information.

**General**

Our Company is a technology-driven, diversified financial services company with approximately $27.4 billion in assets and approximately $43.0 billion of assets under custody and/or administration at Axos Clearing LLC ("Axos Clearing"). Our client-centric, technology platforms provide secure and scalable banking, clearing and custody, and investment advisory solutions to retail and business customers. Axos Bank (the "Bank") provides consumer and commercial banking products through its digital online and mobile banking platforms, low-cost distribution channels and affinity partners. Our Bank offers deposit and lending products to customers nationwide including consumer and business checking, savings and time deposit accounts and single family and multifamily residential mortgages, commercial real estate mortgages and loans, fund and lender finance loans, asset-based loans, auto loans and other consumer loans. Our Bank generates non-interest income from consumer and business products, including fees from loans originated for sale, deposit account service fees, prepayment fees, as well as technology and payment transaction processing fees. We offer securities products and services to independent registered investment advisors ("RIAs") and introducing broker dealers ("IBDs") through Axos Clearing and Axos Advisor Services ("AAS") and direct-to-consumer securities trading and digital investment management products through Axos Invest, Inc. ("Axos Invest"). AAS and Axos Clearing generate interest and fee income by providing comprehensive securities custody services to RIAs and clearing, stock lending and margin lending services to IBDs, respectively. Axos Invest generates fee income from self-directed securities trading and margin lending and fee income from digital wealth management services to consumers. Our common stock is listed on the New York Stock Exchange under the ticker symbol "AX" and is a component of the Russell 2000® Index and the S&P SmallCap 600® Index, among other indices.

Axos Financial, Inc. is supervised and regulated as a savings and loan holding company that has elected to be treated as a financial holding company by the Board of Governors of the Federal Reserve System (the "Federal Reserve") and is required to file reports with, comply with the rules and regulations of, and is subject to examination by, the Federal Reserve.

Our Bank is a federal savings association, which has elected to operate as a covered savings association. The Bank is regulated by the Office of the Comptroller of the Currency ("OCC"), and the Federal Deposit Insurance Corporation ("FDIC") as its deposit insurer. The Bank must file reports with the OCC and the FDIC concerning its activities and financial condition.

------

<u>[**Table of Contents**](#i7c17675c26f44bbd9ee68808b9f08846_7)</u>

As a depository institution with more than $10 billion in assets, our Bank and our affiliates are subject to direct supervision by the Consumer Financial Protection Bureau.

Axos Clearing is a broker-dealer registered with the SEC and the Financial Industry Regulatory Authority, Inc. ("FINRA"). Axos Invest is a Registered Investment Advisor under the Investment Advisers Act of 1940, that is registered with the SEC. Axos Invest LLC is an IBD that is registered with the SEC and FINRA.

**Mergers and Acquisitions**

On September 30, 2025, the Company completed the acquisition of 100% of the membership interests in Verdant Commercial Capital, LLC ("Verdant") in an all-cash transaction, which increases the Company's scale and enhances the Company's existing equipment leasing business. As part of the acquisition, the Company acquired, among other assets and liabilities, approximately $1.0 billion of loans and leases (including $211.0 million of PCD assets) and $212.6 million of equipment under operating lease arrangements.

For additional information on this acquisition, see Note 2, "*Acquisitions*" in the accompanying interim condensed consolidated financial statements.

**Segment Information**

The Company determines reportable segments based on what separate financial information is available and what segment results are evaluated regularly by the Chief Executive Officer in deciding how to allocate resources and in assessing performance. We operate through two segments: the Banking Business Segment and the Securities Business Segment.

***Banking Business Segment.*** The Banking Business Segment includes a broad range of banking services including online banking, concierge banking, and mortgage, vehicle and unsecured lending through online, low-cost distribution channels to serve the needs of consumers and small businesses nationally. In addition, the Banking Business Segment focuses on providing deposit products nationwide to industry verticals (e.g., Title and Escrow), treasury management products to a variety of businesses, and commercial & industrial and commercial real estate lending to clients. The Banking Business Segment includes a bankruptcy trustee and fiduciary service that provides specialized software and consulting services to Chapter 7 bankruptcy and non-Chapter 7 trustees and fiduciaries.

***Securities Business Segment.*** The Securities Business Segment includes the clearing broker-dealer, registered investment advisor custody business, and introducing broker-dealer lines of businesses. These lines of business offer products independently to their own customers as well as to Banking Business Segment clients.

**Critical Accounting Estimates**

The following discussion and analysis of our financial condition and results of operations is based upon our unaudited condensed consolidated financial statements and the notes thereto, which have been prepared in accordance with GAAP. The preparation of these unaudited condensed consolidated financial statements requires us to make a number of estimates and assumptions that affect the reported amounts and disclosures in the unaudited condensed consolidated financial statements. On an ongoing basis, we evaluate our estimates and assumptions based upon historical experience and various factors and circumstances. We believe our estimates and assumptions are reasonable under the circumstances. However, actual results may differ significantly from these estimates and assumptions and could have a material effect on the carrying value of assets and liabilities, our results of operations and/or our cash flows.

Critical accounting estimates are those we consider most important to the portrayal of our financial condition and results of operations because they require our most difficult judgments, often as a result of the need to make estimates that are inherently uncertain. Our critical accounting estimates are described in detail in the 2025 Form 10-K in Note 1*—"Organizations and Summary of Significant Accounting Policies"* and Item 7*—*"*Management's Discussion and Analysis of Financial Condition and Results of Operations*—*Critical Accounting Estimates."*

------

<u>[**Table of Contents**](#i7c17675c26f44bbd9ee68808b9f08846_7)</u>

 **USE OF NON-GAAP FINANCIAL MEASURES**

In addition to the results presented in accordance with GAAP, this report includes the non-GAAP financial measures adjusted earnings, adjusted earnings per common share ("Adjusted EPS"), and tangible book value per common share. Non-GAAP financial measures have inherent limitations, may not be comparable to similarly titled measures used by other companies and are not audited. Readers should be aware of these limitations and should be cautious as to their reliance on such measures. As noted below with respect to each measure, we believe the non-GAAP financial measures disclosed in this report enhance investors' understanding of our business and performance, and our management uses these non-GAAP measures when it internally evaluates the performance of our business and makes operating decisions. However, these non-GAAP measures should not be considered in isolation, or as a substitute for GAAP basis financial measures.

We define "adjusted earnings", a non-GAAP financial measure, as net income without the after-tax impact of non-recurring acquisition-related items, (including amortization of intangible assets related to acquisitions) and other costs (unusual or non-recurring charges). Adjusted EPS, a non-GAAP financial measure, is calculated by dividing non-GAAP adjusted earnings by the average number of diluted common shares outstanding during the period. We believe the non-GAAP measures of adjusted earnings and adjusted EPS provide useful information about the Company's operating performance. We believe excluding the non-recurring acquisition-related costs, and other costs provides investors with an alternative understanding of our core business.

Below is a reconciliation of net income, the nearest comparable GAAP measure, to adjusted earnings and adjusted EPS (Non-GAAP):

---

| | | |
|:---|:---|:---|
| | **For the Three Months Ended September 30,**  | **For the Three Months Ended September 30,**  |
|<br>***(Dollars in thousands, except per share data)*** | **2025** | **2024** |
| Net income | $112352 | $112340 |
| &nbsp;&nbsp;Acquisition-related costs<sup>1</sup> | 2941 | 2554 |
| &nbsp;&nbsp;Verdant acquisition - Provision for credit losses | $7765 |  |
| &nbsp;&nbsp;&nbsp;Income tax effect | (2681) | (752) |
| &nbsp;&nbsp;&nbsp;&nbsp;Adjusted earnings (Non-GAAP) | $120377 | $114142 |
| Average dilutive common shares outstanding | 57782828 | 58168468 |
| Diluted EPS | $1.94 | $1.93 |
| &nbsp;&nbsp;Acquisition-related costs<sup>1</sup> | 0.05 | 0.04 |
| &nbsp;&nbsp;Verdant acquisition - Provision for credit losses | 0.13 |  |
| &nbsp;&nbsp;&nbsp;Income tax effect | (0.05) | (0.01) |
| &nbsp;&nbsp;&nbsp; Adjusted EPS (Non-GAAP) | $2.07 | $1.96 |

---

<sup>1</sup> *Acquisition-related costs includes amortization of intangible assets, and for the three months ended September 30, 2025, also includes $1.3 million of acquisition-related costs associated with the Verdant acquisition.*

We define "tangible book value," a non-GAAP financial measure, as book value adjusted for goodwill and other intangible assets. Tangible book value is calculated using common stockholders' equity minus servicing rights, goodwill and other intangible assets. Tangible book value per common share, a non-GAAP financial measure, is calculated by dividing tangible book value by the common shares outstanding at the end of the period. We believe tangible book value per common share is useful in evaluating the Company's capital strength, financial condition, and ability to manage potential losses.

Below is a reconciliation of total stockholders' equity, the nearest comparable GAAP measure, to tangible book value (Non-GAAP):

---

| | | | |
|:---|:---|:---|:---|
| ***(Dollars in thousands, except per share data)*** | **September 30, <br>2025** | **June 30,<br>2025** | **September 30, <br>2024** |
| Common stockholders' equity | $2793121 | $2680677 | $2405728 |
| &nbsp;&nbsp;&nbsp;Less: servicing rights, carried at fair value | 26243 | 27218 | 27335 |
| &nbsp;&nbsp;&nbsp;Less: goodwill and other intangible assets—net | 205747 | 134502 | 139215 |
| &nbsp;&nbsp;&nbsp;&nbsp;Tangible common stockholders' equity (Non-GAAP) | $2561131 | $2518957 | $2239178 |
| Common shares outstanding at end of period | 56643547 | 56483617 | 57092216 |
| Book value per common share | 49.31 | 47.46 | 42.14 |
| &nbsp;&nbsp;&nbsp;Less: servicing rights, carried at fair value per common share | 0.46 | 0.48 | 0.48 |
| &nbsp;&nbsp;&nbsp;Less: goodwill and other intangible assets—net per common share | 3.63 | 2.38 | 2.44 |
| &nbsp;&nbsp;&nbsp;&nbsp;Tangible book value per common share (Non-GAAP) | $45.22 | $44.60 | $39.22 |

---

------

<u>[**Table of Contents**](#i7c17675c26f44bbd9ee68808b9f08846_7)</u>

**SELECTED FINANCIAL INFORMATION**

---

| | | | |
|:---|:---|:---|:---|
| ***(Dollars in thousands, except per share data)*** | **September 30, <br>2025** | **June 30, <br>2025** | **September 30, <br>2024** |
| ***Selected Balance Sheet Data:*** | | | |
| Total assets | $27431817 | $24783078 | $23569084 |
| Loans—net of allowance for credit losses | 22635137 | 21049610 | 19280609 |
| Loans held for sale, carried at fair value | 12202 | 10012 | 14566 |
| Allowance for credit losses | 307431 | 290049 | 263854 |
| Trading securities | 533 | 649 | 594 |
| Available-for-sale securities | 57798 | 66008 | 137996 |
| Securities borrowed | 182518 | 139396 | 84326 |
| Customer, broker-dealer and clearing receivables | 263095 | 252720 | 262774 |
| Total deposits | 22264753 | 20829543 | 19973329 |
| Advances from the Federal Home Loan Bank | 60000 | 60000 | 90000 |
| Secured financings | 782423 |  |  |
| Borrowings, subordinated notes and debentures | 510064 | 312671 | 313519 |
| Securities loaned | 204620 | 139426 | 95883 |
| Customer, broker-dealer and clearing payables | 385821 | 350606 | 315985 |
| Total stockholders' equity | $2793121 | $2680677 | $2405728 |
| Common shares outstanding at end of period | 56643547 | 56483617 | 57092216 |
| Common shares issued at end of period | 71356152 | 71101642 | 70562333 |
| ***Per Common Share Data:*** |  |  |  |
| Book value per common share | $49.31 | $47.46 | $42.14 |
| Tangible book value per common share (Non-GAAP)<sup>1</sup> | $45.21 | $44.60 | $39.22 |
| ***Capital Ratios:*** |  |  |  |
| Equity to assets at end of period | 10.18% | 10.82% | 10.21% |
| Axos Financial, Inc.: |  |  |  |
| &nbsp;&nbsp;&nbsp;Tier 1 leverage (to adjusted average assets) | 10.26% | 10.73% | 9.78% |
| &nbsp;&nbsp;&nbsp;Common equity tier 1 capital (to risk-weighted assets) | 11.66% | 12.52% | 12.44% |
| &nbsp;&nbsp;&nbsp;Tier 1 capital (to risk-weighted assets) | 11.66% | 12.52% | 12.44% |
| &nbsp;&nbsp;&nbsp;Total capital (to risk-weighted assets) | 15.20% | 15.28% | 15.29% |
| Axos Bank: |  |  |  |
| &nbsp;&nbsp;&nbsp;Tier 1 leverage (to adjusted average assets) | 9.69% | 10.23% | 9.82% |
| &nbsp;&nbsp;&nbsp;Common equity tier 1 capital (to risk-weighted assets) | 11.37% | 12.42% | 12.87% |
| &nbsp;&nbsp;&nbsp;Tier 1 capital (to risk-weighted assets) | 11.37% | 12.42% | 12.87% |
| &nbsp;&nbsp;&nbsp;Total capital (to risk-weighted assets) | 12.62% | 13.70% | 14.06% |
| Axos Clearing LLC: |  |  |  |
| &nbsp;&nbsp;&nbsp;Net capital | $91442 | $86996 | $85292 |
| &nbsp;&nbsp;&nbsp;Excess capital | $86042 | $81834 | $80081 |
| &nbsp;&nbsp;&nbsp;Net capital as a percentage of aggregate debit items | 33.87% | 33.71% | 32.73% |
| &nbsp;&nbsp;&nbsp;Net capital in excess of 5% aggregate debit items | $77942 | $74091 | $72264 |

---

------

<u>[**Table of Contents**](#i7c17675c26f44bbd9ee68808b9f08846_7)</u>

---

| | | |
|:---|:---|:---|
| | **For the Three Months Ended September 30,**  | **For the Three Months Ended September 30,**  |
|<br>***(Dollars in thousands, except per share data)*** | **2025** | **2024** |
| ***Selected Income Statement Data:*** |  |  |
| Interest and dividend income | $465736 | $484262 |
| Interest expense | 174686 | 192214 |
| Net interest income | 291050 | 292048 |
| Provision for credit losses | 17255 | 14000 |
| Net interest income, after provision for credit losses | 273795 | 278048 |
| Non-interest income | 32340 | 28609 |
| Non-interest expense | 156246 | 147465 |
| Income before income taxes | 149889 | 159192 |
| Income taxes | 37537 | 46852 |
| Net income | $112352 | $112340 |
| ***Weighted average number of common shares outstanding:*** |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp; Basic | 56512587 | 56934671 |
| &nbsp;&nbsp;&nbsp;&nbsp; Diluted | 57782828 | 58168468 |
| ***Per Common Share Data:*** |  |  |
| Net income: |  |  |
| &nbsp;&nbsp;&nbsp;Basic | $1.99 | $1.97 |
| &nbsp;&nbsp;&nbsp;Diluted | $1.94 | $1.93 |
| Adjusted earnings per common share (Non-GAAP)<sup>1</sup> | $2.07 | $1.96 |
| ***Performance Ratios and Other Data:*** |  |  |
| Growth in loans held for investment, net | $1585527 | $49224 |
| Loan originations for sale | $47122 | $69570 |
| Return on average assets | 1.77% | 1.92% |
| Return on average common stockholders' equity | 15.94% | 19.12% |
| Interest rate spread<sup>2</sup> | 3.89% | 4.13% |
| Net interest margin<sup>3</sup> | 4.75% | 5.17% |
| Net interest margin<sup>3</sup> – Banking Business Segment | 4.80% | 5.21% |
| Efficiency ratio<sup>4</sup> | 48.32% | 45.99% |
| Efficiency ratio<sup>4</sup> – Banking Business Segment | 42.89% | 39.83% |
| ***Asset Quality Ratios:*** |  |  |
| Net annualized charge-offs to average loans | 0.11% | 0.17% |
| Nonaccrual loans to total loans | 0.74% | 0.89% |
| Non-performing assets to total assets | 0.64% | 0.75% |
| Allowance for credit losses - loans to total loans held for investment | 1.34% | 1.35% |
| Allowance for credit losses - loans to nonaccrual loans<sup>5</sup> | 180.41% | 149.32% |

---

<sup>1</sup> *See "Use of Non-GAAP Financial Measures."*

<sup>2</sup> *Interest rate spread represents the difference between the annualized weighted average yield on interest-earning assets and the annualized weighted average rate paid on interest-bearing liabilities.*

<sup>3</sup> *Net interest margin represents annualized net interest income as a percentage of average interest-earning assets.*

<sup>4</sup> *Efficiency ratio represents non-interest expense as a percentage of the aggregate of net interest income and non-interest income.*

<sup>5</sup> *The increase in the Allowance for credit losses - loans to nonaccrual loans is primarily attributable to the increase in the ACL, including the impact of the Verdant acquisition. For additional information on the Verdant acquisition, see Note 2, "Acquisitions" in the accompanying interim condensed consolidated financial statements.*

------

<u>[**Table of Contents**](#i7c17675c26f44bbd9ee68808b9f08846_7)</u>

**RESULTS OF OPERATIONS**

**Comparison of the Three Months Ended September 30, 2025 and 2024**

For the three months ended September 30, 2025, we had net income of $112.4 million, or $1.94 per diluted share, compared to net income of $112.3 million, or $1.93 per diluted share, for the three months ended September 30, 2024.

**Average Balances, Net Interest Income, Yields Earned and Rates Paid**

The following table presents information regarding (i) average balances; (ii) the total amount of interest income from interest-earning assets and the weighted average yields on such assets; (iii) the total amount of interest expense on interest-bearing liabilities and the weighted average rates paid on such liabilities; (iv) net interest income; (v) interest rate spread; and (vi) net interest margin:

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| | **For the Three Months Ended,** | **For the Three Months Ended,** | **For the Three Months Ended,** | **For the Three Months Ended,** | **For the Three Months Ended,** | **For the Three Months Ended,** |
| | **September 30, 2025** | **September 30, 2025** | **September 30, 2025** | **September 30, 2024** | **September 30, 2024** | **September 30, 2024** |
|<br>***(Dollars in thousands)*** | **Average**<br>**Balance**<sup>1</sup> | **Interest<br>Income/<br>Expense** | **Average Yields**<br>**Earned/Rates**<br>**Paid**<sup>2</sup> | **Average**<br>**Balance**<sup>1</sup> | **Interest<br>Income/<br>Expense** | **Average Yields**<br>**Earned/Rates**<br>**Paid**<sup>2</sup> |
| **Assets:** | | | | | | |
| Loans<sup>3, 4</sup> | $21507709 | $429575 | 7.99% | $19447016 | $438229 | 9.01% |
| &nbsp;&nbsp;Non-purchased loans | 20642301 | 395362 | 7.66% | 18469398 | 382459 | 8.28% |
| &nbsp;&nbsp;Purchased loans<sup>5</sup> | 865408 | 34213 | 15.81% | 977618 | 55770 | 22.82% |
| Interest-earning deposits in other financial institutions | 2538844 | 28195 | 4.44% | 2680503 | 37425 | 5.58% |
| Mortgage-backed and other securities<sup>4</sup> | 61084 | 670 | 4.39% | 142776 | 1960 | 5.49% |
| Securities borrowed and margin lending<sup>6</sup> | 361966 | 6777 | 7.49% | 313102 | 6271 | 8.01% |
| Stock of the regulatory agencies | 29600 | 519 | 7.01% | 19012 | 377 | 7.93% |
| Total interest-earning assets | 24499203 | 465736 | 7.60% | 22602409 | 484262 | 8.57% |
| Non-interest-earning assets | 932414 |  |  | 797127 |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Total assets | $25431617 |  |  | $23399536 |  |  |
| **Liabilities and Stockholders' Equity:** |  |  |  |  |  |  |
| Interest-bearing demand and savings | $17177394 | $157844 | 3.68% | $15915785 | $177815 | 4.47% |
| Time deposits | 1126347 | 11520 | 4.09% | 871876 | 9454 | 4.34% |
| Securities loaned | 150456 | 285 | 0.76% | 97215 | 540 | 2.22% |
| Advances from the FHLB | 60004 | 313 | 2.09% | 90000 | 529 | 2.35% |
| Secured financings | 8505 |  | —% |  |  | —% |
| Borrowings, subordinated notes and debentures | 332004 | 4724 | 5.69% | 323697 | 3876 | 4.79% |
| &nbsp;&nbsp;Total interest-bearing liabilities | 18854710 | 174686 | 3.71% | 17298573 | 192214 | 4.44% |
| Non-interest-bearing demand deposits | 3024076 |  |  | 2971090 |  |  |
| Other non-interest-bearing liabilities | 733586 |  |  | 779561 |  |  |
| Stockholders' equity | 2819245 |  |  | 2350312 |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Total liabilities and stockholders' equity | $25431617 |  |  | $23399536 |  |  |
| Net interest income |  | $291050 |  |  | $292048 |  |
| Interest rate spread<sup>7</sup> |  |  | 3.89% |  |  | 4.13% |
| Net interest margin<sup>8</sup> |  |  | 4.75% |  |  | 5.17% |
| <sup>1.</sup>*Average balances are obtained from daily data.*<br><sup>2.</sup>*Annualized.*<br><sup>3.</sup>*Loans include loans held for sale, loan premiums and unearned fees.*<br><sup>4.</sup>*Interest income includes reductions for amortization of loan and investment securities premiums and earnings from accretion of discounts and loan fees.*<br><sup>5.</sup>*Purchased loans include loans, loan discounts and unearned fees related to the FDIC Loan Purchase.*<br><sup>6.</sup>*Margin lending is the significant component of the asset titled customer, broker-dealer and clearing receivables on the unaudited Condensed Consolidated Balance Sheets.* <br><sup>7.</sup>*Interest rate spread represents the difference between the weighted average yield on interest-earning assets and the weighted average rate paid on interest-bearing liabilities.*<br><sup>8.</sup>*Net interest margin represents annualized net interest income as a percentage of average interest-earning assets.* | <sup>1.</sup>*Average balances are obtained from daily data.*<br><sup>2.</sup>*Annualized.*<br><sup>3.</sup>*Loans include loans held for sale, loan premiums and unearned fees.*<br><sup>4.</sup>*Interest income includes reductions for amortization of loan and investment securities premiums and earnings from accretion of discounts and loan fees.*<br><sup>5.</sup>*Purchased loans include loans, loan discounts and unearned fees related to the FDIC Loan Purchase.*<br><sup>6.</sup>*Margin lending is the significant component of the asset titled customer, broker-dealer and clearing receivables on the unaudited Condensed Consolidated Balance Sheets.* <br><sup>7.</sup>*Interest rate spread represents the difference between the weighted average yield on interest-earning assets and the weighted average rate paid on interest-bearing liabilities.*<br><sup>8.</sup>*Net interest margin represents annualized net interest income as a percentage of average interest-earning assets.* | <sup>1.</sup>*Average balances are obtained from daily data.*<br><sup>2.</sup>*Annualized.*<br><sup>3.</sup>*Loans include loans held for sale, loan premiums and unearned fees.*<br><sup>4.</sup>*Interest income includes reductions for amortization of loan and investment securities premiums and earnings from accretion of discounts and loan fees.*<br><sup>5.</sup>*Purchased loans include loans, loan discounts and unearned fees related to the FDIC Loan Purchase.*<br><sup>6.</sup>*Margin lending is the significant component of the asset titled customer, broker-dealer and clearing receivables on the unaudited Condensed Consolidated Balance Sheets.* <br><sup>7.</sup>*Interest rate spread represents the difference between the weighted average yield on interest-earning assets and the weighted average rate paid on interest-bearing liabilities.*<br><sup>8.</sup>*Net interest margin represents annualized net interest income as a percentage of average interest-earning assets.* | <sup>1.</sup>*Average balances are obtained from daily data.*<br><sup>2.</sup>*Annualized.*<br><sup>3.</sup>*Loans include loans held for sale, loan premiums and unearned fees.*<br><sup>4.</sup>*Interest income includes reductions for amortization of loan and investment securities premiums and earnings from accretion of discounts and loan fees.*<br><sup>5.</sup>*Purchased loans include loans, loan discounts and unearned fees related to the FDIC Loan Purchase.*<br><sup>6.</sup>*Margin lending is the significant component of the asset titled customer, broker-dealer and clearing receivables on the unaudited Condensed Consolidated Balance Sheets.* <br><sup>7.</sup>*Interest rate spread represents the difference between the weighted average yield on interest-earning assets and the weighted average rate paid on interest-bearing liabilities.*<br><sup>8.</sup>*Net interest margin represents annualized net interest income as a percentage of average interest-earning assets.* | <sup>1.</sup>*Average balances are obtained from daily data.*<br><sup>2.</sup>*Annualized.*<br><sup>3.</sup>*Loans include loans held for sale, loan premiums and unearned fees.*<br><sup>4.</sup>*Interest income includes reductions for amortization of loan and investment securities premiums and earnings from accretion of discounts and loan fees.*<br><sup>5.</sup>*Purchased loans include loans, loan discounts and unearned fees related to the FDIC Loan Purchase.*<br><sup>6.</sup>*Margin lending is the significant component of the asset titled customer, broker-dealer and clearing receivables on the unaudited Condensed Consolidated Balance Sheets.* <br><sup>7.</sup>*Interest rate spread represents the difference between the weighted average yield on interest-earning assets and the weighted average rate paid on interest-bearing liabilities.*<br><sup>8.</sup>*Net interest margin represents annualized net interest income as a percentage of average interest-earning assets.* | <sup>1.</sup>*Average balances are obtained from daily data.*<br><sup>2.</sup>*Annualized.*<br><sup>3.</sup>*Loans include loans held for sale, loan premiums and unearned fees.*<br><sup>4.</sup>*Interest income includes reductions for amortization of loan and investment securities premiums and earnings from accretion of discounts and loan fees.*<br><sup>5.</sup>*Purchased loans include loans, loan discounts and unearned fees related to the FDIC Loan Purchase.*<br><sup>6.</sup>*Margin lending is the significant component of the asset titled customer, broker-dealer and clearing receivables on the unaudited Condensed Consolidated Balance Sheets.* <br><sup>7.</sup>*Interest rate spread represents the difference between the weighted average yield on interest-earning assets and the weighted average rate paid on interest-bearing liabilities.*<br><sup>8.</sup>*Net interest margin represents annualized net interest income as a percentage of average interest-earning assets.* | <sup>1.</sup>*Average balances are obtained from daily data.*<br><sup>2.</sup>*Annualized.*<br><sup>3.</sup>*Loans include loans held for sale, loan premiums and unearned fees.*<br><sup>4.</sup>*Interest income includes reductions for amortization of loan and investment securities premiums and earnings from accretion of discounts and loan fees.*<br><sup>5.</sup>*Purchased loans include loans, loan discounts and unearned fees related to the FDIC Loan Purchase.*<br><sup>6.</sup>*Margin lending is the significant component of the asset titled customer, broker-dealer and clearing receivables on the unaudited Condensed Consolidated Balance Sheets.* <br><sup>7.</sup>*Interest rate spread represents the difference between the weighted average yield on interest-earning assets and the weighted average rate paid on interest-bearing liabilities.*<br><sup>8.</sup>*Net interest margin represents annualized net interest income as a percentage of average interest-earning assets.* |

---

------

<u>[**Table of Contents**](#i7c17675c26f44bbd9ee68808b9f08846_7)</u>

**Average Balances, Net Interest Income, Yields Earned and Rates Paid**

The following table sets forth the effects of changing rates and volumes on our net interest income. Information is provided with respect to (i) effects on interest income and interest expense attributable to changes in volume (changes in volume multiplied by prior rate); and (ii) effects on interest income and interest expense attributable to changes in rate (changes in rate multiplied by prior volume). The change in interest due to both volume and rate has been allocated proportionally to each based on the relative changes attributable to volume and changes attributable to rate.

---

| | | | |
|:---|:---|:---|:---|
| | **For the Three Months Ended** | **For the Three Months Ended** | **For the Three Months Ended** |
| | **September 30,** | **September 30,** | **September 30,** |
| | **2025 vs 2024** | **2025 vs 2024** | **2025 vs 2024** |
| | **Increase (Decrease) Due to** | **Increase (Decrease) Due to** | **Increase (Decrease) Due to** |
|<br><br>***(Dollars in thousands)*** | **Volume** | **Rate** | **Total<br>Increase<br>(Decrease)** |
| Increase (decrease) in interest income: |  |  |  |
| Loans | $43767 | $(52421) | $(8654) |
| &nbsp;&nbsp;&nbsp;&nbsp;Non-purchased loans | 49631 | (36728) | 12903 |
| &nbsp;&nbsp;&nbsp;&nbsp;Purchased loans<sup>1</sup> | (5864) | (15693) | (21557) |
| Interest-earning deposits in other financial institutions | (1897) | (7333) | (9230) |
| Mortgage-backed and other securities | (955) | (335) | (1290) |
| Securities borrowed and margin lending | 932 | (426) | 506 |
| Stock of the regulatory agencies | 190 | (48) | 142 |
| &nbsp;&nbsp;Total increase (decrease) in interest income | $42037 | $(60563) | $(18526) |
| Increase (decrease) in interest expense: |  |  |  |
| Interest-bearing demand and savings | $13282 | $(33253) | $(19971) |
| Time deposits | 2636 | (570) | 2066 |
| Securities loaned | 208 | (463) | (255) |
| Advances from the FHLB | (161) | (55) | (216) |
| Secured financings |  |  |  |
| Borrowings, subordinated notes and debentures | 102 | 746 | 848 |
| &nbsp;&nbsp;Total increase (decrease) in interest expense | $16067 | $(33595) | $(17528) |

---

<sup>1</sup> *Purchased loans include loans, loan discounts and unearned fees related to the FDIC Loan Purchase.*

**Net Interest Income**

For the three months ended September 30, 2025, net interest income totaled $291.1 million, a decrease of $1.0 million, or 0.3%, compared to net interest income of $292.0 million for the three months ended September 30, 2024. For the three months ended September 30, 2025, net interest margin decreased by 42 basis points compared to the net interest margin of 5.17% for the three months ended September 30, 2024.

For the three months ended September 30, 2025, total interest and dividend income decreased 3.8% from the three months ended September 30, 2024, primarily due to a $9.2 million decrease in interest income on deposits in other financial institutions, primarily driven by lower rates earned, as well as lower interest earned on loans, reflecting lower rates earned, partially offset by higher average balances.

For the three months ended September 30, 2025, total interest expense decreased 9.1% from the three months ended September 30, 2024, primarily due to a $20.0 million decrease in interest expense on demand and savings deposits, reflecting lower rates paid, partially offset by higher deposit balances.

**Provision for Credit Losses**

The provision for credit losses was $17.3 million for the three months ended September 30, 2025, compared to $14.0 million for the three months ended September 30, 2024. The provision for credit losses consists of provisions for both funded loans and for unfunded lending commitments. The provision for credit losses for funded loans was $15.3 million for the three months ended September 30, 2025, and was primarily driven by the post-acquisition provision for credit losses on the loans and leases acquired in the Verdant acquisition, as well as loan growth and the impact of macroeconomic variables used in the allowance for credit losses model, primarily the U.S. unemployment rate, consumer price and housing price indices, as well as the five-year U.S. Treasury rate.

------

<u>[**Table of Contents**](#i7c17675c26f44bbd9ee68808b9f08846_7)</u>

The provision for credit losses for unfunded lending commitments of $2.0 million for the three months ended September 30, 2025, was primarily driven by unfunded lending commitment growth, primarily in the commercial real estate and commercial & industrial - non-RE portfolios. Provisions for credit losses are charged to income to bring the allowance for credit losses for loans and unfunded lending commitments to a level deemed appropriate by management based on the factors discussed under the heading "Financial Condition—Asset Quality and Allowance for Credit Losses - Loans."

**Non-Interest Income**

The following table sets forth information regarding our non-interest income:

---

| | | | |
|:---|:---|:---|:---|
| | **For the Three Months Ended** | **For the Three Months Ended** | **For the Three Months Ended** |
| | **September 30,** | **September 30,** | **September 30,** |
|<br>***(Dollars in thousands)*** | **2025** | **2024** | **Inc (Dec)** |
| Broker-dealer fee income | $10948 | $11060 | $(112) |
| Advisory fee income | 8525 | 7945 | 580 |
| Banking and service fees | 10820 | 8613 | 2207 |
| Mortgage banking and servicing rights income | 1395 | 450 | 945 |
| Prepayment penalty fee income | 652 | 541 | 111 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total non-interest income | $32340 | $28609 | $3731 |

---

For the three months ended September 30, 2025, non-interest income increased by $3.7 million, or 13.0%, primarily due to an increase in banking and servicing fee income, primarily driven by higher income on BOLI policies, as well as a $0.9 million increase in mortgage banking and servicing rights income, primarily attributable to more favorable servicing rights fair value adjustments in the current period.

**Non-Interest Expense**

The following table sets forth information regarding our non-interest expense:

---

| | | | |
|:---|:---|:---|:---|
| | **For the Three Months Ended** | **For the Three Months Ended** | **For the Three Months Ended** |
| | **September 30,** | **September 30,** | **September 30,** |
|<br>***(Dollars in thousands)*** | **2025** | **2024** | **Inc (Dec)** |
| Salaries and related costs | $76605 | $74293 | $2312 |
| Data and operational processing | 22057 | 18985 | 3072 |
| Depreciation and amortization | 8341 | 7450 | 891 |
| Advertising and promotional | 12207 | 14253 | (2046) |
| Professional services | 13333 | 9895 | 3438 |
| Occupancy and equipment | 4620 | 4318 | 302 |
| FDIC and regulatory fees | 5619 | 5956 | (337) |
| Broker-dealer clearing charges | 4203 | 4307 | (104) |
| General and administrative expense | 9261 | 8008 | 1253 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total non-interest expense | $156246 | $147465 | $8781 |

---

For the three months ended September 30, 2025, non-interest expense increased $8.8 million, or 6.0%, primarily due to increases of:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• $3.4 million in professional services primarily due to higher legal expenses and acquisition-related costs associated with the Verdant acquisition;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• $3.1 million in data and operating processing to support the Company's growth and continued investments in technology; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• $2.3 million in salaries and related costs primarily due to increased headcount and salaries.

These increases were partially offset by a decrease of $2.0 million in advertising and promotional expense primarily as a result of reduced deposit marketing expense in the current period.

------

<u>[**Table of Contents**](#i7c17675c26f44bbd9ee68808b9f08846_7)</u>

**Provision for Income Taxes**

Income tax expense was $37.5 million for the three months ended September 30, 2025, compared to $46.9 million for three months ended September 30, 2024. Our effective income tax rates for the three months ended September 30, 2025 and 2024 were 25.04% and 29.43%, respectively. The decrease in effective income tax rate for the three months ended September 30, 2025 reflects, in part, a change in the State of California income tax law effective beginning with the Company's 2026 fiscal year.

**SEGMENT RESULTS**

Our Company determines reportable segments based on the services offered, the significance of the services offered, the significance of those services to our Company's financial condition and operating results and management's regular review of the operating results of those services. Our Company operates through two operating segments: the Banking Business Segment and the Securities Business Segment. In order to reconcile the two segments to the consolidated totals, our Company includes corporate activities and intercompany eliminations. Inter-segment transactions are eliminated in consolidation and primarily include non-interest income earned by the Securities Business Segment and non-interest expense incurred by the Banking Business Segment for cash sorting fees related to deposits sourced from Securities Business Segment customers.

The following tables present the operating results of the segments:

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **For the Three Months Ended September 30, 2025** | **For the Three Months Ended September 30, 2025** | **For the Three Months Ended September 30, 2025** | **For the Three Months Ended September 30, 2025** |
|<br>***(Dollars in thousands)*** | **Banking <br>Business Segment** | **Securities Business Segment** | **Corporate/Eliminations** | **Axos Consolidated** |
| Net interest income | $287200 | $8194 | $(4344) | $291050 |
| Provision for credit losses | 17255 |  |  | 17255 |
| Non-interest income | 12375 | 29457 | (9492) | 32340 |
| Non-interest expense | 128493 | 29367 | (1614) | 156246 |
| Income before income taxes | $153827 | $8284 | $(12222) | $149889 |
|  | **For the Three Months Ended September 30, 2024** | **For the Three Months Ended September 30, 2024** | **For the Three Months Ended September 30, 2024** | **For the Three Months Ended September 30, 2024** |
| ***(Dollars in thousands)*** | **Banking <br>Business Segment** | **Securities Business Segment** | **Corporate/Eliminations** | **Axos Consolidated** |
| Net interest income | $288492 | $7267 | $(3711) | $292048 |
| Provision for credit losses | 14000 |  |  | 14000 |
| Non-interest income | 8590 | 29902 | (9883) | 28609 |
| Non-interest expense | 118315 | 28091 | 1059 | 147465 |
| Income before income taxes | $164767 | $9078 | $(14653) | $159192 |

---

**Banking Business Segment**

For the three months ended September 30, 2025, the Banking Business Segment had income before income taxes of $153.8 million, compared to income before income taxes of $164.8 million for the three months ended September 30, 2024.

For the three months ended September 30, 2025, the Banking Business Segment's net interest income decreased $1.3 million, or 0.4% compared to net interest income for the three months ended September 30, 2024. The decrease in net interest income was primarily due to a decrease in interest income on deposits in other financial institutions, primarily driven by lower rates earned, as well as lower interest earned on loans, reflecting lower rates earned, partially offset by higher average balances. These decreases were partially offset by a decrease in interest expense on demand and savings deposits, reflecting lower rates paid, partially offset by higher deposit balances.

The increase in non-interest income for the three months ended September 30, 2025 was primarily due to higher income on BOLI policies and more favorable servicing rights fair value adjustments in the current period.

For the three months ended September 30, 2025, the Banking Business Segment's non-interest expense increased $10.2 million, or 8.6%, compared to non-interest expense for the three months ended September 30, 2024. The increase in non-interest expense for the three months ended September 30, 2025 reflected higher professional services expense, primarily due to higher legal expenses and acquisition-related costs associated with the Verdant acquisition, as well as higher data and operational processing expense.

------

<u>[**Table of Contents**](#i7c17675c26f44bbd9ee68808b9f08846_7)</u>

We consider the ratios shown in the table below to be key indicators of the performance of our Banking Business Segment:

---

| | | |
|:---|:---|:---|
| | **For the Three Months Ended September 30,**  | **For the Three Months Ended September 30,**  |
| | **2025** | **2024** |
| Efficiency ratio | 42.89% | 39.83% |
| Return on average assets | 1.79% | 2.17% |
| Interest rate spread | 3.96% | 4.16% |
| Net interest margin | 4.80% | 5.21% |

---

Our Banking Business Segment's net interest margin exceeds our consolidated net interest margin. Our consolidated net interest margin includes certain items that are not reflected in the calculation of our net interest margin within our Banking Business Segment and reduce our consolidated net interest margin, such as the borrowing costs at our Company and the yields and costs associated with certain items within interest-earning assets and interest-bearing liabilities in our Securities Business Segment, including items related to securities financing operations.

**Securities Business Segment**

For the three months ended September 30, 2025, our Securities Business Segment had income before income taxes of $8.3 million, compared to income before income taxes of $9.1 million, for the three months ended September 30, 2024.

For the three months ended September 30, 2025, net interest income increased $0.9 million, or 12.8%, compared to net interest income for the three months ended September 30, 2024. The increase for the three months ended September 30, 2025 was primarily attributable to higher interest earned on securities borrowed, as well as deposits in other financial institutions.

For the three months ended September 30, 2025, non-interest income decreased $0.4 million, or 1.5%, compared to the three months ended September 30, 2024. The decrease was primarily driven by lower broker-dealer fee income as a result of lower rates earned on cash sorting balances, partially offset by higher average cash sorting balances. This decrease was partially offset by higher advisory fee income, primarily attributable to increased advisor statement fees and higher mutual fund balances.

For the three months ended September 30, 2025, non-interest expense increased $1.3 million or 4.5%, compared to the three months ended September 30, 2024. The increase reflects higher data and operational processing and professional services expenses.

The following table provides selected information for Axos Clearing:

---

| | | |
|:---|:---|:---|
| ***(Dollars in thousands)*** | **September 30, 2025** | **June 30, 2025** |
| FDIC insured deposit program balances at banks | $1534502 | $1444830 |
| Margin balances | $239067 | $229387 |
| Cash reserves for the benefit of customers | $197853 | $146835 |
| Securities lending: |  |  |
| &nbsp;&nbsp;Interest-earning assets – securities borrowed | $182518 | $139396 |
| &nbsp;&nbsp;Interest-bearing liabilities – securities loaned | $204620 | $139426 |

---

**FINANCIAL CONDITION**

**Balance Sheet Analysis**

Our total assets increased $2.6 billion, or 10.7%, to $27.4 billion at September 30, 2025, from $24.8 billion at June 30, 2025, primarily attributable to an increase in loans, mainly attributable to the Verdant acquisition, and higher cash and cash equivalents. Our total liabilities increased $2.5 billion, or 11.5%, to $24.6 billion at September 30, 2025 from $22.1 billion at June 30, 2025, primarily attributable to higher deposit balances, as well as secured financings assumed as part of the Verdant acquisition.

------

<u>[**Table of Contents**](#i7c17675c26f44bbd9ee68808b9f08846_7)</u>

**Loans and Allowance for Credit Losses - Loans**

The following table sets forth the composition of the loan portfolio:

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **September 30, 2025** | **September 30, 2025** | **June 30, 2025** | **June 30, 2025** |
|<br>***(Dollars in thousands)*** | **Amount** | **Percent** | **Amount** | **Percent** |
| Single Family - Mortgage & Warehouse | $4540889 | 19.6% | $4395278 | 20.4% |
| Multifamily and Commercial Mortgage | 2793762 | 12.1% | 2940739 | 13.6% |
| Commercial Real Estate | 7295572 | 31.5% | 6937187 | 32.2% |
| Commercial & Industrial - Non-RE | 7980981 | 34.5% | 6795497 | 31.6% |
| Auto & Consumer | 531044 | 2.3% | 482996 | 2.2% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total gross loans | 23142248 | 100.0% | 21551697 | 100.0% |
| Allowance for credit losses - loans | (307431) |  | (290049) |  |
| Unaccreted discounts and loan fees | (199680) |  | (212038) |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total net loans | $22635137 |  | $21049610 |  |

---

Management establishes an allowance for credit losses based upon its evaluation of the expected lifetime credit losses related to the amortized cost basis of loans on the balance sheet. The net charge-off rate for the three months ended September 30, 2025 was 0.11%, compared to 0.17% for the three months ended September 30, 2024. The decrease in the net charge-off rate was primarily driven by lower net charge-offs in the Commercial & Industrial - Non-RE portfolio. For additional information regarding the Company's allowance for credit losses, see Note 5*—"Loans & Allowance for Credit Losses"* in the accompanying interim condensed consolidated financial statements. For a discussion of the provision for credit losses for the three months ended September 30, 2025, see Item 2—"*Management's Discussion and Analysis of Financial Condition and Results of Operations*—*Results of Operations."* We believe that the lower average LTV in the loan portfolio will continue to result in future lower average mortgage loan charge-offs when compared to many other comparable banks.

**Asset Quality** 

***Non-performing Assets.*** Loans reaching 90 days past due are generally placed on nonaccrual status. Loans not yet reaching 90 days past due may be placed on nonaccrual status based on management's assessment of the aging of contractual principal amounts due, among other factors. For an aging analysis of the Company's loans held for investment as of September 30, 2025 and June 30, 2025, see Note 5—"*Loans & Allowance for Credit Losses*" in the accompanying interim condensed consolidated financial statements. Non-performing assets include nonaccrual loans plus other real estate owned and repossessed vehicles.

Non-performing assets consisted of the following:

---

| | | | |
|:---|:---|:---|:---|
| ***(Dollars in thousands)*** | **September 30, 2025** | **June 30, 2025** | **Increase (Decrease)** |
| **Non-performing assets:** | | | |
| &nbsp;&nbsp;Nonaccrual loans: |  |  |  |
| Single Family - Mortgage & Warehouse | $67887 | $44196 | $23691 |
| Multifamily and Commercial Mortgage | 16047 | 33037 | (16990) |
| Commercial Real Estate | 21783 | 29223 | (7440) |
| Commercial & Industrial - Non-RE | 62536 | 61804 | 732 |
| Auto & Consumer | 2157 | 2126 | 31 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total nonaccrual loans | $170410 | $170386 | $24 |
| &nbsp;&nbsp;&nbsp;Foreclosed real estate | 4383 | 4535 | (152) |
| &nbsp;&nbsp;Repossessed vehicles—Autos | 559 | 505 | 54 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total non-performing assets | $175352 | $175426 | $(74) |
| Total nonaccrual loans as a percentage of total loans | 0.74% | 0.79% | (0.05)% |
| Total non-performing assets as a percentage of total assets | 0.64% | 0.71% | (0.07)% |

---

Our non-performing assets remained flat at $175.4 million at September 30, 2025 compared to June 30, 2025, as an increase in the single family - mortgage & warehouse portfolio was offset by decreases in the multifamily and commercial mortgage and commercial real estate portfolios. Non-performing assets as a percentage of total assets decreased to 0.64% at September 30, 2025 from 0.71% at June 30, 2025.

------

<u>[**Table of Contents**](#i7c17675c26f44bbd9ee68808b9f08846_7)</u>

**Available-for-Sale Securities**

Total available-for-sale securities were $57.8 million as of September 30, 2025, compared with $66.0 million at June 30, 2025. During the three months ended September 30, 2025, we received principal repayments of $8.6 million. The remainder of the change for the available-for-sale securities portfolio is attributable to changes in the fair value of the securities.

**Deposits**

Deposits increased by $1.4 billion, or 6.9%, to $22.3 billion at September 30, 2025, from $20.8 billion at June 30, 2025. As of September 30, 2025 compared with June 30, 2025, interest-bearing demand and savings increased $905.6 million, non-interest-bearing deposits increased by $346.6 million and time deposits increased $183.0 million.

The following table sets forth the composition of the deposit portfolio:

---

| | | |
|:---|:---|:---|
| ***(Dollars in thousands)*** | **September 30, 2025** | **June 30, 2025** |
| Non-interest-bearing | $3387318 | $3040696 |
| Interest-bearing demand and savings | $17565868 | $16660290 |
| Time deposits | 1311567 | 1128557 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total interest bearing | $18877435 | $17788847 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total deposits<sup>1</sup> | $22264753 | $20829543 |

---

<sup>1</sup> *Total deposits includes brokered deposits of $2,156.0 million and $1,801.1 million as of September 30, 2025 and June 30, 2025, respectively, which include brokered time deposits of $900.0 million and $700.0 million as of September 30, 2025 and June 30, 2025, respectively.*

The following table sets forth the number of deposit accounts by type:

---

| | | | |
|:---|:---|:---|:---|
| | **September 30, 2025** | **June 30, 2025** | **September 30, 2024** |
| Non-interest-bearing | 51876 | 50967 | 49086 |
| Interest-bearing checking and savings accounts | 562880 | 546678 | 527058 |
| Time deposits | 2704 | 2956 | 4379 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total number of deposit accounts | 617460 | 600601 | 580523 |

---

Total deposits that exceeded the FDIC insurance limit or were not collateralized at September 30, 2025 and June 30, 2025 were $3.0 billion and $2.6 billion, respectively. The maturities of non-collateralized time deposits that exceeded the FDIC insurance limit were as follows:

---

| | |
|:---|:---|
| ***(Dollars in thousands)*** | **September 30, 2025** |
| 3 months or less | $1617 |
| 3 months to 6 months | 5928 |
| 6 months to 12 months | 5750 |
| Over 12 months | 1708 |
| Total | $15003 |

---

**Borrowings and Secured Financings**

The following table sets forth the composition of our borrowings and the interest rates:

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| | **September 30, 2025** | **September 30, 2025** | **June 30, 2025** | **June 30, 2025** | **September 30, 2024** | **September 30, 2024** |
|<br>***(Dollars in thousands)*** | **Balance** | **Weighted Average Rate** | **Balance** | **Weighted Average Rate** | **Balance** | **Weighted Average Rate** |
| FHLB Advances | $60000 | 2.07% | $60000 | 2.07% | $90000 | 2.32% |
| Secured financings | 736968 | 5.52% |  | —% |  | —% |
| Borrowings, subordinated notes and debentures | 510064 | 5.50% | 312671 | 4.55% | 313519 | 4.56% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total borrowings | $1307032 | 5.35% | $372671 | 4.15% | $403519 | 4.06% |
| Weighted average cost of total borrowings during the quarter | 5.03% |  | 4.66% |  | 4.26% |  |
| Total borrowings as a percent of total assets | 4.76% |  | 1.50% |  | 1.71% |  |

---

------

<u>[**Table of Contents**](#i7c17675c26f44bbd9ee68808b9f08846_7)</u>

We regularly use advances from the FHLB to manage our interest rate risk and, to a lesser extent, manage our liquidity position. Generally, FHLB advances with terms between three and ten years have been used to fund the origination of loans and to provide us with interest rate risk protection should rates rise. On September 19, 2025, the Company completed the issuance of $200 million aggregate principal amount of the Company's 2035 Notes, and on October 1, 2025, the Company completed the redemption of the $160.5 million aggregate principal amount outstanding of its 2030 Notes. For additional information see Note 12*—"Borrowings, Subordinated Notes and Debentures"* in the accompanying interim condensed consolidated financial statements.

**Stockholders' Equity**

Stockholders' equity increased $112.4 million to $2,793.1 million at September 30, 2025, compared to $2,680.7 million at June 30, 2025. The increase was primarily the result of net income for the three months ended September 30, 2025 of $112.4 million.

**LIQUIDITY**

Cash flow information is as follows:

---

| | | |
|:---|:---|:---|
| | **For the Three Months Ended** | **For the Three Months Ended** |
| | **September 30,** | **September 30,** |
|<br>***(Dollars in thousands)*** | **2025** | **2024** |
| Operating Activities | $118433 | $70788 |
| Investing Activities | $(1033379) | $(45541) |
| Financing Activities | $1624187 | $592833 |

---

During the three months ended September 30, 2025, we had net cash inflows from operating activities of $118.4 million compared to inflows of $70.8 million for the three months ended September 30, 2024. Net operating cash inflows and outflows fluctuate primarily due to the timing of the following: originations of loans held for sale, proceeds from loan sales, securities borrowed and loaned, and customer, broker-dealer and clearing receivables and payables and changes in other assets and payables.

Net cash outflows from investing activities totaled $1,033.4 million for the three months ended September 30, 2025, while outflows totaled $45.5 million for the three months ended September 30, 2024. The increase in outflows was primarily due a higher net change in loans held for investment in the three months ended September 30, 2025 as compared to the three months ended September 30, 2024, and the Verdant acquisition in the three months ended September 30, 2025.

Net cash inflows from financing activities totaled $1,624.2 million for the three months ended September 30, 2025, compared to net cash inflows from financing activities of $592.8 million for the three months ended September 30, 2024. The increase in net cash inflows from financing was primarily driven by a higher net increase in deposits and the issuance of $200.0 million of subordinated notes during the three months ended September 30, 2025.

As of September 30, 2025, the Bank could borrow up to 35% of its total assets from the FHLB. Borrowings are collateralized by pledging certain mortgage loans and available-for-sale securities to the FHLB. At September 30, 2025, the Company had $2,709.3 million available immediately and $5,294.1 million available with additional collateral and the Company had $4,112.0 million of loans and $0.1 million of securities pledged to the FHLB. At September 30, 2025, the Company had $250.0 million in unsecured federal funds lines of credit with five major banks under which there were no borrowings outstanding.

The Bank has the ability to borrow short-term from the FRBSF Discount Window. At September 30, 2025, the Bank did not have any borrowings outstanding and the amount available from this source was $7,131.5 million. Borrowings are collateralized by pledging commercial loans and consumer loans. At September 30, 2025, the Bank had $8,320.3 million of loans pledged to the FRBSF.

Axos Clearing has a $150 million third-party secured line of credit available for borrowing, as needed. As of September 30, 2025, there was no amount outstanding on this credit facility. This credit facility bears interest at rates based on the Federal Funds rate and is due upon demand.

Axos Clearing has a $110 million third-party unsecured line of credit available for limited purpose borrowing. As of September 30, 2025, there was no amount outstanding on this credit facility. This credit facility bears interest at rates based on the Federal Funds rate and is due upon demand.

------

<u>[**Table of Contents**](#i7c17675c26f44bbd9ee68808b9f08846_7)</u>

We view our liquidity sources to be stable and adequate for our anticipated needs and contingencies for both the short- and long-term. Due to the diversified sources of our deposits, while maintaining approximately 90% of our total Bank deposits in insured or collateralized accounts as of September 30, 2025, we believe we have the ability to increase our level of deposits, and have available other potential sources of funding, to address our liquidity needs for the foreseeable future.

For additional information on certain contractual and other obligations, see Note 10—*"Commitments and Contingencies,"* Note 12—*"Borrowings, Subordinated Notes and Debentures,"* Note 13—*"Other Assets"* and Note 14— *"Variable Interest Entities"* in the accompanying interim condensed consolidated financial statements and refer to Note 11*—"Deposits,"* Note 12—*"Advances from the Federal Home Loan Bank"* and Note 13—*"Borrowings, Subordinated Notes and Debentures"* in the 2025 Form 10-K.

On January 28, 2025, the Company entered into an equity distribution agreement pursuant to which the Company may issue and sell through distribution agents from time to time shares of the Company's common stock in at-the-market offerings with an aggregate offering price of up to $150,000,000. The Company will issue the stock pursuant to a previously effective registration statement and a prospectus supplement filed with the SEC on January 28, 2025. No shares of the Company's common stock have been issued pursuant to this offering.

**CAPITAL RESOURCES AND REQUIREMENTS**

The Company and Bank are subject to regulatory capital adequacy requirements promulgated by federal bank regulatory agencies. Failure by the Company or Bank to meet minimum capital requirements could result in certain mandatory and discretionary actions by regulators that could have a material adverse effect on our Consolidated Financial Statements. The Federal Reserve establishes capital requirements for the Company and the OCC has similar requirements for our Bank. The following tables present regulatory capital information for the Company and Bank. Information presented for September 30, 2025 reflects the Basel III capital requirements for both the Company and Bank. Under these capital requirements and the regulatory framework for prompt corrective action, the Company and Bank must meet specific capital guidelines that involve quantitative measures of the Company and Bank's assets, liabilities and certain off-balance-sheet items as calculated under regulatory accounting practices. The Company's and Bank's capital amounts and classifications are also subject to qualitative judgments by regulators about components, risk weightings and other factors. As part of its capital management, the Bank may pay dividends to the Company from time to time.

Quantitative measures established by regulation require the Company and Bank to maintain certain minimum capital amounts and ratios. Federal bank regulators require the Company and Bank to maintain minimum ratios of tier 1 capital to adjusted average assets of 4.0%, common equity tier 1 capital to risk-weighted assets of 4.5%, tier 1 capital to risk-weighted assets of 6.0% and total risk-based capital to risk-weighted assets of 8.0%. To be "well capitalized," the Company and Bank must maintain minimum leverage, common equity tier 1 risk-based, tier 1 risk-based and total risk-based capital ratios of at least 5.0%, 6.5%, 8.0% and 10.0%, respectively. Additionally, the Bank is required to maintain a tangible capital ratio equal to at least 1.5% of total average assets. At September 30, 2025, the Company and Bank met all the capital adequacy requirements to which they were subject and were "well capitalized" under the regulatory framework for prompt corrective action. Management believes that no conditions or events have occurred since September 30, 2025 that would materially adversely change the Company's and Bank's capital classifications. From time to time, we may need to raise additional capital to support the Company's and Bank's further growth and to maintain their "well capitalized" status.

The Company and Bank both elected the five-year current expected credit losses ("CECL") transition guidance for calculating regulatory capital and ratios, which allowed an entity to add back to regulatory capital the impact of the CECL adoption, subject to the five-year phase out. The phase out ended in fiscal year 2025 and the regulatory capital figures presented as of September 30, 2025 no longer reflect this adjustment.

------

<u>[**Table of Contents**](#i7c17675c26f44bbd9ee68808b9f08846_7)</u>

The Company's and Bank's capital ratios and requirements were as follows:

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| | **Axos Financial, Inc.** | **Axos Financial, Inc.** | **Axos Bank** | **Axos Bank** | **"Well <br>Capitalized"<br>Ratio** | **Minimum Capital<br>Ratio** |
|<br>***(Dollars in thousands)*** | **September 30, <br>2025** | **June 30, <br>2025** | **September 30, <br>2025** | **June 30, <br>2025** | **"Well <br>Capitalized"<br>Ratio** | **Minimum Capital<br>Ratio** |
| **Regulatory Capital:** | | | | | | |
| &nbsp;&nbsp;&nbsp;Tier 1 | $2587308 | $2554071 | $2353480 | $2360284 |  |  |
| &nbsp;&nbsp;&nbsp;Common equity tier 1 | $2587308 | $2554071 | $2353480 | $2360284 |  |  |
| &nbsp;&nbsp;&nbsp;Total capital | $3373421 | $3117763 | $2612328 | $2603589 |  |  |
| **Assets:** |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Average adjusted | $25225934 | $23813242 | $24297872 | $23077089 |  |  |
| &nbsp;&nbsp;&nbsp;Total risk-weighted | $22194624 | $20404204 | $20701053 | $19003094 |  |  |
| **Regulatory Capital Ratios:** |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Tier 1 leverage (to adjusted average assets) | 10.26% | 10.73% | 9.69% | 10.23% | 5.00% | 4.00% |
| &nbsp;&nbsp;&nbsp;Common equity tier 1 capital (to risk-weighted assets) | 11.66% | 12.52% | 11.37% | 12.42% | 6.50% | 4.50% |
| &nbsp;&nbsp;&nbsp;Tier 1 capital (to risk-weighted assets) | 11.66% | 12.52% | 11.37% | 12.42% | 8.00% | 6.00% |
| &nbsp;&nbsp;&nbsp;Total capital (to risk-weighted assets) | 15.20% | 15.28% | 12.62% | 13.70% | 10.00% | 8.00% |

---

Basel III requires all banking organizations to maintain a capital conservation buffer above the minimum risk-based capital requirements in order to avoid certain limitations on capital distributions, stock repurchases and discretionary bonus payments to executive officers. The capital conservation buffer is exclusively composed of common equity tier 1 capital, and it applies to each of the three risk-based capital ratios but not the leverage ratio. At September 30, 2025 and June 30, 2025, our Company and Bank were in compliance with the capital conservation buffer requirement, which sets the common equity tier 1 risk-based, tier 1 risk-based and total risk-based capital ratio minimums to 7.0%, 8.5% and 10.5%, respectively.

**Securities Business**

Pursuant to the net capital requirements of the Exchange Act, Axos Clearing is subject to the SEC Uniform Net Capital (Rule 15c3-1 of the Exchange Act). Under this rule, the Company has elected to operate under the alternate method and is required to maintain minimum net capital of $250,000 or 2% of aggregate debit balances arising from client transactions, as defined. Under the alternate method, the Company may not repay subordinated debt, pay cash distributions, or make any unsecured advances or loans to its parent or employees if such payment would result in net capital of less than 5% of aggregate debit balances or less than 120% of its minimum dollar requirement. As part of its capital management, Axos Clearing may make distributions to the Company from time to time.

The net capital position of Axos Clearing was as follows:

---

| | | |
|:---|:---|:---|
| ***(Dollars in thousands)*** | **September 30, 2025** | **June 30, 2025** |
| Net capital | $91442 | $86996 |
| Excess Capital | $86042 | $81834 |
| Net capital as a percentage of aggregate debit items | 33.87% | 33.71% |
| Net capital in excess of 5% aggregate debit items | $77942 | $74091 |

---

Axos Clearing, as a clearing broker, is subject to the SEC Customer Protection Rule (Rule 15c3-3 of the Exchange Act) which requires segregation of funds in a special reserve account for the exclusive benefit of customers ("Customer Reserve Bank Account") and proprietary accounts of brokers ("PAB Reserve Account"). As of September 30, 2025, Axos Clearing was in compliance with its Customer Reserve Bank Account and PAB Reserve Account deposit requirements.

------

<u>[**Table of Contents**](#i7c17675c26f44bbd9ee68808b9f08846_7)</u>

**ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK**

For further discussion of the Company's market risk, see Item 7A—*"Quantitative and Qualitative Disclosures About Market Risk"* in the 2025 Form 10-K.

We measure interest rate sensitivity as the difference between amounts of interest-earning assets and interest-bearing liabilities that mature or contractually re-price within a given period of time. The difference, or the interest rate sensitivity gap, provides an indication of the extent to which an institution's interest rate spread will be affected by changes in interest rates. A gap is considered positive when the amount of interest rate sensitive assets exceeds the amount of interest rate sensitive liabilities and negative when the amount of interest rate sensitive liabilities exceeds the amount of interest rate sensitive assets.

Absent any subsequent asset and liability actions by management, in a rising interest rate environment, an institution with a positive gap would be in a better position than an institution with a negative gap to invest in higher yielding assets or to have its asset yields adjusted upward, which would cause the yield on its assets to increase at a faster pace than the cost of its interest-bearing liabilities. Conversely, absent any subsequent asset and liability actions by management, during a period of falling interest rates, an institution with a positive gap would tend to have its assets reprice at a faster rate than one with a negative gap, which would tend to reduce the growth in its net interest income.

**Banking Business Segment**

The following table sets forth the amounts of interest earning assets and interest bearing liabilities that were outstanding at September 30, 2025 and the portions of each financial instrument that are expected to mature or reset interest rates in each future period:

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| | **Term to Repricing, Repayment, or Maturity at** | **Term to Repricing, Repayment, or Maturity at** | **Term to Repricing, Repayment, or Maturity at** | **Term to Repricing, Repayment, or Maturity at** | **Term to Repricing, Repayment, or Maturity at** |
| | **September 30, 2025** | **September 30, 2025** | **September 30, 2025** | **September 30, 2025** | **September 30, 2025** |
|<br>***(Dollars in thousands)*** | **Six Months or Less** | **Over Six <br>Months Through <br>One Year** | **Over One<br>Year Through<br>Five Years** | **Over Five<br>Years** | **Total** |
| **Interest-earning assets:** | | | | | |
| Cash and cash equivalents | $2650451 | $— | $— | $— | $2650451 |
| Available-for-sale securities<sup>1</sup> | 31902 | 4650 | 16598 | 4648 | 57798 |
| Stock of the FHLB, at cost | 29737 |  |  |  | 29737 |
| Loans<sup>2</sup> | 15741279 | 2889959 | 3824109 | 179790 | 22635137 |
| Loans held for sale | 11566 |  |  |  | 11566 |
| &nbsp;&nbsp;Total interest-earning assets | 18464935 | 2894609 | 3840707 | 184438 | 25384689 |
| Non-interest-earning assets |  |  |  |  | 1151874 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total assets | $18464935 | $2894609 | $3840707 | $184438 | $26536563 |
| **Interest-bearing liabilities:** |  |  |  |  |  |
| Interest-bearing deposits<sup>3</sup> | $18725056 | $291277 | $177051 | $— | $19193384 |
| Advances from the FHLB |  |  | 60000 |  | 60000 |
| Secured financings | 116843 | 113297 | 530952 | 21331 | 782423 |
| &nbsp;&nbsp;Total interest-bearing liabilities | 18841899 | 404574 | 768003 | 21331 | 20035807 |
| Other non-interest-bearing liabilities |  |  |  |  | 3825056 |
| Stockholders' equity |  |  |  |  | 2675700 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total liabilities and equity | $18841899 | $404574 | $768003 | $21331 | $26536563 |
| Net interest rate sensitivity gap | $(376964) | $2490035 | $3072704 | $163107 | $5348882 |
| Cumulative gap | $(376964) | $2113071 | $5185775 | $5348882 | $5348882 |
| Net interest rate sensitivity gap—as a % of total interest earning assets | (1.49)% | 9.81% | 12.10% | 0.64% | 21.07% |
| Cumulative gap—as % of total cumulative interest earning assets | (1.49)% | 8.32% | 20.43% | 21.07% | 21.07% |

---

<sup>1</sup> *Comprised of U.S. government securities, mortgage-backed securities and other securities. The table reflects contractual repricing dates.*

<sup>2</sup> *Loans includes loan premiums, discounts and unearned fees. The table reflects either contractual repricing dates or expected maturities.*

<sup>3</sup> *The table assumes that the principal balances for demand deposits and savings accounts will reprice in the first year.*

The above table provides an approximation of the projected re-pricing of assets and liabilities at September 30, 2025 on the basis of contractual maturities, adjusted for anticipated prepayments of principal and scheduled rate adjustments. The loan and securities prepayment rates reflected herein are primarily based on modeled cash flows. For the non-maturity deposit liabilities, we use decay rates and rate adjustments based upon our historical experience and the implied forward rate curve, respectively. Actual repayments of these instruments could vary substantially if future experience differs from our historical experience.

------

<u>[**Table of Contents**](#i7c17675c26f44bbd9ee68808b9f08846_7)</u>

Although "gap" analysis is a useful measurement device available to management in determining the existence of interest rate exposure, its static focus as of a particular date makes it necessary to utilize other techniques in measuring exposure to changes in interest rates. For example, gap analysis is limited in its ability to predict trends in future earnings and makes no assumptions about changes in prepayment tendencies, deposit or loan maturity preferences or repricing time lags that may occur in response to a change in the interest rate environment.

The following table indicates the sensitivity of net interest income movements to parallel instantaneous shocks in interest rates for the future 1-12 months' and 13-24 months' time periods. For purposes of modeling net interest income sensitivity the Company assumes no growth in the balance sheet other than for retained earnings:

---

| | | |
|:---|:---|:---|
| | **As of September 30, 2025** | **As of September 30, 2025** |
| | **First 12 Months** | **Next 12 Months** |
|<br>***(Dollars in thousands)*** | **Percentage Change from Base** | **Percentage Change from Base** |
| Up 200 basis points | 6.7% | 12.5% |
| Up 100 basis points | 3.5% | 6.2% |
| Down 100 basis points | (1.7)% | (3.4)% |
| Down 200 basis points | (1.0)% | (3.9)% |

---

We attempt to measure the effect market interest rate changes will have on the net present value of assets and liabilities, which is defined as market value of equity. We analyze the MVE sensitivity to an immediate parallel and sustained shift in interest rates derived from the underlying interest rate curves.

The following table indicates the sensitivity of MVE to the interest rate movement described above:

---

| | |
|:---|:---|
|<br>***(Dollars in thousands)*** | **As of September 30, 2025**<br>**Percentage Change from Base** |
| Up 200 basis points | 4.7% |
| Up 100 basis points | 3.2% |
| Down 100 basis points | (3.9)% |
| Down 200 basis points | (7.7)% |

---

The computation of the prospective effects of hypothetical interest rate changes is based on numerous assumptions, including relative levels of interest rates, asset prepayments (including replacing floating rate loan run-off with loans having similar spread and floor features), runoffs in deposits and changes in repricing levels of deposits to general market rates, and should not be relied upon as indicative of actual results. Furthermore, these computations do not take into account any actions that we may undertake in response to future changes in interest rates. Those actions include, but are not limited to, making changes in loan and deposit interest rates and changes in our asset and liability mix.

**Securities Business Segment**

Our Securities Business Segment is exposed to market risk primarily due to its role as a financial intermediary in customer transactions, which may include purchases and sales of securities, securities lending activities, and in our trading activities, which are used to support sales, underwriting and other customer activities. We are subject to the risk of loss that may result from the potential change in value of a financial instrument as a result of fluctuations in interest rates, market prices, investor expectations and changes in credit ratings of the issuer.

Our Securities Business Segment is primarily exposed to interest rate risk as a result of generating interest-earning assets including customer and correspondent margin loans, and its securities borrowing activities. Our exposure to interest rate risk is also from our funding sources including customer and correspondent cash balances, bank borrowings and securities lending activities. Interest rates on customer and correspondent balances and securities produce a positive spread with rates generally fluctuating in parallel.

With respect to securities held, our interest rate risk is managed by setting and monitoring limits on the size and duration of positions and on the length of time securities can be held. The majority of the interest rates on customer and correspondent margin loans are generally indexed and can vary daily. Our funding sources are generally short term with interest rates that can vary daily.

Our Securities Business Segment is engaged in various brokerage and trading activities that expose us to credit risk arising from potential non-performance from counterparties, customers or issuers of securities. This risk is managed by setting

------

<u>[**Table of Contents**](#i7c17675c26f44bbd9ee68808b9f08846_7)</u>

and monitoring position limits for each counterparty, conducting periodic credit reviews of counterparties, reviewing concentrations of securities and conducting business through central clearing organizations.

Collateral underlying margin loans to customers and correspondents, and with respect to securities lending activities, is marked to market daily and additional collateral is obtained or refunded, as necessary.

**ITEM 4. CONTROLS AND PROCEDURES**

The Company's management, with the participation of its Chief Executive Officer and Chief Financial Officer, conducted an evaluation of the effectiveness of the design and operation of the Company's disclosure controls and procedures, pursuant to Exchange Act Rule 13a-15(e). Based upon that evaluation, our Chief Executive Officer along with our Chief Financial Officer concluded that, as of the end of the period covered by this report, the Company's disclosure controls and procedures were effective to ensure that information required to be disclosed by the Company in reports that it files or submits under the Exchange Act is recorded, processed, summarized and reported within the time periods specified by the Securities and Exchange Commission's rules and forms, and that such information is accumulated and communicated to our management, including our Chief Executive Officer and Chief Financial Officer, as appropriate, to allow timely decisions regarding required disclosure. In addition, there were no changes in the Company's internal control over financial reporting during the quarter ended September 30, 2025 (as defined in Exchange Act Rule 13a-15(f)) that have materially affected, or are reasonably likely to materially affect, internal control over financial reporting.

Management, including the Company's Chief Executive Officer and Chief Financial Officer, does not expect that the Company's internal controls will prevent or detect all errors and all fraud. A control system, no matter how well designed and operated, can provide only reasonable, not absolute, assurance that the objectives of the control system are met. Further, the design of a control system must reflect the fact that there are resource constraints, and the benefits of controls must be considered relative to their costs. Because of the inherent limitations in all control systems, no evaluation of internal controls can provide absolute assurance that all control issues and instances of fraud, if any, have been detected. Also, any evaluation of the effectiveness of controls in future periods is subject to the risk that those internal controls may become inadequate because of changes in business conditions, or that the degree of compliance with the policies or procedures may deteriorate.

------

<u>[**Table of Contents**](#i7c17675c26f44bbd9ee68808b9f08846_7)</u>

**PART II—OTHER INFORMATION**

**ITEM 1. LEGAL PROCEEDINGS**

The information set forth in Note 10*—*"*Commitments and Contingencies*" in the accompanying interim condensed consolidated financial statements is incorporated herein by reference.

In addition, from time to time we may be a party to other claims or litigation that arise in the ordinary course of business, such as claims to enforce liens, claims involving the origination and servicing of loans, and other issues related to the Company's business operations. None of such matters are expected to have a material adverse effect on the Company's financial condition, results of operations or business.

**ITEM 1A. RISK FACTORS**

We face a variety of risks that are inherent in our business and our industry. These risks are described in more detail under Item 1A—*"Risk Factors"* in the 2025 Form 10-K. We encourage you to read these factors in their entirety. Moreover, other factors may also exist that we cannot anticipate or that we currently do not consider to be significant based on information that is currently available.

**ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS** 

The table below sets forth our market repurchases of Axos common stock and the Axos common stock retained in connection with net settlement of RSU awards during the three months ended September 30, 2025.

---

| | | | | |
|:---|:---|:---|:---|:---|
| ***(Dollars in thousands, except per share data)*** | **Number<br>of Shares<br>Purchased** | **Average Price<br>Paid Per Shares** | **Total Number of<br>Shares<br>Purchased as Part of Publicly Announced<br>Plans or Programs** | **Approximate Dollar value of<br>Shares that May<br>Yet be Purchased<br>Under the Plans<br>or Programs** |
| **Stock Repurchases**<sup>1</sup> | | | | |
| ***Quarter Ended September 30, 2025*** | | | | |
| &nbsp;&nbsp;&nbsp;&nbsp;July 1, 2025 to July 31, 2025 |  | $— |  | $— |
| &nbsp;&nbsp;&nbsp;&nbsp;August 1, 2025 to August 31, 2025 |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;September 1, 2025 to September 30, 2025 |  |  |  |  |
| For the Three Months Ended September 30, 2025 |  | $— |  | $— |
| **Stock Retained in Net Settlement**<sup>2</sup> |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;July 1, 2025 to July 31, 2025 | 136 |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;August 1, 2025 to August 31, 2025 | 5706 |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;September 1, 2025 to September 30, 2025 | 88738 |  |  |  |
| For the Three Months Ended September 30, 2025 | 94580 |  |  |  |

---

<sup>1</sup> *On April 27, 2023, the Company announced a program to repurchase up to $100 million of its common stock and on each of February 12, 2024 and May 12, 2025, the Company announced an additional $100 million increase to the common stock repurchase program. The share repurchase program will continue in effect until terminated by the Board of Directors of the Company.*

<sup>2</sup> *The Amended and Restated 2014 Stock Incentive Plan permits net settlement of stock issuances related to equity awards for purposes of payment of a grantee's minimum income tax obligation. Stock retained in net settlement was purchased at the vesting price of associated RSU.*

**ITEM 3.&nbsp;&nbsp;&nbsp;&nbsp;DEFAULTS UPON SENIOR SECURITIES**

None.

**ITEM 4.&nbsp;&nbsp;&nbsp;&nbsp;MINE SAFETY DISCLOSURES**

Not applicable.

**ITEM 5.&nbsp;&nbsp;&nbsp;&nbsp;OTHER INFORMATION**

&nbsp;&nbsp;&nbsp;&nbsp;During the three months ended September 30, 2025, no director or officer of the Company adopted or terminated a "Rule 10b5-1 trading arrangement" or "non-Rule 10b5-1 trading arrangement," as each term is defined in Item 408(a) of Regulation S-K.

------

<u>[**Table of Contents**](#i7c17675c26f44bbd9ee68808b9f08846_7)</u>

**ITEM 6. EXHIBITS**

---

| | | |
|:---|:---|:---|
| Exhibit<br>Number | Description | Incorporated By Reference to |
| 4.1 | Indenture, dated as February 24, 2022, between Axos Financial, Inc. and U.S. Bank Trust Company, as trustee | <u>[Exhibit 4.1 to the Current Report on Form 8-K filed on February 24, 2022](https://www.sec.gov/Archives/edgar/data/1299709/000129970922000038/exh41baseindenture.htm)</u> |
| 4.2 | Second Supplemental Indenture, dated as of September 19, 2025, between Axos Financial, Inc. and U.S. Bank Trust Company, National Association, as trustee. | <u>[Exhibit 4.2 to the Current Report on Form 8-K filed on September 19, 2025](https://www.sec.gov/Archives/edgar/data/1299709/000129970925000162/ex42secondsupplemental.htm)</u> |
| 4.3 | Form of Global Note to represent the 7.00% Fixed-to-Floating Rate Subordinated Notes due 2035 of Axos Financial, Inc. | <u>[Exhibit 4.2 to the Current Report on Form 8-K filed on September 19, 2025](https://www.sec.gov/Archives/edgar/data/1299709/000129970925000162/ex42secondsupplemental.htm)</u> |
| 10.1 | Change of Control Severance Agreement between John Tolla and Axos Bank | <u>[F](ex101cicseveranceagreement.htm)[i](ex101cicseveranceagreement.htm)[led here](ex101cicseveranceagreement.htm)[with.](ex101cicseveranceagreement.htm)</u> |
| 31.1 | Chief Executive Officer Certification Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 | <u>[Filed herewith.](ex3112025093010-qexhibitq1.htm)</u> |
| 31.2 | Chief Financial Officer Certification Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 | <u>[Filed herewith.](ex3122025093010-qexhibitq1.htm)</u> |
| 32.1 | Chief Executive Officer Certification Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 | <u>[Filed herewith.](ex3212025093010-kexhibitq1.htm)</u> |
| 32.2 | Chief Financial Officer Certification Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 | <u>[Filed herewith.](ex3222025003010-qexhibitq1.htm)</u> |
| 101.INS | Inline XBRL Instance Document | The instance document does not appear in the interactive data file because its XBRL tags are embedded within the inline XBRL document. |
| 101.SCH | Inline XBRL Taxonomy Extension Schema Document | Filed herewith. |
| 101.CAL | Inline XBRL Taxonomy Calculation Linkbase Document | Filed herewith. |
| 101.LAB | Inline XBRL Taxonomy Label Linkbase Document | Filed herewith. |
| 101.PRE | Inline XBRL Taxonomy Presentation Linkbase Document | Filed herewith. |
| 101.DEF | Inline XBRL Taxonomy Definition Document | Filed herewith. |
| 104 | Cover Page Interactive Data File | Formatted as Inline XBRL and contained in Exhibit 101 |

---

------

<u>[**Table of Contents**](#i7c17675c26f44bbd9ee68808b9f08846_7)</u>

**SIGNATURES**

In accordance with the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

---

| | | | |
|:---|:---|:---|:---|
| | | | **Axos Financial, Inc.** |
| Dated: | October 30, 2025 | By:&nbsp;&nbsp;&nbsp;&nbsp; | /s/ Gregory Garrabrants |
|  |  |  | Gregory Garrabrants<br>President and Chief Executive Officer<br>(Principal Executive Officer) |
| Dated: | October 30, 2025 | By:&nbsp;&nbsp;&nbsp;&nbsp; | /s/ Derrick K. Walsh |
|  |  |  | Derrick K. Walsh<br>Executive Vice President and Chief Financial Officer<br>(Principal Financial Officer) |

---

## Exhibit 10.1

**BOFI Federal Bank**

**CHANGE OF CONTROL SEVERANCE AGREEMENT**

This Change of Control Severance Agreement (the "Agreement") is made and entered into by and between ("Executive") and BofI Federal Bank (the "Bank"), as of June 15, 2018 (the "Effective Date").

<u>RECITALS</u>

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1.It is expected that the Company from time to time will consider the possibility of an acquisition by another company or other change of control. The Compensation Committee of the Board of Directors of the Company (the "Committee") recognizes that such consideration can be a distraction to Executive and can cause Executive to consider alternative employment opportunities. The Committee has determined that it is in the best interests of the Company and its stockholders to assure that the Company will have the continued dedication and objectivity of Executive, notwithstanding the possibility, threat or occurrence of a Change of Control of the Company.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2.The Committee believes that it is in the best interests of the Company and its stockholders to provide Executive with an incentive to continue his or her employment and to motivate Executive to maximize the value of the Company upon a Change of Control for the benefit of its stockholders.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.The Committee believes that it is imperative to provide Executive with certain severance benefits upon Executive's termination of employment following a Change of Control. These benefits will provide Executive with enhanced financial security and incentive and encouragement to remain with the Company notwithstanding the possibility of a Change of Control.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4.Certain capitalized terms used in the Agreement are defined in Section 5 below.

<u>AGREEMENT</u>

NOW, THEREFORE, in consideration of the mutual covenants contained herein, the parties hereto agree as follows:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1.<u>Term of Agreement</u>. This Agreement will have an initial term commencing on the Effective Date and ending on June 15, 2020 (the "Initial Term"). Thereafter, this Agreement will renew automatically for an additional one (1) year term (the "Additional Term") unless either party provides the other party with written notice of non-renewal at least sixty (60) days prior to the date of automatic renewal. Notwithstanding the foregoing sentence, if a Change of Control occurs at any time during either the Initial Term or an Additional Term, the term of this Agreement will extend automatically through date that is twenty-four (24) months following the effective date of the Change of Control. If Executive becomes entitled to severance benefits under Section 3 during the term of this Agreement, the Agreement will not terminate until all of the obligations of the parties hereto with respect to this Agreement have been satisfied.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2. <u>At-Will Employment</u>. The Company and Executive acknowledge that Executive's employment is and will continue to be at-will, as defined under applicable law. If Executive's employment terminates for any reason, including (without limitation) any termination that occurs other than during the period that is on or within twenty-four (24) months after a Change of Control as provided herein, Executive will not be entitled to any payments, benefits, damages, awards or compensation other than as provided by this Agreement or by the BofI Holding, Inc., 2004 Stock Incentive Plan, as amended, and the BofI Holding, Inc. 2014 Stock Incentive Plan (collectively, the "Stock Plan"), and the payment of accrued but unpaid wages, as required by law, and any unreimbursed reimbursable expenses.

------

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.<u>Severance Benefits</u>.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)<u>Termination without Cause in Connection with a Change of Control</u>. If the Company terminates Executive's employment with the Company without Cause and such termination occurs during the period that is on or within twenty-four (24) months after a Change of Control, and Executive signs and does not revoke a mutually agreeable bi-lateral release, then Executive will receive the following from the Company:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i)<u>Accrued Compensation</u>. The Company will pay Executive all accrued but unpaid vacation, expense reimbursements, wages, and other benefits due to Executive under any Company-provided plans, policies, and arrangements, including but not limited to BofI Holding, Inc., 2004 Stock Incentive Plan, as amended, and the BofI Holding, Inc. 2014 Stock Incentive Plan (collectively, the "Stock Plan").

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii)<u>Severance Payment</u>. Executive will receive a lump sum severance payment (less applicable withholding taxes) equal to 150% of Executive's total compensation during the 12 months immediately prior to Executive's termination date or (if greater) effect immediately prior to the Change of Control.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iii)<u>Equity Awards</u>. Any outstanding unvested equity incentive awards shall become immediately and fully vested.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iv)<u>Continued Employee Benefits</u>. If Executive elects continuation coverage pursuant to the Consolidated Omnibus Budget Reconciliation Act of 1985, as amended ("COBRA") for Executive and Executive's eligible dependents, within the time period prescribed pursuant to COBRA, the Company will reimburse Executive for the COBRA premiums for such coverage (at the coverage levels in effect immediately prior to Executive's termination) until the earlier of (A) a period of twelve (12) months from the last date of employment of the Executive with the Company, or (B) the date upon which Executive and/or Executive's eligible dependents becomes covered under similar plans. COBRA reimbursements will be made by the Company to Executive consistent with the Company's normal expense reimbursement policy.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)<u>Timing of Severance Payments</u>. Unless otherwise required by Section 3(g), the Company will pay any severance payments in a lump sum as soon as practicable following Executive's termination date; provided, however, that no severance or other benefits will be paid or provided until the separation agreement and release of claims becomes effective, and any severance amounts or benefits otherwise payable between Executive's termination date and the date such release becomes effective will be paid on the effective date of such release. If Executive should die before all of the severance amounts have been paid, such unpaid amounts will be paid in a lump-sum payment promptly following such event to Executive's designated beneficiary, if living, or otherwise to the personal representative of Executive's estate.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)<u>Voluntary Resignation; Termination for Cause</u>. If Executive's employment with the Company terminates (i) voluntarily by Executive or (ii) for Cause by the Company, then Executive will not be entitled to receive severance or other benefits except for those (if any) as may then be established under the Company's then existing severance and benefits plans and practices or pursuant to other written agreements with the Company.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d)<u>Intentionally Omitted</u>

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(e)<u>Termination not in Connection with a Change of Control</u>. In the event Executive's employment is terminated for any reason other than as provided in Section 3(a) then Executive will be entitled only to the benefits provided by BofI Holding, Inc., 2004 Stock Incentive Plan, as amended, and

------

the BofI Holding, Inc. 2014 Stock Incentive Plan (collectively, the "Stock Plan") and to any severance as may be provided in the sole discretion of the Chief Executive Officer of the Company.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(f)<u>Exclusive Remedy</u>. In the event of a termination of Executive's employment as set forth in Section 3(a), the provisions of Section 3 are intended to be and are exclusive and in lieu of any other rights or remedies to which Executive or the Company may otherwise be entitled, whether at law, tort or contract, in equity, or under this Agreement (other than the payment of accrued but unpaid wages, as required by law, and any unreimbursed reimbursable expenses). If Executive is terminated consistent with Section 3(a) hereof, Executive shall not be entitled to benefits, compensation or other payments or rights upon termination of employment for the Company's convenience other than those benefits expressly set forth in this Section 3. In consideration of the Company's promises in this Agreement, to the fullest extent permitted by applicable law, Executive hereby waives any other rights or remedies against the Company, its affiliates and subsidiaries, and their respective officers, directors and employees (collectively, the "BofI Parties"). In consideration of the Company's promises in this Agreement, to the fullest extent permitted by applicable law, Executive waives and releases any claims or potential claims against the BofI Parties existing as of Executive's execution and delivery of this Agreement, including, without limitation, (i) any claim, existing as of Executive's execution and delivery of this Agreement, in relation to this Agreement or the negotiation and execution hereof and (ii) any claim, in existence as of the date of Executive's execution and delivery of this Agreement, not known to the Executive upon execution and delivery of this Agreement (**it being understood that this provision includes a waiver of the provisions of California Civil Code Section 1542 regarding a release of unknown claims**). For the avoidance of doubt, this Section 3(f) shall not be construed to limit any applicable right of indemnification from the Company to which Executive may be entitled for good faith actions taken in the course and scope of Executive's employment for the Company; however, this Agreement does not create any right of indemnification from the Company.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(g)<u>Section 409A</u>.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i)Notwithstanding anything to the contrary in this Agreement, if Executive is a "specified employee" within the meaning of Section 409A of the Code and the final regulations and any guidance promulgated thereunder ("Section 409A") at the time of Executive's termination (other than due to death), and the severance payable to Executive, if any, pursuant to this Agreement, when considered together with any other severance payments or separation benefits that are considered deferred compensation under Section 409A (together, the "Deferred Compensation Separation Benefits") that are payable within the first six (6) months following Executive's termination of employment, will become payable on the first payroll date that occurs on or after the date six (6) months and one (1) day following the date of Executive's termination of employment. All subsequent Deferred Compensation Separation Benefits, if any, will be payable in accordance with the payment schedule applicable to each payment or benefit. Notwithstanding anything herein to the contrary, if Executive dies following his termination but prior to the six (6) month anniversary of his termination, then any payments delayed in accordance with this paragraph will be payable in a lump sum as soon as administratively practicable after the date of Executive's death and all other Deferred Compensation Separation Benefits will be payable in accordance with the payment schedule applicable to each payment or benefit. Each payment and benefit payable under this Agreement is intended to constitute separate payments for purposes of Section 1.409A-2(b)(2) of the Treasury Regulations.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii)Any amount paid under the Agreement that satisfies the requirements of the "short-term deferral" rule set forth in Section 1.409A-1(b)(4) of the Treasury Regulations shall not constitute Deferred Compensation Separation Benefits for purposes of clause (i) above.

------

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iii)Amount paid under the Agreement that qualifies as a payment made as a result of an involuntary separation from service pursuant to Section 1.409A-1(b)(9)(iii) of the Treasury Regulations that do not exceed the Section 409A Limit shall not constitute Deferred Compensation Separation Benefits for purposes of clause (i) above.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iv)The foregoing provisions are intended to comply with the requirements of Section 409A so that none of the severance payments and benefits to be provided hereunder will be subject to the additional tax imposed under Section 409A, and any ambiguities herein will be interpreted to so comply. The Company and Executive agree to work together in good faith to consider amendments to this Agreement and to take such reasonable actions which are necessary, appropriate or desirable to avoid imposition of any additional tax or income recognition prior to actual payment to Executive under Section 409A.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4.<u>Limitation on Payments</u>. In the event that the severance and other benefits provided for in this Agreement or otherwise payable to Executive (i) constitute "parachute payments" within the meaning of Section 280G of the Code, and (ii) but for this Section 4, would be subject to the excise tax imposed by Section 4999 of the Code, then Executive's severance benefits under Section 3(a) will be either:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)delivered in full, or

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)delivered as to such lesser extent which would result in no portion of such severance benefits being subject to excise tax under Section 4999 of the Code,

whichever of the foregoing amounts, taking into account the applicable federal, state and local income taxes and the excise tax imposed by Section 4999, results in the receipt by Executive on an after-tax basis, of the greatest amount of severance benefits, notwithstanding that all or some portion of such severance benefits may be taxable under Section 4999 of the Code. Unless the Company and Executive otherwise agree in writing, any determination required under this Section 4 will be made in writing by the Company's independent public accountants immediately prior to a Change of Control or such other person or entity to which the parties mutually agree (the "Accountants"), whose determination will be conclusive and binding upon Executive and the Company for all purposes. For purposes of making the calculations required by this Section 4, the Accountants may make reasonable assumptions and approximations concerning applicable taxes and may rely on reasonable, good faith interpretations concerning the application of Sections 280G and 4999 of the Code. The Company and Executive will furnish to the Accountants such information and documents as the Accountants may reasonably request in order to make a determination under this Section. The Company will bear all costs the Accountants may incur in connection with any calculations contemplated by this Section 4.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5.<u>Definition of Terms</u>. The following terms referred to in this Agreement will have the following meanings:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)<u>Cause</u>. "Cause" will mean:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i)Executive's continued intentional and demonstrable failure to perform his or her duties customarily associated with Executive's position as an employee of the Company or its respective successors or assigns, as applicable (other than any such failure resulting from Executive's mental or physical Disability) after Executive has received a written demand of performance from the Company with specifically sets forth the factual basis for the Company's belief that Executive has not devoted sufficient time and effort to the performance of his or her duties and has failed to cure such non- performance within thirty (30) days after receiving such notice (it being understood that if Executive is in good-faith performing his or her duties, but is not achieving results the Company deems satisfactory for Executive's position, it will not be considered to be grounds for termination of Executive for "Cause");

------

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii)Executive's conviction of, or plea of nolo contendere to, a felony that the Board of Directors of the Company (the "Board") reasonably believes has had or will have a material detrimental effect on the Company's reputation or business; or

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iii)Executive's commission of an act of fraud, embezzlement, misappropriation, willful misconduct, or breach of fiduciary duty against, and causing material harm to, the Company or its respective successors or assigns, as applicable.

If and only if Executive is terminated as provided in Section 3(a) hereof, Executive will receive notice and an opportunity to be heard before the Board with Executive's own attorney before any termination for Cause is deemed effective. Notwithstanding anything to the contrary, the Board may immediately place Executive on administrative leave (with full pay and benefits to the extent legally permissible) but will allow reasonable access to Company information, employees and business should Executive wish to avail himself and prepare for his or her opportunity to be heard before the Board prior to the Board's termination for Cause. If Executive avails himself of his or her opportunity to be heard before the Board, and then fails to make himself or herself available to the Board within thirty (30) days of such request to be heard, the Board may thereafter cancel the administrative leave and terminate Executive for Cause. Likewise, if the Board fails to make itself available to Executive and his or her counsel within thirty (30) days of Executive's request to be heard, Executive will be entitled to terminate his or her employment with the Company and such termination will be treated as a resignation by Executive for Good Reason.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)<u>Change of Control</u>. "Change of Control" will mean the occurrence of any of the

following events:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i)<u>Change in Ownership of the Company</u>. A change in the ownership of the

Company which occurs on the date that any one person, or more than one person acting as a group ("Person"), acquires ownership of the stock of the Company that, together with the stock held by such Person, constitutes more than 50% of the total voting power of the stock of the Company, except that any change in the ownership of the stock of the Company as a result of a private financing of the Company that is approved by the Board will not be considered a Change of Control; or

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii)<u>Change in Effective Control of the Company</u>. A change in the effective control of the Company which occurs (a) on the date that a majority of members of the Board is replaced during any twelve (12) month period by Directors whose appointment or election is not endorsed by a majority of the members of the Board prior to the date of the appointment or election or (b) on the date that the Chief Executive Office of the Bank as of the date of this Agreement ceases to be the chief executive officer of the Bank.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iii)<u>Change in Ownership of a Substantial Portion of the Company's Assets</u>. A change in the ownership of a substantial portion of the Company's assets which occurs on the date that any Person acquires (or has acquired during the twelve (12) month period ending on the date of the most recent acquisition by such person or persons) assets from the Company that have a total gross fair market value equal to or more than 50% of the total gross fair market value of all of the assets of the Company immediately prior to such acquisition or acquisitions. For purposes of this subsection (iii), gross fair market value means the value of the assets of the Company, or the value of the assets being disposed of, determined without regard to any liabilities associated with such assets.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)<u>Intentionally Omitted</u>

------

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d)<u>Section 409A Limit</u>. "Section 409A Limit" will mean the lesser of two (2) times: (i) Executive's annualized compensation based upon the annual rate of pay paid to Executive during the Executive's taxable year preceding the Executive's taxable year of Executive's termination of employment as determined under, and with such adjustments as are set forth in, Treasury Regulation 1.409A- 1(b)(9)(iii)(A)(1) and any Internal Revenue Service guidance issued with respect thereto; or (ii) the maximum amount that may be taken into account under a qualified plan pursuant to Section 401(a)(17) of the Code for the year in which Executive's employment is terminated.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;6.<u>Successors</u>.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)<u>The Company's Successors</u>. Any successor to the Company (whether direct or indirect and whether by purchase, merger, consolidation, liquidation or otherwise) or to all or substantially all of the Company's business and/or assets will assume the obligations under this Agreement and agree expressly to perform the obligations under this Agreement in the same manner and to the same extent as the Company would be required to perform such obligations in the absence of a succession. For all purposes under this Agreement, the term "Company" will include any successor to the Company's business and/or assets which executes and delivers the assumption agreement described in this Section 6(a) or which becomes bound by the terms of this Agreement by operation of law.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)<u>Executive's Successors</u>. The terms of this Agreement and all rights of Executive hereunder will inure to the benefit of, and be enforceable by, Executive's personal or legal representatives, executors, administrators, successors, heirs, distributees, devisees and legatees.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;7.<u>Arbitration</u>.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)The Company and Executive each agree that any and all disputes arising out of the terms of this Agreement, Executive's employment by the Company, Executive's service as an officer or director of the Company, or Executive's compensation and benefits, their interpretation and any of the matters herein released, will be subject to binding arbitration under the arbitration rules set forth in California Code of Civil Procedure Sections 1280 through 1294.2, including Section 1281.8 (the "Act"), and pursuant to California law. Disputes that the Company and Executive agree to arbitrate, and thereby agree to waive any right to a trial by jury, include any statutory claims under local, state, or federal law, including, but not limited to, claims under Title VII of the Civil Rights Act of 1964, the Americans with Disabilities Act of 1990, the Age Discrimination in Employment Act of 1967, the Older Workers Benefit Protection Act, the Sarbanes-Oxley Act, the Worker Adjustment and Retraining Notification Act, the California Fair Employment and Housing Act, the Family and Medical Leave Act, the California Family Rights Act, the California Labor Code, claims of harassment, discrimination, and wrongful termination, and any statutory or common law claims. The Company and Executive further understand that this Agreement to arbitrate also applies to any disputes that the Company may have with Executive.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)<u>Procedure</u>. The Company and Executive agree that any arbitration will be administered by Judicial Arbitration & Mediation Services, Inc. ("JAMS"), pursuant to its Employment Arbitration Rules & Procedures (the "JAMS Rules"). The Arbitrator will have the power to decide any motions brought by any party to the arbitration, including motions for summary judgment and/or adjudication, motions to dismiss and demurrers, and motions for class certification, prior to any arbitration hearing. The Arbitrator will have the power to award any remedies available under applicable law, and the Arbitrator will award attorneys' fees and costs to the prevailing party, except as prohibited by law. The Company will pay for any administrative or hearing fees charged by the Arbitrator or JAMS except that Executive will pay any filing fees associated with any arbitration that Executive initiates, but only so much of the filing fees as Executive would have instead paid had he or she filed a complaint in a court of law. The Arbitrator will administer and conduct any arbitration in accordance with California law, including the California Code of Civil Procedure, and the Arbitrator will apply substantive and

------

procedural California law to any dispute or claim, without reference to rules of conflict of law. To the extent that the JAMS Rules conflict with California law, California law will take precedence. The decision of the Arbitrator will be in writing. Any arbitration under this Agreement will be conducted in Santa Clara County, California.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)<u>Remedy</u>. Except as provided by the Act and this Agreement, arbitration will be the sole, exclusive, and final remedy for any dispute between Executive and the Company. Accordingly, except as provided for by the Act and this Agreement, neither Executive nor the Company will be permitted to pursue court action regarding claims that are subject to arbitration.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d)<u>Administrative Relief</u>. Executive understand that this Agreement does not prohibit him or her from pursuing any administrative claim with a local, state, or federal administrative body or government agency that is authorized to enforce or administer laws related to employment, including, but not limited to, the Department of Fair Employment and Housing, the Equal Employment Opportunity Commission, the National Labor Relations Board, or the Workers' Compensation Board. This Agreement does, however, preclude Executive from pursuing court action regarding any such claim, except as permitted by law.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(e)<u>Voluntary Nature of Agreement</u>. Each of the Company and Executive acknowledges and agrees that such party is executing this Agreement voluntarily and without any duress or undue influence by anyone. Executive further acknowledges and agrees that he or she has carefully read this Agreement and has asked any questions needed for him or her to understand the terms, consequences, and binding effect of this Agreement and fully understand it, including that ***Executive is waiving his or her right to a jury trial***. Finally, Executive agrees that he or she has been provided an opportunity to seek the advice of an attorney of his or her choice before signing this Agreement.

-

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;8.<u>Notice</u>.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)<u>General</u>. Notices and all other communications contemplated by this Agreement will be in writing and will be deemed to have been duly given when personally delivered or when mailed by

U.S. registered or certified mail, return receipt requested and postage prepaid. In the case of Executive, mailed notices will be addressed to him or her at the home address which he or she most recently communicated to the Company in writing. In the case of the Company, mailed notices will be addressed to its corporate headquarters, and all notices will be directed to the attention of its President.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)<u>Notice of Termination</u>. Any termination by the Company for Cause or by Executive for Good Reason will be communicated by a notice of termination to the other party hereto given in accordance with Section 8(a) of this Agreement. Such notice will indicate the specific termination provision in this Agreement relied upon, will set forth in reasonable detail the facts and circumstances claimed to provide a basis for termination under the provision so indicated, and will specify the termination date (which will be not more than thirty (30) days after the giving of such notice). The failure by Executive to include in the notice any fact or circumstance which contributes to a showing of Good Reason will not waive any right of Executive hereunder or preclude Executive from asserting such fact or circumstance in enforcing his or her rights hereunder.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;9.<u>Miscellaneous Provisions</u>.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)<u>No Duty to Mitigate</u>. Executive will not be required to mitigate the amount of any payment contemplated by this Agreement, nor will any such payment be reduced by any earnings that Executive may receive from any other source.

------

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)<u>Other Requirements</u>. Executive's receipt of any payments or benefits under Section 3 will be subject to Executive continuing to comply with the terms of any confidential information agreement executed by Executive in favor of the Company and the provisions of this Agreement.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)<u>Waiver</u>. No provision of this Agreement will be modified, waived or discharged unless the modification, waiver or discharge is agreed to in writing and signed by Executive and by an authorized officer of the Company (other than Executive). No waiver by either party of any breach of, or of compliance with, any condition or provision of this Agreement by the other party will be considered a waiver of any other condition or provision or of the same condition or provision at another time.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d)<u>Headings</u>. All captions and section headings used in this Agreement are for convenient reference only and do not form a part of this Agreement.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(e)<u>Entire Agreement</u>. This Agreement constitutes the entire agreement of the parties hereto and supersedes in their entirety all prior representations, understandings, undertakings or agreements (whether oral or written and whether expressed or implied) of the parties with respect to the subject matter hereof, including, without limitation, the Addendum to Stock Option Agreement applicable to any stock option award of Executive. For the avoidance of doubt, this Agreement shall not be deemed to supersede or affect any benefit entitlements vested as of the date of the Executive's termination of employment pursuant to written terms of any Company employee benefit plan, including without limitation the Company's Executive Retiree Medical Plan. No waiver, alteration, or modification of any of the provisions of this Agreement will be binding unless in writing and signed by duly authorized representatives of the parties hereto and which specifically mention this Agreement.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(f)<u>Choice of Law</u>. The validity, interpretation, construction and performance of this Agreement will be governed by the laws of the State of California (with the exception of its conflict of laws provisions). Any claims or legal actions by one party against the other arising out of the relationship between the parties contemplated herein (whether or not arising under this Agreement) will be commenced or maintained in any state or federal court located in the jurisdiction where Executive resides, and Executive and the Company hereby submit to the jurisdiction and venue of any such court.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(g)<u>Severability</u>. The invalidity or unenforceability of any provision or provisions of this Agreement will not affect the validity or enforceability of any other provision hereof, which will remain in full force and effect.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(h)<u>Withholding</u>. All payments made pursuant to this Agreement will be subject to withholding of applicable income, employment and other taxes.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i)<u>Counterparts</u>. This Agreement may be executed in counterparts, each of which will be deemed an original, but all of which together will constitute one and the same instrument.

Intentionally Blank – Signatures on Following Page

------

IN WITNESS WHEREOF, each of the parties has executed this Agreement, in the case of the Company by its duly authorized officer, as of the day and year set forth below.

---

| | |
|:---|:---|
| COMPANY | BofI Federal Bank |
|  | By: /s/Gregory Garrabrants |
|  | Title: Chief Executive Officer |
|  | Date: October 18, 2018 |
| EXECUTIVE | By: /s/ John Tolla |
|  | Title: EVP Chief GRC Officer |
|  | Date: October 17, 2018 |

---

## Exhibit 31.1

**Exhibit 31.1**

**CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER**

**PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002**

I, Gregory Garrabrants, certify that:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1.I have reviewed this Quarterly Report on Form 10-Q of Axos Financial, Inc.;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4.The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d -15(f)) for the registrant and have:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a.Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;b.Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;c.Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;d.Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5. &nbsp;&nbsp;&nbsp;&nbsp;The registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of registrant's board of directors (or persons performing the equivalent functions):

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a.All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;b.Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal controls over financial reporting.

---

| | | |
|:---|:---|:---|
| Dated: | October 30, 2025 | /s/ GREGORY GARRABRANTS |
| | | GREGORY GARRABRANTS <br>*President and Chief Executive Officer (Principal Executive Officer)* |

---

## Exhibit 31.2

**Exhibit 31.2**

**CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER**

**PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002**

I, Derrick K. Walsh, certify that:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1.I have reviewed this Quarterly Report on Form 10-Q of Axos Financial, Inc.;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4.The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d -15(f)) for the registrant and have:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a.Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;b.Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;c.Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;d.Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5. &nbsp;&nbsp;&nbsp;&nbsp;The registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of registrant's board of directors (or persons performing the equivalent functions):

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a.All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;b.Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal controls over financial reporting.

---

| | | |
|:---|:---|:---|
| Dated: | October 30, 2025 | /s/ DERRICK K. WALSH |
| | | DERRICK K. WALSH<br>*Executive Vice President and Chief Financial Officer (Principal Financial Officer)* |

---

## Exhibit 32.1

**Exhibit 32.1**

**CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER**

**PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO**

**SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002**

In connection with the Quarterly Report of Axos Financial, Inc. (the "Company") on Form 10-Q for the period ended September 30, 2025 (the "Report"), as filed with the Securities and Exchange Commission on the date hereof, I, Gregory Garrabrants, hereby certify in my capacity as President and Chief Executive Officer of the Company, pursuant to 18 U.S.C. section 1350, as adopted pursuant to section 906 of the Sarbanes-Oxley Act of 2002, that:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a)the Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;b)the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company as of the dates and for the periods presented in the financial statements included in such Report.

---

| | | |
|:---|:---|:---|
| Dated: | October 30, 2025 | /s/ GREGORY GARRABRANTS |
| | | GREGORY GARRABRANTS <br>*President and Chief Executive Officer (Principal Executive Officer)* |

---

## Exhibit 32.2

**Exhibit 32.2**

**CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER**

**PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO**

**SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002**

In connection with the Quarterly l Report of Axos Financial, Inc. (the "Company") on Form 10-Q for the period ended September 30, 2025 (the "Report"), as filed with the Securities and Exchange Commission on the date hereof, I, Derrick K. Walsh, hereby certify in my capacity as Executive Vice President and Chief Financial Officer of the Company, pursuant to 18 U.S.C. section 1350, as adopted pursuant to section 906 of the Sarbanes-Oxley Act of 2002 that:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a)the Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;b)the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company as of the dates and for the periods presented in the financial statements included in such Report.

---

| | | |
|:---|:---|:---|
| Dated: | October 30, 2025 | /s/ DERRICK K. WALSH |
| | | DERRICK K. WALSH <br>*Executive Vice President and Chief Financial Officer (Principal Financial Officer)* |

---

<br>